Quarterlytics / Industrials / Industrial - Pollution & Treatment Controls / Inspecs Group PLC

Inspecs Group PLC

spec · LSE Industrials
Claim this profile
Ticker spec
Exchange LSE
Sector Industrials
Industry Industrial - Pollution & Treatment Controls
Employees 1001-5000
← All annual reports
FY2020 Annual Report · Inspecs Group PLC
Sign in to download
Loading PDF…
I

N

S

P

E

C

S

G

r

o

u

p

p

l

c

A

n

n

u

a

l

R

e

p

o

r

t

&

A

c

c

o

u

n

t

s

2

0

2

0

LEADER IN 
EYEWEAR 
SOLUTIONS

ANNUAL REPORT & ACCOUNTS 2020

 
 
 
 
 
 
WELCOME 
TO OUR 
2020 
ANNUAL 
REPORT

INSPECS is a global provider of solutions to  
the eyewear market from the largest optical 
chains to individual consumers.

INSPECS has been transformed by two 
acquisitions. The extended group has a robust 
and resilient global platform for future growth.

Superdry Optical SS21

www.inspecs.com

> Strategic Report

FINANCIAL PERFORMANCE

REVENUE

UNDERLYING EBITDA

GROSS MARGIN

$47.4m

2020
2019

$47.42m

$61.25m

H1 2020
H2 2020

$16.73m

$30.69m

$4.5m

$4.51m

2020
2019

H1 2020
H2 2020

$0.68m

$3.83m

$20.5m

$12.99m

2020
2019

$20.52m

$27.54m

H1 2020
H2 2020

$7.44m

$13.08m

PROFIT & LOSS AFTER TAX

DILUTED EPS

FRAMES MANUFACTURED

$(8.9)m

$(0.13)c

2.9m 

$(8.91)m

2020
2019

$6.44m

$(0.13)c

2020
2019

$0.11c

2020
2019

2.91m

4.55m

$(7.49)m

$(1.42)m

H1 2020
H2 2020

H1 2020
H2 2020

1.04m

1.87m

OPERATIONAL HIGHLIGHTS

NORVILLE
Acquisition of Norville giving further vertical 
integration and access to the lens market.

MANUFACTURING CAPACITY

8.5m+

2020
2019

5.0m

8.5m+

7 NEW HOUSE-BRANDS ADDED
• Titanflex
• Humphrey’s
• TURA
• BOTANIQ™

• Jos. Eschenbach
• Freigeist
• Brendel

FIRST SUSTAINABLE EYEWEAR DESIGNED 
AND PRODUCED BY THE GROUP
• BOTANIQ™
• O’Neill-Wove

ESCHENBACH
Acquisition of Eschenbach giving a strong 
platform to the independent retail market in 
Europe and the USA.

12 NEW BRANDED LICENCES ADDED
• Ted Baker
• Marc O’Polo
• Mini
• Geoffrey Beene
• L.A.M.B.
• Buffalo

• GX
• Zuma Rock
• Lulu Guinness
• Talbot Runhof
• Roald Dahl
• Free Country

CONTENTS

STRATEGIC REPORT
Group Overview 
Chairman’s Statement 
Chief Executive Officer’s Review 
Our Business Model 
Market Overview 
Chief Financial Officer’s Review 
Key Performance Indicators 
Sustainability 
Section 172 Statement 
Principal Risks and Uncertainties 

GOVERNANCE REPORT
Corporate Governance Statement 
Board of Directors 
Key Management 
Audit and Risk Committee Report 
Remuneration and Nomination 
Committee Report 
Directors’ Report 
Statement of Directors’ Responsibilities 

42
46
48
50

52
54
57

04
08
10
14
23
24
27
28
36
38

60
70

FINANCIAL STATEMENTS
Independent Auditor’s Report to  
the Members of INSPECS Group plc 
Consolidated Income Statement  
Consolidated Statement of  
Comprehensive Income 
71
Consolidated Statement of Financial Position  72
Consolidated Statement of Changes in Equity  74
75
Consolidated Statement of Cash Flows 
Notes to the Consolidated Financial  
Statements 
Parent Company Financial Statements 
Appendix 1 – Reconciliation  
of underlying EBITDA 
Company Information and Advisers 

127
128

76
118

1

> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020BOTANIQ Optical 
SS21 Campaign

2

STRATEGIC

REPORT

Group Overview 
Chairman’s Statement 
Chief Executive Officer’s Review 
Our Business Model 
Market Overview 
Chief Financial Officer’s Review 
Key Performance Indicators 
Sustainability 
Section 172 Statement 
Principal Risks and Uncertainties 

04
08
10
14
23
24
27
28
36
38

3

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020 
Group Overview

BUILDING  
A PLATFORM 
FOR FUTURE 
GROWTH

INSPECS is a truly global company.  
Following our IPO on 27 February 2020,  
the acquisitions of Norville and Eschenbach 
Group have created a well-balanced 
vertically integrated business serving the 
global retail chains and the independent 
optical market. The enlarged INSPECS 
Group now has a worldwide distribution 
network serving over 70,000 retail outlets 
giving further growth opportunities.

As a result the enlarged group now has:

•  Resilient and diverse channel distribution of eyewear 
products in over 80 countries, with 14 sales offices 
and a 270-strong sales team.

•  A risk-managed customer base with not more than 

7% of group revenue estimated for 2021 attributed to 
any one customer.

•  Industry benchmark manufacturing, from frames to 

lenses including complete frames and lens packages 
and low vision optical products.

•  Price points and brands for all market opportunities, 

from private label to premium.

•  Award-winning design and marketing team based in 
the UK, the USA, Portugal, Hong Kong and Germany.

GLOBAL TEAM1,800

Our balanced customer profile includes many of the 
largest chain retailers in the world, with whom new long-
term strategic partnerships have been formed, including 
the supply of private label and premium brands.

By integrating the product offer across our companies, 
INSPECS Group can target new markets and maximise 
existing ones. With Eschenbach, the group has acquired 
a global sales force able to deliver to a large network 
of independent opticians principally in the USA and 
Europe which was largely untapped prior to acquisition. 
The acquisition of Norville completes part of the vertical 
integration and enhances our complete frame and lens 
offering to the market.

A global team of designers, marketers, sales and in-
house manufacturing bring together a powerful mix of 
capabilities that can help achieve the company’s future 
goals including, vertically integrated and environmentally 
sensitive production, sales and global distribution. 
INSPECS Group plc is now well positioned to be a 
leading name in eyewear solutions to customers globally.

From this robust platform, the group is already realising 
plans to take market share in the globally expanding 
eyewear market.

4

GLOBAL DISTRIBUTION

RESILIENT AND DIVERSE CHANNEL DISTRIBUTION  
OF EYEWEAR PRODUCTS IN OVER

COUNTRIES80

SALES OFFICES14

DESIGN, BRANDS, 
MARKETING,  
DISTRIBUTION (UK)

AWARD-WINNING 
DESIGN AND 
MARKETING TEAM 
BASED IN UK, USA, 
LISBON, HONG KONG, 
NEW YORK AND 
GERMANY.

PRICE POINTS 
AND BRANDS 
FOR ALL MARKET 
OPPORTUNITIES,  
FROM PRIVATE LABEL  
TO PREMIUM.

270

STRONG SALES TEAM

FRAME MANUFACTURE

INDUSTRY BENCHMARK 
MANUFACTURING, FROM 
FRAMES TO LENSES 
INCLUDING COMPLETE 
FRAMES AND LENS 
PACKAGES.

LENS MANUFACTURE

OUR GEOGRAPHICAL FOOTPRINT

Scandinavia Sales
Poland Sales
Czech Republic Sales
Germany Nuremburg 
Logistics, Sales & Distribution

Holland Sales

Birmingham, UK International  
Eyewear – Sales, Design & Distribution

Bath, UK Global HQ Production Design, 
Operations, Logistics, Sales, Finance, HR

France Sales
Spain Sales

New York USA  
Logistics, Sales & Distribution

Florida USA Office 
Logistics, Sales & Distribution

Lisbon, Portugal  
Design & Customer Service

Switzerland Sales

Cadore, Italy  
Manufacturing 

Austria Sales

A RISK-MANAGED 
CUSTOMER BASE 
WITH NOT MORE  
THAN

7%

OF EXPECTED GROUP 
2021 REVENUE 
ATTRIBUTED TO ANY 
ONE CUSTOMER

Above: 
Killine factory 
technician preparing 
frame hinges.

Below: 
Sunglass lenses 
colouration process.

Zhongshan Torkai Optical 
Production & Engineering

Shenzhen China 
Quality Control

Wenzhou Zouyou,  
China Production

Japan Sales

Hong Kong 
Logistics & Design

Macau China 
Administration & Sales

Vietnam Neo Optical 
Production, Logistics

5

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020 
 
Group Overview 
continued

LOOKING 

FORWARD

We are among the top eyewear companies 
in the world, providing a complete eyewear 
solution to the market. 

This journey began to accelerate in early 2017 with the 
first part of our vertical integration strategy. Acquiring our 
own manufacturing base has transformed the group from 
an intermediary (subcontract) supplier using third party 
manufacturers of branded eyewear to a self-sufficient supplier  
of both branded and private label products with a fully 
transparent supply chain. 

Since IPO in February 2020, INSPECS has continued its vertical 
integration, adding lens manufacturing capability through the 
acquisition of Norville and widening its sales distribution in 
Europe and the USA with the acquisition of Eschenbach.

Our management teams are now utilising the complete vertically 
integrated platform to further develop opportunities for the group 
in both existing and innovative products to enhance distribution to 
existing and new customers. In addition the group will also:

•  Continue to expand production capacity of our current Vietnam 

manufacturing sites to over 7m frames per annum.

•  Expand manufacturing plant capacity in Europe.

•  Grow the B2B website, launched in 2020, where independent 
opticians can shop online 24/7. As an example, 63% of our 
independent customers in the UK are already registered, with 
43% of UK independent orders now taking place without the 
need for physical sales visits. 

•  Develop the direct-to-consumer market opportunity in the 

premium end of the market, with a convenient frame-plus-lens 
package utilising the capabilities of the new group.

•  Continue to make strategic acquisitions that can be beneficial 
utilising the enlarged group’s distribution and manufacturing 
capabilities.

•  Expand our range of frame and lens packages for our customers.

•  Continue the development of our low vision products for 

the market.

24/7 ONLINE SHOP

63%

INDEPENDENT CUSTOMERS 
IN THE UK ARE ALREADY 
REGISTERED

6

 
PRESCRIPTION EYEWEAR
Ophthalmic frames produced 
under world-famous brand names 
and private labels for some of the 
biggest optical retailers in the world.

SUNGLASSES
Award-winning eyewear designs 
for licence and in-house brands, 
supplying high quality sunglasses 
from the catwalk to the high street.

SAFETY EYEWEAR
A full PPE eyewear offer under the 
Caterpillar brand.

AN ENHANCED PRODUCT OFFER
Our expanded INSPECS Group brand portfolio is more desirable 
than ever. The acquisition of Eschenbach added over 11 brands 
to our offer. New, relevant products and brands for the future 
are already in development. The group’s design teams in the 
UK, USA, Germany, Portugal and Hong Kong are working in 
collaboration, targeting regional and global sales opportunities in 
both the chain and independent markets.

Creating environmentally sustainable products will form part of 
our future growth. Highlights include our new brand BOTANIQ™, 
sustainable eyewear thoughtfully designed and made in-house 
and our award-winning O’Neill ‘Wove’ frame made from recycled 
and recyclable materials.

We are especially proud to have contributed to the national and 
global COVID effort with our work on special PPE eyewear for the 
NHS and other health providers around the globe. 

Guided by a strong and experienced management team, our 
global team of 1,800 people gives INSPECS Group a powerful 
springboard for future growth.

OUTLOOK
Looking forward, the group is well-positioned in the global 
eyewear marketplace, strengthening its reputation for quality, 
design and delivery. 

The group has had a successful start to 2021, with sales of $67m 
in the first quarter. The group continues to win new customers 
and in particular the new Vietnam facility is now completed and 
operational. Our order books at the time of this report are higher 
than at the same time in 2020 on a like-for-like basis.

We are pleased to report that Eschenbach has performed well 
since its acquisition on 16 December 2020 and trading has been 
positive in the first five months of the year.

Whilst COVID-19 will continue to cause disruption, all our 
employees across the world have adapted successfully and 
performed well in difficult circumstances. From this robust and 
resilient position the group can continue to deliver in the coming 
years for all stakeholders.

Robin Totterman 
Chief Executive Officer

Christopher Kay 
Chief Financial Officer

7

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Chairman’s Statement

LORD 
IAN MACLAURIN

UNPRECEDENTED 
  CHALLENGES

Since the outbreak of the pandemic, our first priority has been 
the safety and welfare of people both working and connected 
to the group. In the first quarter of 2020, the pandemic affected 
our production site in China, steps were taken by management in 
China to keep production running on a reduced scale and ensure 
through working with the authorities that the site complied with 
fast-moving new legislation. Through regular inspection and 
liaison with the authorities, we were able to continue production 
in difficult circumstances. 

Vietnam was then affected by the border closing with China, 
and the supply chain of raw materials and parts from China to 
Vietnam was severely disrupted. On a 12-month basis, shipments 
from China were only reduced by 26% from 1.87m frames to 
1.38m frames and in Vietnam by 40% from 3.39m frames to 
2.04m frames. 

As the virus spread, we were subsequently affected by the first 
global lockdown when our customers were forced to close their 
doors, although our online customers still remained open. This 
meant that our factories could not deliver pre-ordered stock, 
as the distribution depots were shut around the world, severely 
impacting our business. Our executive and senior management 
team set in motion a cost reduction plan, as well as implementing 
a programme for people to work from home where practicable. 

The net effect was borne out in our interim results, which showed 
a reduction in turnover to $16.7m and an underlying EBITDA 
of $0.7m. I am pleased to report that our second half was a 
significant improvement on our first-half trading, with turnover 
of $30.7m and an underlying EBITDA of $3.8m.

Overview  
The group is publishing its 
Annual Report and accounts for 
the year ended 31 December 
2020 following a time when our 
people, customers and suppliers 
faced unprecedented challenges 
as a result of the COVID-19 
pandemic and its effect on  
our business.

8

Design offices at Eschenbach headquarters 
Germany

TRANSFORMATION
As outlined in our IPO documentation it was a key part of 
our growth strategy to use the IPO funds to make strategic 
acquisitions in keeping with our vertically integrated model. 
In July 2020, the group purchased the assets of Norville, a 
well-established lens manufacturer with sites in Gloucester, 
Livingstone, Bolton and Seaham. I would like to express my 
gratitude to those employees at Norville who continued to keep 
the business alive during administration in very uncertain times 
and then, when INSPECS acquired the assets of the business, 
continued to work and help grow the business. New senior 
management was quickly recruited by our executive team. 

I am pleased to report that the restructuring of the business 
has already started, with the company achieving sales of $4.2m 
since acquisition on the 14 July 2020. A new lease on a modern 
manufacturing facility has been completed and the factory will 
move in the autumn of 2021 to a new state-of-the-art facility, 
allowing increased production efficiencies and also speed up 
of turnaround time. It is exciting to see how many integration 
possibilities there are with lens manufacturing and the rest of 
the group.

Having successfully completed the Norville acquisition, the 
executive team worked throughout the summer and autumn 
on the purchase of Eschenbach Holdings Gmbh, which was 
completed on 16 December 2020. Eschenbach again fits with 
the group strategy for growth. It has a number of very successful 
house brands and also some major licensed global brands. The 
Eschenbach workforce is approximately 580 people and mainly 
distributes to independent opticians around the globe with its 
full-time sales workforce of over 250 people. This acquisition 
now gives the group a strong European presence, and with the 
addition of its subsidiary Tura Inc in the USA, the group now has 
direct access to the important independent optical market in 
those regions. The acquisition also included Eschenbach Optik, a 
low vision manufacturing, research & development arm, offering 
further optical expertise in this growing market.

I would like to thank both our CEO Robin Totterman and our 
CFO Chris Kay, who led both acquisitions, for the work that 
they did over many months in completing two ground-breaking 
acquisitions in extremely difficult circumstances.

RESULTS
The group achieved a significant increase in revenue and 
underlying EBITDA in the second half but overall turnover was 
down 22.5% to $47.4m from $61.2m and underlying EBITDA was 
down from $13.0m to $4.5m.

DIVIDENDS
Due to the acquisitions in 2020 and the economic landscape the 
group will not pay a dividend at present, but this will be reviewed 
on a regular basis by the Board.

OUTLOOK
The economic landscape has improved since late spring of 2020. 
However, during 2020 and 2021 there have been continued 
restrictions around the world as governments endeavour to 
safeguard communities and ensure that their hospital services are 
not overwhelmed. This has meant that we are still experiencing 
continued headwinds in our business around the globe. However, 
the group remains profitable and cash generative in the first six 
months of 2021 with continuing debt reduction. I am sure that 
over the next 12 months the executive team will continue to 
deliver on its sustainable growth strategy for all our stakeholders. 
The group has had a successful start to 2021, with sales of $67m 
in the first quarter. The group continues to win new customers 
and in particular the Vietnam new facility is now completed and 
operational. Our order books at the time of this report are higher 
than at the same time in 2020 on a like for like basis.

Lord MacLaurin
Chairman

June 2021

9

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Chief Executive Officer’s Review

ROBIN 
TOTTERMAN

A YEAR TO
   REMEMBER

2020 has been a year to remember! 
Within a week of our IPO, the world  
as we knew it had changed. We are 
especially proud to have contributed PPE 
eyewear to NHS trusts without profiting 
while continuing to develop the business. 
2020 was also the year of exceptional  
recognition for INSPECS, which racked  
up a slew of prestigious awards for 
innovation and design.

10

It is over a year since the pandemic began to wreak havoc across 
the globe, and only the countries and communities who have 
managed to vaccinate a meaningful part of their population are 
beginning to relax restraints. 

I am greatly encouraged by the resilience and results our 
customers and the group has shown during the past year. As a 
group, our interaction with COVID-19 started in January 2020 
when widespread lockdowns took hold in China and Vietnam. As 
soon as our factories were able to open the rest of the world, and 
crucially to us, the warehouse and distribution hubs closed. For  
a time, our factories were unable to deliver ready goods on order.

The group is performing well, most notably our US colleagues 
at Tura under the watchful eye of Scott Sennet. Norville under 
Nevil Trotter is coming on in leaps and bounds. I am confident 
that once the move to the new location happens and new more 
scalable manufacturing methods are implemented, we will see  
a significant increase in the business.

International Eyewear is being integrated into the UK  
operation of INSPECS and Norville with the aim of selling  
frame and lens packages.

Germany and much of Europe seem to go from lockdown to 
lockdown, but despite this, the business is doing well. Tura 
and Eschenbach Optik are solid businesses run by excellent 
management who are keen to integrate with the rest of the group. 
Tura is far advanced on bringing INSPECS brands and our new 
BOTANIQ™ range to market. They are working with Killine to 
vertically integrate the business.

NORVILLE BECOMES AN 
INTEGRATED PART OF 
THE INSPECS GROUP

INSPECS Showroom
UK

I’m delighted to report that INSPECS has won the coveted 
Queen’s Award for International Trade for a second time – the 
UK’s most prestigious business accolade. The group has also 
won a number of green and design awards – the International 
Green Award for our recycled and recyclable O’Neill sunglasses 
‘Wove’ and four highly-coveted Red Dot Awards for Eschenbach’s 
designs.

I would like to thank all our employees across the group 
companies who, regardless of location or seniority, all responded 
fantastically to the unprecedented events that started to roll out 
in the early part of 2020. Special thanks go to Michael Zhang in 
China and Ha Bui in Vietnam and their teams for their efforts in 
what was unchartered territory. 

As the first lockdown hit, our management took immediate steps 
to protect our employees and ensure their health and safety while 
ensuring that INSPECS could continue to deliver its products 
to its customer base despite multiple disruptions. Many of our 
staff took voluntary pay reductions and reduced their hours. Our 
CFO, Chris Kay, and I took an immediate 60% pay reduction and 
the Board a 20% pay reduction in line with the rest of the group. 
Most appreciated, as this was despite the Board meeting more 
frequently throughout the year to assist with acquisitions. 

ACQUISITIONS 
The optical market is particularly dominated by a few major 
players, and the cost of entry into this market is substantial. The 
administration of Norville gave an opportunity for the group 
to enter this market at a considerably reduced cost. Once the 
transaction was complete, the assets were purchased by Norville 
(20/20) Limited, and the remaining 28 employees were transferred 
to the new INSPECS subsidiary company. Since that date, we 
have increased employment to 92 employees at Norville and 
saw month by month growth from August onwards. The vertical 
integration allows us to offer both high-quality lenses as well as a 
frame and lens package to the opticians.

11

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Chief Executive Officer’s Review 
continued

THE ACQUISITION 
OF ESCHENBACH 

GIVES A PLATFORM TO 
THE INDEPENDENT RETAIL  
MARKET IN THE USA 
AND EUROPE

80+

COUNTRIES AROUND  
THE WORLD BUY OUR  
EYEWEAR PRODUCTS

Initial design sketches

12

ESCHENBACH 
Eschenbach was founded in 1913 and has an enviable reputation 
for supplying high-quality eyewear in Germany and across 
the world, with a significant subsidiary in the United States 
called Tura Inc, which supplies US independent opticians. 
Eschenbach principally operates in the independent market, 
whereas traditionally INSPECS has operated in the chain market. 
Combining the two business will allow for multiple integration 
opportunities across the business platform and reduces the 
group’s risk, as we now supply both the high-volume chain and 
independent optical markets around the globe. Eschenbach’s 
house brands, TitanFlex and Humphrey’s, were rated No.1 
in the German Market in 2019–20 and continue to show 
significant growth.

MANAGEMENT 
As a direct result of the acquisitions the group has made since 
2017, I think it is important to stress that our business now has a 
wealth of talent across the globe with many capable individuals 
having both the experience and the capabilities to step into roles 
across the group and help drive future growth. 

MANUFACTURING INVESTMENT 
I wrote last year that we were expanding our Vietnam operation 
from 4,300m2 to 8,800m2, and I am pleased to report that this new 
manufacturing facility was completed in 2020. We suffered delays 
as a direct result of COVID-19 and the inability of our Chinese 
technical experts to cross into Vietnam due to border control 
restrictions. While it is disappointing that COVID-19 has directly 
delayed the implementation of this plant, I am pleased to report 
that manufacturing has now started with a large order to the USA. 
Our new sustainable eco-friendly BOTANIQ™ range is being 
produced in the new Vietnam facility.

 
Eschenbach reception area
Germany

COVID-19
COVID-19 undoubtedly disrupted our business during the last  
part of Q1 2020 and through Q2 and partly into Q3 of 2020. 

The optical industry has proven its resilience by continuing 
to trade, albeit at a reduced level, by adopting strict PPE 
requirements early. Although footfall is significantly reduced, 
conversion rates continue to be exceptional. In addition, 
shrinkage (theft) is practically non-existent due to the need to 
pre-book optical appointments. Whilst difficulties persist, the 
group has made significant adjustments to the new environment, 
and our budgets and forecast for 2021 are based on continued 
disruption within the market. As a true global distributor, the 
pandemic will continue to have some effect on our normal 
business activity for the foreseeable future. The group will 
continue to ensure the safety of its 1,800 employees across the 
globe and has new working practices in place that permit the 
business to continue to operate.

OUTLOOK
2020 was the year of acquisitions. 2021 is the year of integrating 
the new companies and developing synergies and strategies 
across the group to generate future growth. I am pleased to 
report that steady progress has been made, and as a result, 
I am confident in the group’s ability to create and maximise 
opportunities and to deliver to all stakeholders. Current trading 
to date remains positive. 

Robin Totterman
Chief Executive Officer

June 2021

13

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Our Business Model

OUR BUSINESS 
MODEL

INSPECS continued growth has 
further established its position 
as one of the world’s leading 
eyewear companies. 

Our model to achieve sustained and 
balanced growth for the benefit of all 
stakeholders is based on four main 
fundamental drivers.

STRATEGY FOR GROUP SUSTAINED GROWTH

GROW OUR IN-HOUSE 
FRAMES MANUFACTURING 
CAPACITY 

EXPAND OUR CHAIN AND 
INDEPENDENT OPTICAL 
CUSTOMER BASE AROUND 
THE GLOBE

During 2020 the group completed 
its expansion of Vietnam by the 
addition of an additional 4,000m2 
of manufacturing base allowing 
production capacity to rise from 
3.5m frames per annum to 7m+ 
per annum.

INSPECS has continued despite 
COVID-19 to increase its offering 
of both branded and private label 
frames to our global optical chains 
and continues to grow the number 
of independent opticians that  
it supplies.

GROW OUR LENS 
MANUFACTURING 
CAPACITY AND EXPAND 
GLOBALLY OUR HIGH 
END PRODUCTS

The group has agreed terms 
for a new manufacturing site in 
Gloucester, UK raising expected lens 
manufacturing capacity from 1,200 
to 4,000 jobs per day. The new plant 
is planned to be fully operational by 
the end of 2021.

MAKE SELECTIVE 
ACQUISITIONS TO 
BOOST GROWTH AND 
PROFITABILITY IN 
FUTURE YEARS 

The group made two major 
acquisitions in 2020 and is 
continuing to work on further 
strategic acquisitions in 2021.

14

Superdry Optical 
SS21 Adalina frame

15

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Our Business Model 
continued

HOW OUR  
MODEL WORKS

WE 
DESIGN

Our design teams around the world 
follow the latest trends in the market. 
Our teams are looking for ideas not 
only from the eyewear market but 
also from both the consumer fashion 
and parallel industries. Our design 
teams are principally in the UK, USA, 
Germany, Portugal and Hong Kong.

WE 
MANUFACTURE

Our production teams work with 
our in-house CAD design teams in 
our facility to ensure either home 
manufacture, if appropriate, or 
engage with one or our tested 
subcontracted factories.

BRANDS UNDER LICENCE: 
Brands are selected with potential to 
grow market share in a geographical 
region, or for broader, global 
distributions. We are specialists in 
working with brand owners in 
partnership, to help deliver growth 
for both companies.

HOUSE BRANDS: 
Targeting specific market segments 
with our in-house brand offer, we 
elevate group-owned patents and 
manufacturing techniques by building 
a brand around them, and successfully 
taking them to market.

PRIVATE LABEL/OEM: 
We’re helping some of the biggest 
retailers in the world to grow, by 
targeting specific consumer 
opportunities in store. Our 360 degree 
service delivers expertly-designed 
private label eyewear, with the 
reassurance of traceable industry 
benchmark in-house manufacture. 

16

WE 
MARKET

WE 
DISTRIBUTE

Our marketing teams constantly plan 
work with the optical market to bring 
our products to consumer attention 
and work in partnership with the 
brand owner.

Through our network of over 70,000 
optical and retail outlets across 80 
countries our products are sold both 
in well-known high street chains and 
to independent opticians globally.

WHAT SETS US APART
•  Vertically integrated model providing 

a complete eyewear solution.

•  Innovative design and creativity.

•  Global experienced manufacturing 

teams.

•  In-house design.

•  Acquisition of lens manufacturers 

allowing combination frame and lens 
packages to be created.

•  Trusted supplier to global retail chains 

with full traceability.

•  We operate as a fair organisation and all 
our employees are key. We endeavour 
to give the best industry working 
environment for all our staff.

BRANDS

20+

DISTRIBUTED FRAMES

4.9m

17

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Our Business Model 
continued

LICENSED BRANDS

Our teams around the globe 
work with leading brands to 
create award-winning eyewear 
collections.

Hype provides inspiring designs and 
concepts for the teens with trend 
setting designs.

The epitome of individuality and 
a tempting range of shades with 
models to suit all ages.

Iconic British designed frames for 
men and women with the spirit of 
Japan.

Fashion eyewear creating updated 
classics and trend-led design.

Eyewear for men and women 
offering a striking assortment of 
shades and styles to suit all ages and 
tastes.

Finding solutions to help build 
a better world. Cat engineering 
DNA can be found throughout our 
range of eyewear. Quality products 
designed and built to last.

The Original California Surf, Snow 
& Lifestyle Brand, since 1952. The 
innovator of the wetsuit, and a 
pioneer of protecting our oceans. 
Eyewear for O’Neill has a strong 
sustainable O’Neill Blue ethos.

Crafted in high-quality materials  
with inspiration from vintage fashion 
and Lulu’s iconic designs.

A glamorous high fashion collection.

A refined, classic look with two- 
tone colours giving an updated  
and contemporary feel.

Distinctively British, crafting 
beautiful eyewear combining iconic 
style with quality craftsmanship.

Fashion-forward yet timeless 
eyewear, underlying the  
wearers natural style.

18

HOUSE BRANDS

Combining old traditions and values 
to the new, modern brand in subtle 
Nordic colours and characterised by 
natural earthy tones.

Combining wearing comfort with 
resilience, low weight with modern 
design with quality.

Luxury eyewear with attitude, by 
Gwen Stefani. Her L.A.M.B. fashion 
and accessories label mixes classic 
Hollywood glamour with modern 
streetwear influences.

The highest level of quality with 
commitment to perfect design and 
inspired by structural clarity and 
architectural design.

The HUMPHREY’S DNA is 
individual and authentic following 
the fashion code with trendy and 
energetic frames.

“Many wonderful surprises await 
you…” with the splendiferous Roald 
Dahl Eyewear collection. Designs 
feature original Quentin Blake 
illustrations from much loved tales 
and spectacular hidden quotes for 
the cheekiest of chiddlers eyes only!

Fashion inspired by the work of 
renowned fashion designers, 
stylists and make-up artists.

Elevating eyeglasses from 
accessory to a work of art offering 
both rimless and semi-rimless 
frames with a contemporary look.

An iconic brand in the denim fashion 
industry, Buffalo David Bitton is a 
global lifestyle brand with a long-
standing tradition of quality.

British tailored eyewear finely 
crafted from luxury material. 
Timeless classic pieces made 
from the name synonymous 
with heritage, quality and style. 
Trademarked, designed and  
made in-house. 

Free Country is one of the outdoor 
industry’s most sought-after brands 
offering superior style, functionality, 
performance and value at a fraction 
of the cost of their competitors.

19

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Our Business Model 
continued

OUR PRINCIPAL MANUFACTURING SITES

TORKAI OPTICAL 
FACTORY
China

500

WORKFORCE

Torkai Optical has built an industry 
reputation as a high-class manufacturer 
of quality eyewear, in particular titanium 
frames. With a workforce of around 
500 it is also able to support the group 
as a whole with product design and 
engineering solutions. It has its own 
plating and mould production plant.

50+

ENGINEERS AND 
TECHNICIANS

FULLY TRACEABLE 

IN-HOUSE PLATING 
AND MOULD SHOP

ADVANCED  
TOOL MAKING

INNOVATIVE 
ENGINEER 
SOLUTIONS

20

OUR PRINCIPAL MANUFACTURING SITES

NEO 
OPTICAL
Vietnam

NEO Optical is the largest optical frame 
manufacturer in Vietnam. With the 
addition of its new facility the site now 
has the capacity to produce in excess of 
7m frames annually, increasing from 3.5m 
frames previously.

500+

STAFF

QUALITY 
PRODUCTION 
AT COMPETITIVE 
PRICES

LARGEST LOCAL 
EMPLOYER

FULLY TRACEABLE

ACETATE AND 
INJECTED 
MOULDING 
PRODUCTION

21

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Our Business Model 
continued

OUR PRINCIPAL MANUFACTURING SITES

NORVILLE-LENS 
MANUFACTURERS

90+

STAFF

DELIVERING INDEPENDENT 
LENS SUPPLY SOLUTIONS TO 
THE OPHTHALMIC INDUSTRY

70+

YEARS 
MANUFACTURING 
HERITAGE

ANCILLARY SITES 
IN SEAHAM AND 
LIVINGSTONE

ABILITY TO OFFER 
FRAME AND LENS 
PACKAGE

UNIQUE LENS 
MANUFACTURING

22

Market Overview

MARKET OVERVIEW

The eyewear market has been affected by COVID-19 during 2020 but has proved to  
be resilient and, despite lockdowns around the globe, access to ophthalmic eyewear  
has been deemed to be essential and much of the market has remained open.

The global eyewear market is 
expected to grow from $139 
billion in 2019 to $259 billion 
in 2027 at a CAGR of 8.1%.

(Source: Statista 2021)

300

250

200

150

100

50

D
S
U
n
o

i
l
l
i

b
n

i

e
u
a
v

l

t
e
k
r
a
M

258.63

239.25

221.33

204.74

189.4

175.21

162.08

149.93

138.7

2019

2020

2021

2022

2023

2024

2025

2026

2027

DISTRIBUTION CHANNELS

SEGMENTAL ANALYSIS

79%

75%

The brick and mortar segment still 
dominates the eyewear market in 
2020, accounting for 79% of the 
market, but the e-commerce market 
continues to grow.

The ophthalmic spectacle segment 
accounted for 75% of the total 
market in 2020 with sunglasses and 
then contact lenses as the next 
largest market segments.

DRIVING FORCES
The key factors driving the 
market growth are the number of 
ophthalmic disorders, increased 
awareness of eye examinations and 
the perceptions of eyewear as a 
fashion accessory.

INSPECS operates across all the 
major parts of the market supplying 
frames and lenses to the ophthalmic 
eyewear market and sunglasses. 
INSPECS continues to grow its 
e-commerce presence.

23

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020 
 
 
 
Chief Financial Officer’s Review

CHRIS KAY

DESPITE COVID-19 THE GROUP HAS 
MAINTAINED POSITIVE MOMENTUM 
IN 2020 CREATING A STRONG PLATFORM  
FOR GROWTH IN 2021

Revenue

Gross profit

Operating expenses

Underlying EBITDA

Share-based payments

Depreciation and amortisation

Restructuring costs

Foreign exchange on funding for 
acquisitions

Post acquisition insurance costs

Operating (loss)/profit before 
non-underlying costs

(Loss)/profit before tax and 
non-underlying costs

Reconciliation to reported results

Operating (loss)/profit before 
non-underlying costs

Non-underlying costs

Negative goodwill on bargain purchase

Movement in fair value on derivative

Exchange adjustment on borrowings

Share of associate profit

Net finance costs

(Loss)/profit before tax

Tax credit/(charge)

(Loss)/profit after tax

FY20

47,415

20,522

(16,017)

4,505

(1,706)

(3,906)

(185)

(1,085)

(563)

FY19

61,247

27,536

(14,549)

12,987

(1,917)

(3,125)

–

–

–

(2,940)

7,946

(5,400)

10,174

(2,940)

(5,763)

506

(740)

(382)

–

(1,844)

(11,163)

2,250

(8,913)

7,946

(2,827)

–

2,865

715

14

(1,365)

7,347

(907)

6,440

Our results in H2 showed considerable 
improvement as the group adjusted 
to COVID-19 restrictions. Excluding 
the Eschenbach acquisition our H2 
underlying EBITDA increased from 
$0.7m in H1 to $5.1m in H2. We have 
also completed two acquisitions in 
2020 and production has started in our 
new Vietnamese factory. The group is 
now well-positioned for the future as 
economies around the globe expand 
as lockdowns start to ease.

24

REVENUE
Revenue for the year ended 31 December 2020 was $47.4m, a 
decrease of 22.5%. H2 group revenue was $30.7m including $7.1m 
contribution from acquisitions. Growth in H2 over H1 excluding 
acquisitions was 41.3%.

COVID-19
As a result of COVID-19, the Board implemented actions to 
reduce costs whilst continuing to invest and improve both the 
short and long-term prospects of the group. We continued to 
invest in our brands and our manufacturing capacity, completing 
our new Vietnam manufacturing facility.

OPERATING EXPENSES 
Operating expenses increased by $1.5m. Excluding acquisitions, 
operating expenses decreased $2.4m as the group reduced costs 
to offset restrictions in trade caused by COVID-19.

GROSS MARGIN
The overall group gross margin decreased from 45.0% to 43.3%. 
Excluding acquisitions, the gross margin decreased from 45.0% 
to 43.5%.

CASH POSITION
The group ended the year with cash balances of $30.0m 
compared to an opening position of $6.5m as a result of  
share placing and the acquisitions in the period.

FINANCE INCOME AND EXPENSE
The group’s net finance costs increased from $1.37m to $1.84m. 
Excluding loan arrangement fees written off on refinancing ahead 
of IPO, net finance costs reduced by $0.5m.

DEPRECIATION AND AMORTISATION
Group depreciation and amortisation costs increased from  
$3.1m to $3.9m, including $0.7m from acquisitions in the year. 

UNDERLYING EBITDA
On 16 December 2020, the group acquired Eschenbach which 
had limited sales from 17 to 31 December 2020. As a result, 
Eschenbach had a technical accounting underlying EBITDA of 
$(1.3)m for the year to 31 December 2020. The group targets 
underlying EBITDA as a primary KPI and during the year, 
excluding the Eschenbach acquisition, our underlying EBITDA 
decreased from $13.0m to $5.8m, a decrease of 55%. I am pleased 
to report that excluding Eschenbach, our H2 underlying EBITDA 
was $5.1m against H1 of $0.7m.

NET DEBT
The group’s opening net debt was $13.7m ($12.5m excluding 
leases) and the closing net debt following IPO and two 
acquisitions in the year was $47.2m ($26.9m excluding leases).

EARNINGS PER SHARE
Earnings per share for the year to 31 December 2020 is  
$(0.13)c (2019: $0.12c) with EPS on a fully diluted basis of  
$(0.13)c (2019: $0.11c). 

LEVERAGE
The group’s year-end leverage as a multiple of EBITDA, 
increased from 0.8 in 2019 to 1.6 in 2020 as a result of funding the 
acquisitions in the year. The leverage ratio has continued to drop 
since the year-end against a required covenant level of 2.5 for the 
12 months to 31 December 2021.

EQUITY PLACING
On 11 December 2020 the group issued 30.5 million shares at 
£2.10 in order to fund the Eschenbach acquisition of $115.5m.

GOING CONCERN
Given the significant effects of COVID-19 encountered 
during 2020 and into 2021, the Directors have undertaken a 
comprehensive assessment of the group’s ability to trade out to 
December 2022. Details of this review are shown in the Directors’ 
Report on pages 54 to 56. Taking the above into consideration 
the Directors have a reasonable expectation that the group 
and the company have adequate resources to continue to trade 
throughout this review period. Therefore, the Directors continue 
to adopt the going concern basis of accounting in preparing the 
consolidated and Parent Company financial statements.

(LOSS)/PROFIT AFTER TAX
The group loss after tax for the year was $8.9m compared to a 
profit of $6.4m in 2019. This loss includes $5.8m of non-underlying 
costs borne by the group as a result of the IPO and acquisitions 
made during the year as shown on page 24.

Chris Kay
Chief Financial Officer

June 2021

Design offices at  
Eschenbach headquarters
Germany

25

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Radley Sunglasses 
SS21 Campaign

26

Key Performance Indicators

Our business focusses on eight key performance indicators that are used 
by the Board and Senior Management to review future outcomes and 
the successful delivery of the group’s overall strategy.

TURNOVER

GROSS PROFIT

-23%
$47.42m

-26%
$20.52m

2019: $61.25m

2019: $27.54m

UNDERLYING EBITDA

GROSS PROFIT MARGIN

-65%
$4.51m

-1.7PTS
43.3%

2019: $12.99m

2019: 45.0%

FRAMES MANUFACTURED

NET CASH FROM OPERATING ACTIVITIES

-36%
2.91m

-107%
$(0.75)m

2019: 4.55m

2019: $10.59m

NET CURRENT ASSETS

+1,498%
$59.62m

2019: $3.73m

FULLY DILUTED EPS

-101%
$(0.13)c

2019: $0.11c

27

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Sustainability

A SUSTAINABILITY ACTION  
PLAN FOR INSPECS

INSPECS is committed to ensuring that its business activities are conducted 
with full consideration to their effect on the environment.

We are committed to reducing 
our impact on the environment 
and have set out the following 
key pillars for the group for 
the future.

We have created a department to assess 
and monitor operations across the group, 
building targeted action plans with KPIs 
to improve INSPECS business operations 
and make progress towards the UN’s 
sustainable development goals.

Recruitment for this new department is 
already underway with support from the 
Board to implement the review during 
2021. Whilst we await the outcome we 
made good progress towards a more 
sustainable business in 2020.

WORKING WITH  
OUR EMPLOYEES

UTILITY CONSUMPTION

As a group we will endeavour to 
learn from our employees who have 
demonstrated ideas and plans 
across the group to reduce waste.

As a manufacturing group we have 
set up a group department that 
will target continued reduction in 
our energy and water consumption 
across the group.

SUPPLY CHAIN

RECYCLING

The group will endeavour to 
work with all our stakeholders 
to ensure that our distribution 
around the globe has a long-term 
goal of reducing its effect on the 
environment.

The group will continue to develop 
its recycling efforts across the globe. 
This will include lighting, heating, 
electronics, paper, packaging and 
supplies. 

CHEMICAL WASTE 

ACCOUNTABILITY  
AND MEASUREMENT

The group will continue to use 
environmentally friendly chemical 
products and where these cannot 
be used the group will ensure the 
minimum use and correct disposal  
of chemical products.

The group will continue to invest in 
a sustainability department that will 
be tasked with not only new ideas 
but monitoring and tracking our 
performance and reporting to all 
our stakeholders.

28

 
ACHIEVEMENTS 
FOR 2020

INSPECS made good progress in 2020 towards its five key sustainability goals.  
Some of our key achievements are as follows:

USING SUSTAINABLE MATERIALS
BOTANIQ™ is a new sustainable 
eyewear collection offering a truly 
end-to-end solution for opticians 
and the consumer. The frames are 
manufactured from biodegradable 
and recyclable materials and we 
ensure that all packaging is fully 
recyclable. We have a responsible 
waste solution for the consumer 
allowing them to recycle their 
purchase. We also pledge to plant 
one tree for every frame sold, with 
the organisation One Tree Planted.

CARBON OFFSET
The group has engaged with 
Wanderlands to offset its UK 
business travel and energy 
consumption, leading to an 
estimated 2,500 trees being planted 
in forests in the UK in 2021 and 
more trees for 2022 to offset our 
carbon footprint.

REDUCING CO2 EMISSIONS
In 2020, INSPECS purchased its first 
electric vehicles as company cars, 
with three more to be added in 2021. 
The electric vehicles covered 
85,000km and saved 11 tonnes of 
CO2 emissions during the year. The 
impact of this initiative is expected 
to grow as national lockdown 
restrictions are eased and normal 
business operations can resume.

COVID-19 has reduced the amount 
of air and rail travel in this financial 
year and carbon emissions have 
therefore reduced dramatically.

The group has taken the 
opportunity to hold virtual 
meetings via Zoom and Teams 
during the pandemic and this 
practice will continue to be 
promoted as a way to reduce  
travel in the future.

CUTTING CARBON FOOTPRINT
Many of the world’s volume glazing 
labs are based in the Far East. We 
established a smarter and more 
environmentally responsible logistic 
solution with one of our major retail 
customers in the USA.

INSPECS now stores products at 
the point of manufacture in China, 
shipping straight to Thailand and on 
behalf of the customer for glazing. 
This avoids thousands of air miles 
per frame. In 2020 we stored and 
shipped over 37,000 frames in this way.

INSPECS will continue to promote 
a more environmentally sustainable 
distribution model to other key 
chains around the globe.

INNOVATION GREEN  
PRODUCT AWARD
In 2021, INSPECS was presented 
this prestigious award for its 
O’Neill Wove sunglasses. Over 
1,400 Companies from 52 countries 
entered the award. These sunglasses 
and their packaging are made from 
recycled and recyclable materials, 
such as fishing nets, rubber tyres, 
plastic bottles, stainless steel, 
mineral glass or water soluble paper.

INSPECS  Annual Report & Accounts 2020

29

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Sustainability 
continued

MANAGING OUR ESG 
RESPONSIBILITIES

DIVERSITY AND INCLUSION
INSPECS will not allow any discrimination in any of its business 
operations nor engage with other organisations where such 
activity is detected. This culture is paramount to how we operate 
but INSPECS acknowledges that this is a continuing process in 
which it will invest and ensure that our ambition is maintained.

PEOPLE
To sustain our long-term future INSPECS recognises that a key 
risk is the ability of the group to continue to attract, recruit and 
retain employees across the group. This will ensure going forward 
our group will be able to achieve its long-term growth and meet 
our customers’ needs. In order to achieve this INSPECS aims to 
continue to be an ‘Employer of Choice’ in the communities we 
operate. Our focus therefore to:

•  Ensure we have a great workplace where employees feel 

safe, supported and highly valued.

•  Ensure that remuneration and benefits are attractive.

•  Develop a sustained career path for employees.

•  Ensure inclusivity and equal opportunity for all.

•  Allow open debate and communication at all levels across 

the group.

•  Ensure that the group meets and exceeds all Employee 

Legislation in whatever jurisdiction it operates.

DIVERSITY & INCLUSION

EMPLOYEE MIX BY GENDER

EMPLOYEE YEARS OF SERVICE

EMPLOYEE CATEGORY

35% Male

65% Female

18% < 2 years service

82% > 2 years service

55% Production

18% Administration

27% Sales

30

INSPECS GROUP PLC’S 
EMPLOYEE BASE

AVERAGE NUMBER OF EMPLOYEES AS AT 31 DECEMBER

TOTAL

1750

1221

1138

952

HEALTH AND SAFETY
INSPECS as a manufacturer has Health and Safety as a standing 
part of Board meetings. INSPECS will continue to improve Health 
and Safety and has regular assessments and external reviews 
and implements recommendations across the group. At each 
quarterly Board meeting reports are received from each of our 
key operations and this is monitored on a monthly basis by senior 
management to ensure compliance with local legislation.

Male – 35% 
Female – 65%

Male – 22% 
Female – 78%

MODERN SLAVERY STATEMENT

612

269

2020

2019

2020

2019

2020

2019

Total

Female

Male

2020

2019

BOARD

6

4

5

4

Male – 83% 
Female – 17%

Male – 100% 
Female – 0%

1

0

2020

2019

2020

2019

2020

2019

Total

Female

Male

2020

2019

DIVERSITY AND INCLUSION
INSPECS Group is committed to equality of treatment for all 
employees and for those seeking employment with the group 
regardless of gender, marital status, race, ethnic origin, disability, 
sexual orientation or social status. The group is committed to 
complying with all current legislation pertaining to employment 
in all areas where it operates. INSPECS Group is committed to 
ensuring a good work/life balance for all employees and our 
people are key to our continued sustained growth and their 
wellbeing is a priority for the group.

Our Commitment
One of our key principles is ‘to treat everyone fairly and with 
dignity and respect’. This includes those from within our business 
and those within our supply chain.

Corporate Social Responsibility
Our corporate responsibility is to protect human rights and we 
seek to ensure that our high-quality products are sourced and 
manufactured in a fair, ethical, environmentally and socially 
responsible way.

The business is responsible for the end-to-end processes and 
procedures which are established to ensure traceable quality 
control and transparency through the group’s operational 
processes, from design to distribution.

The group’s approach to sustainability seeks to address both 
environmental and social impacts, whilst meeting client demands. 

We seek to ensure that our partners and affiliates have similarly 
high standards, respect local laws and customs along with 
meeting international laws and regulations, and we will never 
knowingly deal with any organisation which is connected to 
slavery or human trafficking.

COVID-19 Awareness
As part of our on-going analysis the senior team will continue 
to monitor and mitigate actions as required. All key business 
decisions are based on a risk analysis and we will continue to 
make decisions by putting employee and supplier safety first. 
With all our continuing operations this will be conducted in line 
with local government COVID-19 guidelines.

31

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Sustainability 
continued

80+

COUNTRIES OF 
DISTRIBUTION

4

MANUFACTURING
SITES

70k

GLOBAL POINTS
OF SALE

1,800

GLOBAL 
WORKFORCE

Global Distributor
Industry benchmark manufacturing, from frames to lenses to 
complete frame-and-lens packages. Resilient eyewear products 
in over 80 countries, with 14 sales offices and a 270-strong sales 
team. Our balanced customer profile now includes many of the 
largest chain retailers in the world, and a large global network of 
independent opticians. 

Governance, Operational Policies, Procedures  
and Recruitment Practices
As part of our commitment to combating modern slavery, and 
to conduct business in an ethical and transparent manner, along 
with mitigating risk of non-compliance, we have the following 
policies within our organisation:

Due Diligence
The group strives to maintain the highest standard of ethical 
integrity and expects the same of its business partners, 
employees and affiliated parties. As part of our new suppliers 
and new product process, we assess suppliers to ensure they can 
support the business and take steps to consider any areas of risk.

Owning our own manufacturing sites ensures the group has 
high levels of traceability throughout the supply chains and can 
maintain quality control to high standards. The group’s sites 
are subject to regular independent audits by its global retail 
customers and licensors. In addition to the company’s policies 
and internal risk management activities, these independent 
audits evidence that governance and industry standards are 
being maintained and legal and regulatory requirements are met.

•  Anti-Slavery and Human Trafficking.

•  Whistleblowing.

•  Safeguarding.

•  Anti-Harassment and Bullying.

•  Equal Opportunities.

Our policies also invite staff to contribute to the development 
of policies and provide suggestions as to how the group may 
improve its governance and risk management framework, 
processes and controls.

Each of our business divisions have access to an externally 
facilitated whistleblowing hotline that enables all employees to 
raise any concerns that they might have without fear of reprisals. 
We are pleased to confirm that no incidents have been raised or 
reported to date.

Our recruitment practices are compliant with applicable 
employment and health and safety legislation in the relevant 
countries.

In order to minimise our exposure to risks that may arise in 
relation to slavery and human trafficking, we always aim to recruit 
staff directly and do not make frequent use of temporary workers 
sourced through an intermediary or employment agency.

Management and Compliance
The group’s risk appetite is determined by the Board. Our 
enhanced risk management framework provides that we will not 
tolerate slavery or human trafficking within our supply chains.

While modern slavery can be found among any population, we 
recognise that certain groups are particularly vulnerable to the 
risks of modern slavery including:

•  Domestic and foreign migrant workers.

•  Contract, agency and temporary workers.

•  Vulnerable populations (e.g. refugees).

•  Young or student workers.

We actively manage our relationships with third-party agents 
and service suppliers to mitigate any potential risk of modern 
slavery. The company requires those who are charged with 
providing services to conduct robust checks on any potential new 
employee, including eligibility to work in the relevant country, to 
safeguard against human trafficking or individuals being forced to 
work against their will.

INSPECS Group is proud of the organisation’s culture and 
corporate ethos, and the collaborative relationships our staff 
actively maintain with customers and suppliers externally. Our 
organisation’s culture and the approach we take when dealing 
with clients, partners, advisers and other third parties has been 
instrumental in ensuring that we have low levels of staff turnover 
and few changes in the supply chain.

32

FUTURE GOALS
INSPECS plans are to improve its carbon footprint. 
This includes steps to:

•  Move our electric power consumption to green power 

suppliers where possible thus reducing our carbon footprint.

•  Continue to encourage our customers to use green routes 

for shipping and reduce the transport miles of our products.

•  Innovate and expand our range of sustainable products.

•  Continue to reduce our water usage in production.

•  Continue our policy of recycling across the group.

•  Set up our internal sustainability department reporting to 

the Board.

•  Continue to use more biodegradable packaging where 

possible.

•  Continue to plant trees in the communities in which we 

operate to offset carbon usage.

ENERGY AND CARBON REPORTING
Streamlined Energy Carbon reporting (SECR) was introduced 
by the UK Government on 1 April 2019. The group sets out 
its main power and water consumptions for 2020 for the 
UK- based companies. For 2021 onwards we will continue 
optimising our reduction in emissions and work in line with 
current and future environmental legislation.

The group has used the following averages to estimate its 
carbon emission. 
Gas: 183 grams per kilowatt hour 
Electricity: 233 grams per kilowatt hour

Electricity

Gas

Water

UK energy  

usage in kWh

728,466

321,851

198,921

Business fuel

44,859 miles

Total for the  
period in the UK

Intensity ratio in the 
UK (per employee)

UK GHG  
Emissions 
in tCO2e

169.83

59.18

0.07

13.02

242.10

1.68

TARGETED REDUCTION
The group aims to reduce energy consumption on an intensity 
ratio basis over the next five years and we will continue to 
review performance against our goals.

The amount of both international and domestic travel across 
the group was successfully reduced in 2020 due to COVID-19 
restrictions. The group has relied increasingly on virtual face 
to face meetings but we do expect to start to exhibit our 
products at more international exhibitions in the later half of 
2021. The group aims to maintain its business travel below pre-
pandemic levels in the future.

Training
The company’s formal training and induction processes for new 
staff are firmly established across the group. The standard and 
behaviours expected of our employees are detailed within a 
number of policies and code of conduct, in addition to those 
listed above. All new employees have access to the employee 
policies required as part of an induction and training as required.

Management and support staff remain mindful of their duty 
and legal obligation to escalate any matters of concern in 
relation to human rights abuses, in line with company policies. 
All our employees are encouraged to identify and report any 
potential breaches of the organisation’s policies within the wider 
understanding of whistleblowing.

Commitment
As a global supplier and brand partner with a world-wide 
distribution network, we understand that there is a risk of modern 
slavery taking place in supply chains. Having considered a range 
of factors, including the nature of our products, the sector in 
which we operate, the various group policies and procedures 
in place and independent audits carried out across the globe, 
we believe that the company is at low risk of exposure to slavery 
and human trafficking. We are not aware of any areas of our 
operations and supply chain where there has been a breach of the 
Modern Slavery Act 2015. Recognising that the human rights risk 
may change over time as the business enterprise’s operations  
and operating context evolve, we will continue to:

•  Re-evaluate the exposure to the risk of modern-slavery 

occurring in our supply chain.

•  Review and enhance our governance and risk management 

frameworks.

•  Monitor external adviser independent assessments, due 

diligence and assurance work to ensure we comply with legal 
and regulatory obligations. Apply appropriate risk-based due 
diligence processes to mitigate risk of non-compliance with the 
Act.

•  Continually review our induction and training programmes to 
support our zero-tolerance approach to human rights abuses.

•  Continue training to our Board, executive leadership team 

and key members of the global procurement and supply chain 
teams to build on their understanding.

•  Work with stakeholders across the group to develop key 

performance indicator metrics as a tool to monitor compliance 
with the group’s governance frameworks and policies.

INSPECS  Annual Report & Accounts 2020

33

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Sustainability 
continued

SKUNK WORKS

DREAM THE 
IMPOSSIBLE

HAVE FUN
CRAZY IDEAS,
GO FOR IT

APPLY THE  
RESOURCES OF  
INSPECS TEAMS  
AROUND THE  
GLOBE

At INSPECS in 2020 we 
started our own Skunk Works 
department. This small but 
growing team has a remit to 
think outside the box and has 
a high degree of autonomy, 
is unhampered by normal 
constraints and is tasked with 
dreaming the impossible.

Already, its main focus has been to 
improve the environment and has at 
the date of this report filed six patent 
applications for environmentally 
sustainable products and devices that 
we are working to bring to market. This 
is a committed strategy and we hope to 
produce a list of its achievements next 
year. The team reports to the Executive 
team once a month to test ideas and 
update on projects.

34

‘Skunk Works’ was the name given to a 
secret R&D team at Lockheed Aircraft 
Corp. that was tasked with quickly 
developing a jet fighter for the United 
States during World War II. 

The name is now used to describe a 
small department that is allowed to 
operate outside the normal procedures 
and systems of a company, so that it 
has the freedom to develop new ideas 
and products. 

BRING TO
MARKET

TEST  
PROTOTYPES  
AND TEST  
MARKET

COLLABORATE  
WITH WORLD  
LEADING  
UNIVERSITIES

UNIVERSITY COLLABORATION
During 2020, INSPECS partnered with a number of companies 
and universities in the UK and Europe. On 12 May 2021 an 
agreement was signed with 2-D Tech Limited, a subsidiary of 
Versarien Plc to develop the first antibacterial frames and lenses 
impregnated with graphene.

These new patented products will be available to the market in 
2021 and other unique products are being worked on. 

The Board will consider the creation of a design and innovation 
scholarship at a leading UK university once income is generated 
from Skunk Works, with other similar developments planned in 
Europe and the USA.

INSPECS  Annual Report & Accounts 2020

35

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020Section 172 Statement 

36

The Board of INSPECS Group is proud of the  
high standards of corporate governance that it has 
established and continues to monitor and improve.

The Board continues to look at the expectations of all company stakeholders and  
reflects on the choices the Board makes and their effects on all our stakeholders.  
The Board considers the long-term effects of key decisions on stakeholders and this 
helps INSPECS Group to maintain suitable and beneficial relationships for the future.  
The main considerations likely to promote the success of the company for the benefit  
of all stakeholders are set out below.

OUR EMPLOYEES

HOW WE ENGAGE

Training, development 
and career prospects

Health and Safety

Diversity – fair and 
equal pay

The employees of the group have annual appraisals 
and the group operates an Employee Long-Term 
Incentive plan for the future leadership. The 
company actively encourages all employees to have 
access to further training to enhance their skills and 
develop their careers.

The group reviews heath and safety on a monthly 
basis and it is reviewed by the Board on a quarterly 
basis.

The group has the highest standards in relation to 
diversity and fair pay to all employees regardless of 
age, sex or ethnicity.

OUR INVESTORS

HOW WE ENGAGE

Demonstrate a clear 
investment case and 
strategy for continued 
sustained growth

•  Ensure good risk and 
corporate governance.

•  Demonstrate KPIs.
•  Continue our ethical 

behaviour in all business 
matters.

Individual meetings with institutional shareholders 
throughout the year including communication 
during the interim, final and share placing that 
occurred in 2020.

Reports and Accounts available at Companies 
House and on the new company website.

Quarterly turnover numbers now released to the 
market to continue relevant information flow to 
all stakeholders including KPIs in the Annual Report.

Our website will continue to show how we improve 
our ethical behaviour.

OUR CUSTOMERS

HOW WE ENGAGE

Continue to create new 
well-designed products

The group design hubs in the UK, Lisbon, Germany, 
Hong Kong and the USA regularly engage directly 
with customers to create new and exciting ranges 
each year.

Continue to deliver to our 
customers on time

The group continues to invest in the latest 
production machinery to ensure efficient supply.

Demonstrate to our 
customers our fully 
traceable supply

The group maintains independent audit facilities 
available to our chains to monitor and audit our 
factories.

Engage in customer 
feedback to ensure continual 
improvement of our supply

The group reviews its six-monthly or annual 
feedback from our global chains and aims to 
constantly improve our performance.

Develop more 
sustainable products  
for our customer base

The group has developed two new sustainable 
eyewear ranges in 2020 and won multiple awards.

THE BOARD REVIEWED 
AND CONSIDERED THE 
ONGOING EFFECTS 
OF COVID-19 ON THE 
BUSINESS DURING 2020 
AND CONTINUES TO 
MONITOR ITS EFFECTS.

In accordance with Section 172 of the 
Companies Act 2006 the table opposite 
demonstrates how the Board has fulfilled 
its duties.

This provides a summary of the Board’s 
strategic aims, decision-making process, 
and the key stakeholders of the company 
whom the Board considered and engaged 
with. Stakeholder benefits arising from 
the decisions are shown below. Further 
information that demonstrates how the 
directors have fulfilled their duties are 
shown within the Strategic Report and 
Directors’ Report.

The Board of INSPECS believes that it 
has acted and made decisions in a way 
considered most likely to promote the 
success of the company for the benefit  
of its members. In doing so we gave 
regard to:

OUR COMMUNITIES

HOW WE ENGAGE

The group now operates 
globally and we are 
expected to operate in a 
responsible way ensuring 
consideration to those 
around us and continuing to 
minimise our effect on the 
environment

During 2020 the group has developed and supplied 
PPE to NHS Trusts and Healthcare Centres in the 
USA. The group continues to design and develop 
new PPE products.

Our new facility in Vietnam has been built to ensure 
less water and electricity consumption.

We have developed a relationship with tree planting 
companies so we can offset some of our carbon 
emissions.

OUR SUPPLIERS

HOW WE ENGAGE

Fair trading and 
payment terms

The group ensures that all suppliers are paid and 
treated equally and the Board reviews average 
supplier days.

Collaboration and 
long-term partnerships

We engage with our key suppliers for the long term 
and aim to create a partnership of supply.

Supplier engagement check 
that they comply with 
modern slavery laws

We monitor key suppliers to ensure compliance with 
modern slavery laws.

ENVIRONMENT

HOW WE ENGAGE

Ensuring the group takes 
into effect climate change 
on both its business and its 
supply chain and continues 
to manage its pollution 
and waste

The group continues to move to renewable energy 
where possible and is establishing an annual review 
of key operations and the effect of climate change 
on those operations. The group has introduced new 
efficient supply chain routes and developed a range 
of new environmentally friendly products. 

1    

The likely long-term consequences of 
any decision;

KEY DECISIONS

2    

The interests of the company’s 
employees;

3    

The need to foster the company’s 
business relationships with suppliers, 
customers and others;

4    

The impact of the company’s 
operations on the community and 
the environment;

5    

The company’s desire to maintain  
a reputation for business conduct  
of the highest standard; and

6    

The need to act fairly between 
members of the company.

1   REDUCTION IN OPERATING EXPENSES OF THE BUSINESS

 The group where appropriate moved to a 4-day week and cost reductions 
were implemented. This allowed the group to reduce cash expenditure and 
maintain profitability.

2   ENSURING PPE EQUIPMENT IS AVAILABLE TO ALL STAFF

 The Board ensured relevant PPE equipment is available to all employees at all 
company locations.

3   CANCELLATION OF FY 2020 DIVIDENDS

 The Board agreed not to pay any dividends to preserve cash.

4  WORK FROM HOME INSTIGATED

 The Board agreed working from home for employees and authorised the 
company to invest where necessary to ensure that employees could work with 
minimum disruption. This allowed the group to trade effectively despite the 
COVID-19 disruptions.

5  BOARD SALARY REDUCTIONS

 The Board took 20% pay reductions from April 2020 and the Executive team’s pay 
was reduced by 60% from April 2020 to December 2020.

37

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020 
 
 
 
 
Principal Risks and Uncertainties

ADDRESSING RISK AT INSPECS

Our risk management framework covers every part of our business.

The Board meets regularly to identify risks in 
our operations as they arise. Having identified a 
new risk, the Boards receives an assessment of 
the risk and then reviews and approves plans to 
mitigate it.

RISK RESPONSIBILITY
The Board of INSPECS has the overall responsibility for risk 
management and ensuring mitigation and continual monitoring 
of risk. Responsibility for reviewing risk is delegated to the Audit 
Committee and the Executive team and operational heads are 
responsible for implementing controls and processes across 
our business.

The final step in the process is the continual 
management by both the Board and the key 
employees of the inherent risks in the business.

The Board has a zero tolerance in relation to health and safety 
issues within our control in all jurisdictions within which we 
operate.

1

IDENTIFY RISK 
AS A CONTINUAL 
ASSESSMENT

2

MITIGATE  
RISK

3

MANAGE AND 
MONITOR

RISK MANAGEMENT
The Board is responsible for reviewing risks to ensure that the business is not 
exposed to unnecessary or poorly managed risks.

RISK

POTENTIAL IMPACT

MITIGATION

COVID-19 
and potential 
health risk

New risk

COVID-19 virus and public health issues 
amongst our staff, our supply chain and 
our distribution network and their impact 
on the ability of the company to trade.

•  Transition to remote working for many positions completed 

and operated at short notice.

•  Management direction and collaboration of all staff.
•  Continued stress testing of finances to ensure robust stability.
•  Cost reduction implemented quickly.

Disruption to 
our supply chain 
and distribution 
network

Disruption to both our factory production 
and our subcontracted production could 
limit the ability of the group to supply its 
customers.

•  The group has continued to retain its relationship with key 
subcontracted manufacturers, which allows a switch in 
production if necessary from our own factories.

•  Work undertaken with key customers to transfer supply from 

air routes to sea when possible.

•  Increased stock of key production materials.

Poor quality or inconsistent quality of the 
group’s products could reduce future 
demand for the group’s products.

•  Dedicated in-house Quality Control (‘QC’) teams embedded 

in production facilities in Vietnam and China.

•  Secondary QC teams visits key subcontracted factories to 

Misappropriation of cash or group assets 
could impact the group’s ability to trade.

ensure quality control.

•  Major chain QC teams embedded in factory production 

facilities in China and Vietnam.

•  Cash balances monitored daily.
•  Multi-level authorisation required to transfer cash.
•  HSBC banking platform in the process of being rolled out 

across key parts of the group.

•  Fixed asset register in place and reviewed.
•  Group Insurance in place covering all major risks and assets.

Existing risk

Quality control 
of products 
supplied

Existing risk

Integrity of cash 
and material 
group assets 

New risk

38

RISK

POTENTIAL IMPACT

MITIGATION

Data protection 
and GDPR

New risk

Economic and 
political risk

Loss of data used to conduct our 
business and information on customers 
received under GDPR could lead to both 
reputational and Government penalties.

Recession or downturn in the global 
economy may reduce consumer demand. 
Cost may increase due to Government 
policy and legislation.

The impact of Brexit could interrupt our 
daily inflow and outflow of goods. Sudden 
surge in exchange rates and import tariffs 
could affect our business.

Loss of key management and senior 
employees could impact the group’s 
ability to continue to trade and affect the 
intended growth of the group.

Existing risk

Brexit

New risk

Loss of staff

Existing risk

Rapid change 
in size of 
group and 
complexity

New risk

•  GDPR policies constantly updated in group’s operating 

manuals.

•  Training on GDPR in place across the group.
•  New Head Office IT department created in 2020.

•  The Board constantly monitors legislation changes that may 

affect the group.

•  Diversified regional supply chain established.
•  Group operates in over 80 countries worldwide.
•  Multi-channel revenue streams.
•  Group operates in markets deemed by Governments as 
essential allowing trade to continue during lockdowns at 
present.

•  The Board continues to monitor Brexit issues and the effects 

on the group’s trading.

•  The group has distribution and operational offices in both 
Germany, Portugal and the UK, thus allowing the group to 
operate throughout Europe.

•  The group has the ability to divert if required products direct 

to its German distribution hub.

•  Each key trading subsidiary has highly experienced 

management team in place.

•  All key senior management are part of the group LTIP Scheme.
•  Business plans and initiatives are documented and prepared with 
cross-functional input to reduce reliance on single individuals.

•  Remuneration Committee seeks to ensure rewards are 

commensurate with performance and aides the retention of 
key employees.

Key management time and resources 
engaged in integration which may slow 
the growth of the group.

•  Additional accounting and IT Staff have been recruited to 

ensure smooth integration.

•  Additional senior management retained with the acquisition.

Treasury and 
financial control

Inefficient use of cash resources with 
potential increase in interest costs.

•  New Chief Treasury Officer positioned to monitor treasury and 

cash custody.

New risk

Product safety

Existing risk

Credit risk

Reduced risk

Risk of adverse reaction to one of our 
products, constituting a safety risk for  
our consumers

•  Products are tested and certified by independent laboratories 

as safe for use.

•  Maintenance of regulatory approval for all our products in the 

markets we trade in.

•  Maintenance of public and product liability insurance to give 

the company appropriate protection.

The group has managed its credit risk successfully during 2020 and following a review, the groups exposure to 
bad debts and other credit risks has not been material. Though considered a low risk in 2019, it has now been 
removed as a risk but is regularly monitored.

39

> Strategic Report> Corporate Governance> Financial StatementsINSPECS Annual Report & Accounts 2020BOTANIQ Optical  
SS21 Campaign

40

CORPORATE
  GOVERNANCE

Corporate Governance Statement 
Board of Directors 
Key Management 
Audit and Risk Committee Report 
Remuneration and Nomination 
Committee Report 
Directors’ Report 
Statement of Directors’ Responsibilities 

42
46
48
50

52
54
57

41

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceCorporate Governance Statement

INTRODUCTION 
FROM THE 
CHAIRMAN

Lord MacLaurin
Chairman
INSPECS Group plc

As INSPECS Group plc Chairman I lead the Board with overall 
responsibility for corporate governance in promoting the values 
of the group both internally to employees and externally to our 
stakeholders. The Board recognises and values the importance of 
good corporate governance and how an appropriate corporate 
governance framework supports the operational, financial and 
risk management of the group and this in turn effectively drives 
performance and enables the achievement of strategic objectives 
to be reached for the benefit of all stakeholders.

As part of our commitment to a high standard of governance 
the Board recognises the importance of having suitably qualified 
Non-Executive Directors who are independent in character and 
are free from any relationship that could affect their judgement. 
Our Non-Executive team consists of Richard Peck who has over 
20 year’s industry experience with eyewear and supports the 
Executive team together with Angela Farrugia who has a wealth 
of experience in relation to brands and consumer products, and 
finally Christopher Hancock who is a Chartered Accountant and 
has been involved in multiple corporate transactions over the 
years and is able to support our Executive team on acquisitions. 

The Board firmly believes that driving our long-term goals should 
not be at the expense or detriment to others with whom we 
engage and also the environment in which we globally operate. 
We are committed to generating our long-term goals for all our 
stakeholders with as little impact on the environment as possible.

The Board complies with all the principles of the QCA Corporate 
Governance Code. The Board recognises that it is accountable 
to a wide variety of stakeholders including employees, 
shareholders, customers, suppliers and the wider communities 
in which we operate.

The corporate governance framework which is currently operated 
is based on practices which the Board believes are proportionate 
to the size and footprint of the company. This coming year 
the Board will hold meetings when travel permits at principal 
overseas subsidiaries allowing the Board to directly meet with 
senior management and employees in these principal areas.

THE BOARD IS 
RESPONSIBLE 
FOR THE GROUP 
STRATEGY AND 
FOR ITS OVERALL 
MANAGEMENT.
The Strategic Report on pages 4 to 39 
summarises the approach by the Board 
in promoting sustainable long-term 
growth of our business.

42

BOARD DIVERSITY

BOARD COMPOSITION

1

2

Male

Female

5

Independent

Executive

4

HOW THE BOARD OPERATES
The Board is responsible for the group’s overall strategy and  
for the overall management of the group. The Strategic Report 
on pages 4 to 39 outlines the key approach of the Board to 
ensuring and promoting the long-term sustainable growth  
of the company for all shareholders.

The main matters for consideration by the Board include:

•  Financial reporting and financial controls.

•  Monitoring of health and safety across the group.

•  Approval of material contracts and group expenditure.

•  Communication with stakeholders.

•  Financing and capital adequacy of the group.

•  Agreeing budgets and forecasts.

•  Reviewing acquisitions.

•  Oversight of the Executive team.

BOARD MEETINGS
The Board was scheduled in 2020 to hold six meetings to review quarterly updates including the AGM and then two subsequent one-
day meetings to agree the interim and year-end financial accounts. However, due to COVID-19 and material acquisitions in the year it 
was agreed that the whole Board would meet on a regular basis to review and question these material transactions. As such and due 
to COVID-19 and subsequent acquisitions the Board met more frequently than was originally planned.

Scheduled Meetings

Board 

Remuneration 
Committee

Audit 
Committee

Lord Ian MacLaurin

Angela Farrugia

Richard Peck

Christopher Hancock

Robin Totterman

Christopher Kay

* 

In attendance.

20

14

19

22

22

22

2

–

2

2

–

2*

3

–

3

3

–

3*

Directors are expected to attend all meetings of the Board 
and the Committees on which they sit. In the event of a Board 
member not being able to attend their respective Committee or 
the Board their comments are passed to the Chairman.

43

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceCorporate Governance Statement 
continued

BOARD COMMITTEES
The Board has delegated some specific responsibilities to the 
Audit and Risk Committee and Remuneration and Nomination 
Committee. The respective reports are shown on pages 50 to 53.

DEVELOPMENT
The company Secretary ensures that all Directors are kept up to 
date with changes in relevant legislation. This includes liaising 
with the group’s advisers, principally our Nomads, Peel Hunt  
and our group corporate lawyers, Macfarlanes.

BOARD COMPOSITION
The Board consists of five male and one female Director. The 
Board believes it has the right skill sets and knowledge and up to 
date experience to discharge its duties responsibly and deliver on 
the goals of the group’s strategy for the long-term growth of the 
company for the benefit of all stakeholders.

The Board fully supports the Financial Conduct Council’s aim of 
encouraging diversity. A full breakdown of gender representation 
for directors is shown on page 43 of this report. 

BOARD AND BOARD COMMITTEE EFFECTIVENESS REVIEW
The Board is undertaking a review of its effectiveness and this 
review will include the following but not exclusively:

•  Response to new events and unscheduled developments.

•  COVID-19.

•  Acquisitions.

•  Conduct rigorous discussion and debate.

•  Setting strategy.

•  Composition of the Board and future development.

BOARD MEMBERS’ INDEPENDENCE
The Board considers and ensures that each of the Directors is 
independent of management. The Board is led by the Chairman 
who ensures fair and constructive debate where appropriate.

The founder and CEO has a substantial shareholding in the group 
but this does not detract from the Board’s ability to exercise 
independent judgement and enquiry.

CONFLICTS OF INTEREST
The Board ensures that each member of the Board declares 
any interest in matters to be discussed and regularly reminds 
Board members of their duty to disclose any potential conflicts 
of interest.

DIRECTORS’ AND OFFICERS’ LIABILITY INSURANCE
The group has purchased Directors’ and Officers’ insurance 
during the period and holds insurance to the benefit of the 
Executive team.

SENIOR INDEPENDENT DIRECTOR
Christopher Hancock is the Senior Independent Director and is 
also Deputy Chair-elect and will act as Lord MacLaurin’s alternate 
when required.

ELECTION OF DIRECTORS
All Directors will offer themselves for re-election at the 
forthcoming Annual General Meeting.

RELATIONSHIP WITH STAKEHOLDERS
Continuing engagement with shareholders and stakeholders 
in the group is of prime importance to the Board. This 
communication is both by the Annual Report and Accounts and 
its interim accounts and RNS releases when appropriate. The 
group communicates through its website www.inspecs.com and 
investor information is available on the website.

The Non-Executive team is available to discuss matters that 
stakeholders may wish to raise and the Executive team holds 
meetings with investors on a timely basis. In the period under 
review feedback from stakeholders did not give rise to a change 
in the group strategy. 

The group has regular reviews from material customers on 
its performance and these are closely monitored, and the 
group maintains regular communication with a wide range of 
stakeholders.

ANNUAL GENERAL MEETING
The Annual General Meeting of the company will take place on 
19 July 2021. The Notice of Annual General Meeting and the 
Ordinary and Special Resolutions to be put before the meeting 
are contained in the Notice of the Annual General Meeting 
accompanying this Annual Report.

CORPORATE GOVERNANCE CODE
The Board recognises the corporate responsibility in the way 
that INSPECS operates around the globe. In January 2020 the 
Board approved the adoption of the Quoted Companies’ Alliance 
Corporate Governance Code for small and mid-sized quoted 
companies, known as the QCA Code.

The Board is accountable to a wide range of stakeholders and to 
ensuring its primary goal of long-term sustained growth whilst 
acting in a sustainable manner. Examples of our continued work 
on sustainability are covered in pages 28 to 35 of this report.

The Board has ultimate responsibility for internal control and how 
we manage this process is shown on pages 38 and 39.

Our gender diversity is shown on pages 30 and 31 of this report. 
The principal elements of internal control are as follows:

44

THE QCA CORPORATE GOVERNANCE CODE

Governance Principles

Compliant Explanation

Further Reading

DELIVER GROWTH

1

2

3

4

Establish a strategy and 
business model which 
promotes long-term value for 
shareholders.

Seek to understand and meet 
shareholders’ needs and 
expectations.

Take into account wider 
stakeholders and social 
responsibilities and their 
implications for long-term 
success.

Embedded effective risk 
management, considering 
both opportunities and threats 
throughout the organisation.

The Board is responsible for group strategy and 
its implementation. This strategy is debated and 
tracked by the Board who monitor its progress.

See pages 6 to 23 to learn 
more about our strategy 
and business model.

Meetings are held with investors and analysts at 
half-yearly interim and final accounts. The AGM 
provides a forum for all shareholders to meet and 
hear from the Directors, and shareholder comments 
and suggestions are welcomed by the Board.

See page 36 to see how 
we communicate. Further 
information is available  
on our on website  
www.INSPECS.com.

The Board has identified the key stakeholders in 
the business and discusses the impact of the long-
term growth strategy and how our business model 
may affect these stakeholders.

See pages 36 and 37 to see 
how we communicate and 
deal with our stakeholders.

The Audit Committee and the Board review risks 
to the group, both internal and external. Health 
and Safety is of paramount importance and a 
standard Board meeting agenda item.

See pages 38 and 39 for 
further detailed information 
on risk management.

MAINTAIN A DYNAMIC MANAGEMENT FRAMEWORK

5

6

7

8

9

Maintain the Board as a well-
functioning, balanced team led 
by the Chairman.

Ensure that between them the 
Directors have the necessary 
up-to-date experience, skills 
and capabilities.

Evaluate Board performance 
based on clear and relevant 
objectives, seeking continuous 
improvement.

Promote a corporate culture 
that is based on ethical values 
and behaviours.

Maintain governance structure 
and processes that are fit for 
purpose and support good 
decision-making by the Board.

BUILD TRUST

10

Communicate how the 
company is governed and is 
performing by maintaining 
dialogue with shareholders and 
other relevant stakeholders.

The Board consists of three experienced relevant 
Non-Executive Directors and the CEO and CFO. 
The Board has a wealth of experience on strategy, 
operations and financial matters. The Chairman 
engages in open debate and new goals are 
challenged.

See Board Director 
information pages 46 and  
47 for further guidance.

The Board believes that it has the required skills 
and correct balance of capabilities to manage the 
group. Members of the Board keep their skill levels 
up in a variety of ways throughout the year.

See pages 46 and 47 of our 
Corporate Governance 
Report.

During 2021 a Board evaluation will take place to 
ensure the Board have the required necessary 
collective skills. This review will take place on an 
annual basis.

The criteria to be used to 
evaluate the Board is set  
out on page 52.

The Board promotes and encourages, across 
the group, the core values of the group. The aim 
is to deliver continual improvement in both the 
economic performance of the group but also its 
social responsibility to the wider community.

The Board’s governance model is widely known 
as the unitary system. The Board is aided by 
two subcommittees to undertake specific work. 
The Board has regular information flows and has 
regular meetings to ensure they have the ability to 
review, debate and make well-informed decisions.

See pages 42 to 44 of the 
Corporate Governance 
Report.

See more information on 
the Committee Reports on 
pages 50 to 53.

INSPECS has open communication with a wide 
range of stakeholders. This includes regular 
updates with investors, yearly and half yearly 
reports and regulatory news service releases on 
key corporate matters.

See pages 36 and 37 of the 
Strategic Report.

45

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceBoard of Directors

AN EXPERIENCED AND FOUNDER LED TEAM

Lord MacLaurin  
Audit and Risk Committee 
Member, Remuneration and 
Nomination Committee Member

Angela Farrugia  
Independent Director

Richard Peck 
Audit and Risk Committee 
Member, Remuneration and 
Nomination Committee Member

TENURE

Lord MacLaurin has served 
as Board Chairman since 
8 March 2017.

Angela was appointed as a 
member of the Board in 
12 May 2020.

Richard has served as a 
Board member since 
10 January 2020.

SKILLS, COMPETENCE AND EXPERIENCE 

Lord Ian MacLaurin is a well-
known figure in business 
with a stellar track record 
of successfully leading plc 
companies through significant 
change. Having served as a 
Chairman of Tesco between 
1985 and 1997, which he is 
credited with building up into 
the UK’s largest retailer, Lord 
MacLaurin went on to serve 
as the Chairman of Vodafone 
between 1999 and 2006. His 
tenure in the House of Lords 
lasted over two decades. Lord 
MacLaurin brings invaluable 
insights and experience to the 
group’s ambitious and global 
growth plans.

Founder of one of the 
most successful brand 
management companies in 
the world, Angela formed TLC 
(The Licensing Company Ltd) 
in London in 1996. Creating 
a new breed of agency, the 
business grew to encompass 
24 offices in 16 countries and 
amassed a roster of leading 
brand representations in 
various sectors, generating 
over $12.4bn in retail sales 
annually for its clients. In 
addition to 22 years operating 
experience gained within 
a challenging international 
business environment, 
Angela’s appointment has 
satisfied one of the Board’s 
objectives, increased Board 
diversity.

Richard Peck has over 37 years 
of optical experience. Richard 
brings a wealth of experience 
from working in other leading 
eyewear companies, such as 
David Clulow and Luxottica, 
where he held the position 
of Managing Director Retail 
Northern Europe between 
2010 and 2018. Richard’s 
retail background increases 
the Board’s diversity of skills, 
knowledge and experience.

COMMITTEE MEMBERSHIP KEY

Audit & Risk Committee

Remuneration & Nomination Committee

Group Projects & Acquisitions Committee

C

Chairman

46

EXECUTIVE TEAM

Christopher Hancock FCA 
Audit and Risk Committee Chair
Remuneration and Nomination 
Committee Chair

C

C

Robin Totterman 
Group Chief Executive Officer

Chris Kay 
Group Chief Financial Officer

Christopher has served as a 
Board member for INSPECS 
Holdings Limited since 
8 March 2017.

Robin has been a Board 
member since founding 
INSPECS in 1988.

Christopher Hancock FCA 
has 30 years experience 
in business development, 
restructuring and corporate 
finance. Christopher qualified 
as a chartered accountant 
with Arthur Andersen before 
entering investment banking, 
where he spent 10 years with 
JP Morgan. He established 
his own consultancy practice 
in 2009 and co founded an 
FCA regulated corporate 
finance and investment 
management firm in 2012. 
Christopher brings a broad 
range of experience in 
business development, M&A 
and corporate finance across 
several sectors.

Robin Totterman is 
an entrepreneur and 
forerunner in the branded 
eyewear industry with over 
30 years experience in 
eyewear licensing, design, 
manufacture and wholesale. 
Robin’s passion for design 
and fashion brought the 
first branded eyewear to the 
UK optical market (Jean-
Paul Gaultier). His ability 
to recognise value and 
seize opportunity saw him 
complete the acquisition 
of Killine in 2017, creating a 
vertically integrated group 
rivalled by only a small 
number of eyewear firms. 
Prior to INSPECS, Robin 
worked at UBS Swiss Bank 
and Banque Paribas.

Chris has been involved 
with INSPECS since it was 
founded in 1988 and has 
served as a Board member 
for INSPECS Holdings Limited 
since 13 November 2013.

Chris Kay is a qualified 
chartered accountant and 
became a partner of Thorne 
Lancaster Parker, a UK 
accountancy and taxation 
firm, in 1992. He became 
Finance Director of INSPECS 
in 2013 and works closely with 
Robin Totterman on strategy 
for the group. Chris’ business 
development and M&A 
experience was pivotal to the 
execution and integration 
of INSPECS’ Killine group 
acquisition in 2017 and further 
acquisitions of Norville and 
Eschenbach in 2020.

Chairman

47

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceKey Management

KILLINE GROUP

Marc Lefebvre

Ha Bui

Michael Zhang

ESCHENBACH GROUP

Jorg Zobel

Holger Mass

Matthias Anke

Scott Sennett

Ken Bradley

Jennifer Coppel

48

NORVILLE

Nevil Trotter

Sean Donnachie

Paul Jones

INSPECS UK

Steve Tulba

Clare Lovett

Jon Bloom

INSPECS USA

Vance Wright

Monika Hladik

Michael Dorling

49

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceAudit and Risk Committee Report

COMMITTEE CHAIR

COMMITTEE MEMBERS

Christopher Hancock FCA  
Audit and Risk Committee Chair

Lord MacLaurin

Richard Peck

The members of the Audit and Risk Committee are all 
independent, Non-Executive Directors in compliance with 
the QCA Code. The Audit and Risk Committee is chaired 
by Christopher Hancock and is responsible for the following 
main areas. 

INTERNAL AUDIT
The group does not have an internal audit function. However,  
due to the enlarged group size it is expected that this will be in 
place by 2022.

•  Reviewing and monitoring the financial performance of 

the group.

•  Reviewing the integrity of the financial statements.

•  Reviewing the internal control and risk management systems.

RISK GOVERNANCE
The Committee meets at least twice a year to consider the 
risks faced by the group and to ensure that policies are in place 
to mitigate them. The results of this review are set out under 
Principal Risks and Uncertainties on pages 38 and 39.

INTERNAL CONTROL ENVIRONMENT
The group uses both manual and automated systems to control, 
monitor and report risk matters. The principal elements of the 
group’s internal control are:

•  Close management and monitoring of the group’s Executive 

Directors.

•  Monitoring the organisational structure and promoting risk 

based decision-making.

•  A comprehensive annual budgeting process producing 

detailed profit and loss, balance sheets, and cash flows on  
a rolling 12-month basis.

•  Comprehensive monthly reporting of KPI control of risk  
areas and capital expenditure and banking facilities.

•  Advising on the suitability and independence of the 

external auditors.

•  Reviewing extent of non-audit services provided to the group.

•  Engaging with the external audits and ensuring the scope of 

the audit is acceptable.

•  Monitoring the disclosures in the Annual Reports and Accounts.

•  Reviewing changes in accounting policies.

EXTERNAL AUDIT
The external auditors EY were reappointed on 30 June 2020. 
The fee for the audit to 31 December 2020 is $901,000 (2019: 
$724,000). The Audit Committee undertakes a review of the 
effectiveness and independence of the group auditors. The fee 
increase incurred in 2020 was primarily as a result of the change 
in complexity of the group following the acquisition that took 
place in 2020 of the Norville and Eschenbach businesses.

MEETINGS, ATTENDANCE AND TIME COMMITMENT
The Audit and Risk Committee has unrestricted access to 
the group’s auditors and is mandated to meet twice a year. In 
addition the Committee has meetings with external auditors 
without management present. The group CFO attends the 
meetings of the Committee by invitation.

50

 
SIGNIFICANT FINANCIAL JUDGEMENTS
During the year the Audit Committee considered the following 
significant issues regarding the financial statements and having 
reviewed were satisfied that they were appropriately stated.

•  COVID-19 and the effects on the group at both the 

performance and also at the going concern level. The 
Committee continues to monitor the effect of COVID-19 and 
the impact on any assets as a result of the disruption to trade 
caused by COVID-19.

•  The Committee reviewed the acquisition of the Norville and 

Eschenbach businesses and the fair value of intangible assets 
and valuation of goodwill. For the acquisition of Eschenbach, 
KPMG were appointed to carry out the conversion of the 
principal statements from German GAAP to IFRS accounting 
standards, as well as the identification and valuation of 
intangible assets arising on the acquisition and the allocation 
of goodwill.

•  Goodwill and intangible assets are significant values in the 
balance sheets and the Committee reviewed any potential 
impairment that might be required and the cash flows of the 
CGU (cash-generating units) and the discount rates applicable 
to the CGU.

•  The Committee reviewed revenue recognition and in particular 
the right of return assessment impacting on new acquisitions 
in 2020.

•  The Committee reviewed the tax provisions recognised relating 

to transfer pricing and permanent establishment risks.

MEETINGS AND ATTENDANCE

Member

Attendance

Christopher Hancock

Lord MacLaurin

Richard Peck

3/3

3/3

3/3

51

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate Governance 
Remuneration and Nomination Committee Report

COMMITTEE CHAIR

COMMITTEE MEMBERS

Christopher Hancock FCA  
Remuneration and Nomination Committee Chair

Lord MacLaurin

Richard Peck

The Remuneration and Nomination Committee is chaired by 
Christopher Hancock and its members Lord MacLaurin and 
Richard Peck are all independent Directors, in line with the 
QCA code. 

MANDATE 
The Committee operates under the Board’s agreed terms of 
reference and is responsible for: 

•  Considering and monitoring the group’s policy in relation to 
employment terms and packages of the Executive Directors 
and key employees in the group. 

•  Evaluating the performance of the Executive Directors and 
making recommendations to the Board relating to their 
remuneration and terms of employment. 

•  Reviewing and approving the LTIP share option plan and 
proposals for the issue of share options and pension 
arrangements.

MEETINGS AND ATTENDANCE

Member

Attendance

Christopher Hancock

Lord MacLaurin

Richard Peck

2/2

2/2

2/2

Long-Term Incentive Plan: Following admission to AIM on 
27 February 2020, options were granted at the mid-market 
price to Executive Directors and key senior employees. On 
22 December 2020 further options were granted following 
the successful acquisition of Eschenbach.

Option 
Granted

549,460

150,000

150,000

50,000

50,000

1,373,650

1,180,000

Date

27/02/2020

22/12/2020

22/12/2020

22/12/2020

22/12/2020

27/02/2020

22/12/2020

Price 
£

1.95

2.10

2.10

2.10

2.10

1.95

2.10

Name

Christopher Kay

Robin Totterman

Angela Farrugia

Richard Peck

Senior employees

Senior employees

52

These options have a three year vesting period from the date 
of grant. The total options outstanding as at 31 December 2020 
were 4,327,307 and this represents 4.3% of the company’s issued 
share capital as at 31 December 2020.

2020 ANNUAL BONUS
As the performance targets of the group were not met in the year 
to 31 December 2020 no profit-related bonus is payable.

The Committee notes that the CEO, CFO and all the Non-
Executive Directors took immediate pay reductions in March 
2020 as a result of the COVID-19 restrictions and these reductions 
remained in place to the end of the financial year.

SERVICE CONTROLS
The Executive Directors signed new service contracts on 
27 February 2020. They have no fixed duration. These service 
contracts are terminable with six months’ notice.

The CEO and CFO are invited to attend the Remuneration and 
Nomination Committee meetings as appropriate but will make 
themselves absent as and when required.

DIRECTORS’ INTEREST IN SHARES
The interests of the Directors as at 31 December 2020, including 
their family, in the Ordinary Shares of the company were.

Ordinary Shares of 1p each

Lord MacLaurin

Robin Totterman

Richard Peck

Angela Farrugia

Christopher Hancock

78,346

19,381,048

9,523

11,904

16,440

Christopher Kay

2,191,426

DIRECTORS’ EMPLOYMENT AND PENSION 
CONTRIBUTIONS TO 31 DECEMBER 2020

DIRECTORS’ EMPLOYMENT AND PENSION 
CONTRIBUTIONS TO 31 DECEMBER 2019

Remuneration and 
Pension Contribution 
of Individual Directors

USD

Salary 
or Fees

Taxable 
Benefits

Total 
Remuneration

Lord MacLaurin

–

Robin Totterman

170,106

Richard Peck

Angela Farrugia

Christopher Hancock

–

–

–

–

–

–

–

–

–

170,106

–

–

–

Christopher Kay

93,449

14,996

108,445

TRANSACTION WITH DIRECTORS
The only material transaction between the Directors and the 
company were as follows:

•  Rent payable by INSPECS Limited on Kelso Place, the 

headquarters of the company. This rent is reviewed to ensure 
it is on a normal commercial basis and amounted to $113,000 
in the year to 31 December 2020 (2019: $160,000). The building 
is owned by Kelso Place LLP of which Robin Totterman is the 
controlling partner.

•  Christopher Hancock is a partner of Farm Street Partners which 
charged the group fees of $13,000 (2019: $15,000) during the 
year.

•  Angela Farrugia is a Director of BXS Projects Limited which 

charged the group $10,000 (2019: $nil) during the year.

The price movement of the shares in the company following 
admission to the London AIM from the lowest to highest 
is set out below:

27 February 2020

Highest market price

Lowest market price

£1.95

£3.30

£1.40

Remuneration and 
Pension Contribution 
of Individual Directors

Lord MacLaurin

Salary 
or Fees

34,828

USD

Taxable 
Benefits

Total 
Remuneration

–

Robin Totterman

185,802

3,384

Richard Peck

Angela Farrugia

Christopher Hancock

42,102

27,726

42,102

–

–

–

34,828

189,185

42,102

27,726

42,102

Christopher Kay

137,345

14,838

152,184

53

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceDirectors’ Report

The Directors present their report together with the audited financial statements for the 
period ended 31 December 2020. The Corporate Governance Statement on pages 42 to 45 
also forms part of this Director’s Report.

REVIEW OF BUSINESS
The Chairman’s Statement on page 8 and the Strategic Report 
on pages 4 to 39 provides a review of the business, the group’s 
trading for the year ended 31 December 2020, key performance 
indicators and an indication of future developments.

RESULT AND DIVIDEND
The group has reported its Consolidated Financial Statements in 
accordance with International Financial Reporting Standards as 
adopted by the European Union.

The group results for the year are set out in the Consolidated 
Statement of Comprehensive Income on page 71. The company 
financial statements have been prepared under FRS 101 for the 
year ended 31 December 2020.

The group’s revenue of $47.4m (FY19: $61.2m), gross margin of 
43% (FY19: 45%) and loss after tax of $8.9m (FY19: profit $6.4m) 
represent an encouraging year for the business given the 
challenging circumstances relating to COVID-19.

Period ended

Revenue ($m)

Gross Margin %

(Loss)/profit after tax ($m)

Reported IFRS

31 December 2020 31 December 2019

47.4

43.3

(8.9)

61.2

45.0

6.4

The Board is not recommending a final dividend.

DIRECTORS
The Directors of the group during the period were:

Executive

Robin Totterman

Christopher Kay

Non-Executive

Lord Ian MacLaurin

Angela Farrugia

Richard Peck

Christopher Hancock

The names of the Directors, along with their brief biographical 
details are given on pages 46 and 47.

DIRECTOR’S INTEREST
The Directors’ interest in the share capital of the company at 
31 December 2020 is shown below:

Robin Bjorn Christian Totterman

Christopher Kay

Lord Ian MacLaurin

Christopher Hancock

Angela Farrugia

Richard Peck

2020

19,381,048

2,191,426

78,346

16,440

11,904

9,523

POLITICAL DONATIONS
The group made no political donations in the financial period.

DISCLOSURE OF INFORMATION TO AUDITOR
As far as the Directors are aware, there is no relevant audit 
information (that is, information needed by the group’s auditor 
in connection with preparing their report) of which the group’s 
auditor is unaware, and each Director has taken all reasonable 
steps that he or she ought to have taken as a Director in 
order to make himself or herself aware of any relevant audit 
information and to establish that the group’s auditor is aware 
of that information.

FINANCIAL RISKS
The financial risk management objectives of the group, 
including credit risk, interest rate risk and foreign exchange 
risk, are provided in note 34 to the Consolidated Financial 
Statements on page 115.

SHARE CAPITAL STRUCTURE
At 31 December 2020, the company’s issued share capital was 
£1,012,909 divided into 101,290,898 Ordinary Shares of 0.01p each. 
The holders of Ordinary Shares are entitled to one vote per share 
at the general meetings of the company.

54

SUBSTANTIAL SHAREHOLDERS
At 31 December 2020, the company had been notified of the 
following substantial shareholders comprising of 4% or more of 
the issued Ordinary Share capital:

% of issued share capital

Robin Bjorn Christian Totterman

Canaccord Genuity Group Inc

Amati Global Partners

Janus Henderson Group Plc

Aberdeen Standard Investments

Chelverton Asset Management Ltd

Royal London Asset Management

Tellworth Investments

BlackRock

19.1%

14.8%

6.1%

5.6%

4.8%

4.7%

4/6%

4.4%

4.0%

SHARE OPTION SCHEMES
Details of employee share scheme are set out in note 33 to the 
Consolidated Financial Statements.

PURCHASE OF OWN SHARES
There was no purchase of our own shares in the period.

GOING CONCERN
The group continues to respond well to the challenges associated 
with the COVID-19 pandemic which did cause disruption to the 
business during 2020. This was predominantly experienced in 
the first half of the year when major distribution hubs and the 
optical retail markets were closed except for emergencies as 
lockdowns were introduced around the globe in response to the 
pandemic. During subsequent lockdowns later in the year, the 
optical retail market was deemed essential which resulted in the 
group gradually returning to normal trading levels. For the rest 
of the year the group was therefore able to trade profitably and 
generate cash with the supply chain unaffected. 

Looking to the future, the group has performed a going concern 
review, going out until December 2022, considering both a base 
case and a downside case (described below). Having reviewed 
this forecast and having applied a reverse stress test (also 
described below), the possibility that financial headroom could be 
exhausted and a covenant could be breached is considered to be 
remote. 

The base case assumes COVID-19 related restrictions consistent 
with those in place in January 2021 remain for the duration of 
2021 with normal trading resuming in 2022, results in a 10% year 
on year increase to sales. The restrictions in place at this time 
restricted a return to office working, reduced footfall on the high 
streets and reductions in non-prescription sales as a result of the 
continuing closure of airports and non-essential retail. The base 
case also assumes no cash flow mitigations are actioned during 
the period covered by the going concern review. 

The downside case assumes the same restriction remain as in 
the base case but with a 10% reduction in sales from April 2021 
compared to the base case, and these same restrictions also 
being in place during 2022. In this scenario we also assumed 
some cost saving measures being implemented at a conservative 
level. These measures are consistent with those which were 
implemented in 2020 and which we therefore know the group  
can achieve and relate to reductions in factory overheads.

The directors consider the main risks to going concern to be 
liquidity and compliance with covenants, and so have performed 
a reverse stress test which incorporates the breach of the 
covenant. The group would breach a covenant before it runs  
out of cash in any scenario.

The group’s borrowings with HSBC, amounting to $35.0m, 
contains two covenants being one leverage ratio and one 
interest cover ratio. Compliance with these covenants is based 
on 12 month rolling EBITDA results and 12 month rolling 
interest payments respectively. In addition, the newly acquired 
Eschenbach Group has covenants relating to equity ration, 
leverage ratio and EBITDA. These covenants are less sensitive 
than the HSBC covenants and the group would be able to repay 
these loans before a covenant breach using available cash. The 
group has the ability to transfer cash across different group 
entities as needed. In order for the business to breach one of 
the HSBC covenants, the reverse stress test requires that, after 
implementing all available mitigating scenarios, there is a 22% 
reduction to the sales forecasted in the base case from April 2021 
through to December 2022 along with a 4% drop in gross margin. 
This scenario also factors in full repayment of all borrowings aside 
from the HSBC facility and settlement of an uncertain tax position 
at the highest possible range. 

55

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceAUDITOR
Ernst & Young has expressed its willingness to continue in office 
as auditor and a resolution to reappoint them will be proposed at 
the forthcoming Annual General Meeting.

ANNUAL GENERAL MEETING
The Annual General Meeting will be held on 19 July 2020. The 
ordinary business comprises receipt of the Directors’ Report and 
audited financial statements for the year ended 31 December 
2020, the re-election of directors, the reappointment of Ernst 
Young as auditor and authorisation of the directors to determine 
the auditor’s remuneration. Special resolutions are also proposed 
to authorise the directors, to a limited extent consistent with 
pre-emption group guidelines, to allot new shares, to disapply 
statutory pre-emptions rights and to make market purchases of 
the company’s shares. The Notice of Annual General Meeting sets 
out the ordinary and special resolutions to be put to the meeting.

APPROVAL
This Directors’ Report was approved on behalf of the Board on 
18 June 2021.

Christopher Kay
Chief Financial Officer
Director

18 June 2021 

Directors’ Report continued

This scenario would see the group breach the leverage ratio 
covenant test resulting in the total borrowed amount becoming 
payable on demand. In this case, cash flow mitigations would be 
implemented, mostly reductions in discretionary spending and 
changes to supplier payment timings which are based on the 
group’s previous ability to implement such steps. The directors 
believe that this scenario is remote as a result of the historic 
evidence gained from our performance during 2020, which was 
a year impacted significantly by COVID-19. Throughout 2020 
the group’s cash collections have remained strong, with bad 
debt write off’s similar to a usual year. In the current year to 
date the group is trading ahead of budget and cash collections 
remain strong.

Therefore, the directors are confident in the ongoing resilience 
of the group, and its ability to continue in operation and meet 
its commitments as they fall due over the going concern period. 
Accordingly, the directors adopt the going concern basis in 
preparing the financial statements.

POST BALANCE SHEET EVENTS
The Board considers that no other material post balance sheet 
events occurred between the end of the period and the date of 
publication of this report.

FUTURE DEVELOPMENTS
The Board intends to continue to pursue the business strategy  
as outlined in the Strategic Report on pages 6 and 7.

STAKEHOLDER INVOLVEMENT POLICIES
The directors believe that the involvement of employees, 
customers and suppliers is an important part of the business 
culture and contributes to the successes achieved to date (see  
our Sustainability Report on pages 28 to 35).

EQUAL OPPORTUNITIES
The group is committed to eliminating discrimination and 
encouraging diversity. Its aim is that its people will be truly 
representative of all sections of society and that each person  
feels respected and is able to perform to the best of their ability. 
The group aims for its people to reflect the business diverse 
customer base.

The group won’t make assumptions about a person’s ability to 
carry out their work, for example based on their ethnic origin, 
gender, sexual orientation, marital status, religion or other 
philosophical beliefs, age or disability. Likewise, it won’t make 
general assumptions about capabilities, characteristics and 
interests of particular groups that may influence the treatment  
of individuals, the assessment of their abilities and their access  
to opportunities for training, development and promotion.

56

Statement of Directors’ Responsibilities

The directors are responsible for preparing the Annual Report and the  
financial statements in accordance with applicable law and regulation.

The directors as responsible for the maintenance and integrity 
of the company’s website. Legislation in the United Kingdom 
governing the preparation and dissemination of financial 
statements may differ from legislation in other jurisdictions.

DIRECTORS’ CONFIRMATION
The directors consider that the Annual Report and Accounts, 
taken as a whole are fair, balanced and understandable. They 
provide the information necessary for shareholders to assess the 
group and parent company’s position and performance, business 
model and strategy.

On behalf of the Board

Robin Totterman
Chief Executive Officer

18 June 2021

Company law requires the directors to prepare financial 
statements for each financial year. Under that law, the directors 
have prepared the group financial statements in accordance with 
International Financial Reporting Standards (IFRSs), as adopted by 
the European Union, the parent company financial statements in 
accordance with United Kingdom Generally Accepted Accounting 
Practice (United Kingdom Accounting Standards, comprising FRS 
101 ‘Reduced Disclosure Framework’, and applicable law. Under 
company law, directors must not approve the financial statements 
unless they are satisfied that they give a true and fair view of the 
state of affairs of the group and parent company, and of the profit 
or loss of the group and the parent company for that period.

In preparing these financial statements, the directors are 
required to:

•  Select suitable accounting policies and then apply them 

consistently;

•  State whether applicable IFRSs, as adopted by the European 
Union, have been followed for the group financial statements 
and United Kingdom Accounting Standards, comprising FRS 
101, have been followed for the parent company financial 
statements, subject to any material departures disclosed and 
explained in the financial statements;

•  Make judgements and accounting estimates that are 

reasonable and prudent; and 

•  Prepare the financial statements on the going concern basis 
unless it is inappropriate to presume that the group and the 
parent company will continue in business.

The directors are also responsible for safeguarding the assets 
of the group and the parent company, and hence for taking 
reasonable steps for the prevention and detection of fraud  
and other irregularities.

The directors are responsible for keeping adequate accounting 
records that are sufficient to show and explain the group and 
the parent company’s transactions and disclose, with reasonable 
accuracy at any time, the financial position of the group and the 
parent company, and enable them to ensure that the financial 
statements comply with the Companies Act 2006.

57

> Financial StatementsINSPECS Annual Report & Accounts 2020> Strategic Report> Corporate GovernanceMini eyewear –  
SS21 Campaign shoot

58

FINANCIAL

STATEMENTS

60
70

Independent Auditor’s Report to  
the Members of INSPECS Group plc 
Consolidated Income Statement  
Consolidated Statement of 
Comprehensive Income 
71
Consolidated Statement of Financial Position  72
Consolidated Statement of Changes  
in Equity 
Consolidated Statement of Cash Flows 
Notes to the Consolidated Financial  
Statements 
Parent Company Financial Statements 
Appendix 1 – Reconciliation  
of underlying EBITDA 
Company Information and Advisers 

127
128

76
118

74
75

59

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic Report 
Independent Auditor’s Report
to the Members of INSPECS Group plc

OPINION
In our opinion:

•  INSPECS Group plc’s group financial statements and parent company financial statements (the “financial statements”) give a true 

and fair view of the state of the group’s and of the parent company’s affairs as at 31 December 2020 and of the group’s profit for the 
year then ended;

•  the group financial statements have been properly prepared in accordance with international accounting standards in conformity 

with the requirements of the Companies Act 2006;

•  the parent company financial statements have been properly prepared in accordance with United Kingdom Generally Accepted 

Accounting Practice; and

•  the financial statements have been prepared in accordance with the requirements of the Companies Act 2006.

We have audited the financial statements of INSPECS Group Plc (the ‘parent company’) and its subsidiaries (the ‘group’) for the year 
ended 31 December 2020 which comprise:

Group 

Parent company

Consolidated income statement for the year ended 31 December 
2020

Consolidated statement of comprehensive income for the year 
then ended

Company statement of financial position as at 31 December 2020

Company statement of changes in equity for the year then ended

Consolidated statement of financial position as at 31 December 
2020

Related notes 1 to 8 to the financial statements including a 
summary of significant accounting policies

Consolidated statement of changes in equity for the year ended 
31 December 2020

Consolidated statement of cash flows for the year then ended

Related notes 1 to 35 to the financial statements, including a 
summary of significant accounting policies

The financial reporting framework that has been applied in their preparation is applicable law and international accounting standards 
in conformity with the requirements of the Companies Act 2006 and, as regards to the parent company financial statements, as applied 
in accordance with section 408 of the Companies Act 2006. The financial reporting framework that has been applied in the preparation 
of the parent company financial statements is applicable law and United Kingdom Accounting Standards, including FRS 101 “Reduced 
Disclosure Framework.

BASIS FOR OPINION
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our 
responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements 
section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of 
the financial statements in the UK, including the FRC’s Ethical Standard as applied to listed entities, and we have fulfilled our other 
ethical responsibilities in accordance with these requirements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

CONCLUSIONS RELATING TO GOING CONCERN
In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the 
preparation of the financial statements is appropriate. Our evaluation of the directors’ assessment of the group and parent company’s 
ability to continue to adopt the going concern basis of accounting included:

•  Obtaining management’s assessment and understanding the process undertaken by management to perform the going concern 

assessment, including the evaluation of any operational and economic impacts of COVID-19 on the group.

•  Testing the clerical accuracy of the model used to prepare the group’s going concern assessment, including the forecast 

covenant compliance.

•  Confirming the availability of debt facilities and review of underlying terms, including covenants up to December 2022 and 

confirming that no payments are due within this period.

60

•  Assessing the reliability of the cashflow forecast by analysing management’s historical forecasting accuracy. We understood key 

inputs underpinning the group’s forecasts which includes sales receipts and cash payment schedules, and challenged these using 
supporting evidence including debt agreements, existing facilities, our audited income statement, current period performance and 
independent industry forecasts.

•  Challenging, based on our own independent sensitivity testing, whether the downside case prepared by management could lead to 

a covenant breach. Our assessment included consideration of the impact and likelihood of:

 – The loss of major customers

 – The loss of significant brand licences

 – Ongoing COVID-19 restrictions

•  Evaluating management’s key assumptions underpinning the group’s forecasts (such as revenue growth), by proposing alternatives 

such as a lower growth rate reflecting the uncertainties arising from COVID-19, and challenging management’s assessment by 
modelling our own stressed scenarios.

•  Considering a “reverse stress test” scenario that would lead to a covenant breach and challenging management’s assessment as to 

whether the scenario is remote by considering current year trading performance and external market data.

•  Assessing whether the disclosures in the financial statements relating to going concern and COVID-19 reflected a fair and balanced 

reflection of the assumptions and sensitivities considered by the directors.

Our key observations:

•  We observed that the group experienced a high level of disruption from the impact of the pandemic from a revenue and profitability 
perspective in the first half of 2020 – due to the closure of manufacturing facilities and retain outlets during this period. Subsequent 
to this, the group has demonstrated its resilience as customers’ optical outlets in most territories were classified as essential and 
remained open during further lockdowns or customers’ sales moved to the online channel.

•  Whilst the group revenue for the year ended 31 December 2020 decreased by 23% compared to the prior year to $47.4m, the 

group’s cash balance is $32.6m. The cash balance is driven by the recently acquired Eschenbach Group holding $19.3m at the time of 
acquisition and the better performance of the group in the second half of the year. Therefore, management’s forecasts focused on 
the compliance with the HSBC banking covenants as other liabilities could be repaid if required.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, 
individually or collectively, may cast significant doubt on the group and parent company’s ability to continue as a going concern for the 
period to December 2022.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of 
this report. However, because not all future events or conditions can be predicted, this statement is not a guarantee as to the group’s 
ability to continue as a going concern.

OVERVIEW OF OUR AUDIT APPROACH

Audit scope

•  We performed an audit of the complete financial information of 5 components and audit procedures 

on specific balances for a further 4 components.

•  The components where we performed full or specific audit procedures accounted for 93% of Profit 

before tax, 96% of Revenue and 100% of Total assets.

Key audit matters

•  Acquisition accounting

•  Inappropriate revenue recognition

•  Valuation of goodwill

•  Valuation of uncertain tax positions

•  Accounting for IPO

Materiality 

•  Overall group materiality of $1,059,000 which represents 0.5% of total assets.

61

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportIndependent Auditor’s Report continued
to the Members of INSPECS Group plc

AN OVERVIEW OF THE SCOPE OF THE PARENT COMPANY AND GROUP AUDITS

Tailoring the scope
Our assessment of audit risk, our evaluation of materiality and our allocation of performance materiality determine our audit scope 
for each company within the group. Taken together, this enables us to form an opinion on the consolidated financial statements. 
We take into account size, risk profile, the organisation of the group and effectiveness of group wide controls, and changes in the 
business environment when assessing the level of work to be performed at each company.

In assessing the risk of material misstatement to the group financial statements, and to ensure we had adequate quantitative coverage 
of significant accounts in the financial statements, of the 32 reporting components of the group, we selected 11 components covering 
entities within the UK, Hong Kong, Germany and the USA which represent the principal business units within the group.

Of the 11 components selected, we performed an audit of the complete financial information of 6 components (“full scope 
components”) which were selected based on their size or risk characteristics. For the remaining 5 components (“specific scope 
components”), we performed audit procedures on specific accounts within that component that we considered had the potential 
for the greatest impact on the significant accounts in the financial statements either because of the size of these accounts or their 
risk profile.

The reporting components where we performed audit procedures accounted for 93% of the Group’s Profit before tax (2019: 100%), 96% 
of the group’s Revenue (2019: 97%) and 100% of the group’s Total assets (2019: 98%). For the current year, the full scope components 
contributed 86% of the group’s Profit before tax (2019: 100%), 80% of the group’s Revenue (2019: 97%) and 98% of the group’s Total 
assets (2019: 98%). The specific scope components contributed 7% of the group’s Profit before tax (2019: 0%), 16% of the group’s 
Revenue (2019: 0%) and 2% of the group’s Total assets (2019: 0%). The audit scope of these components may not have included testing 
of all significant accounts of the component but will have contributed to the coverage of significant accounts tested for the group. We 
also instructed 4 locations to perform specified procedures over cash which included obtaining bank confirmations.

Of the remaining 21 components that together represent 0% of the Group’s total assets. For these components, we performed other 
procedures, including analytical review and testing of consolidation journals and intercompany eliminations to respond to any potential 
risks of material misstatement to the group financial statements.

The charts below illustrate the coverage obtained from the work performed by our audit teams.

PROFIT BEFORE TAX 
(or adjusted PBT measure used)

REVENUE

TOTAL ASSETS

86%

7%

7%

80%

4%

16%

98%

2%

Full scope components

Specific scope components

Other procedures

62

CHANGES FROM THE PRIOR YEAR
The acquisitions by the group of Eschenbach and Norville during the year has resulted in a significant change in scope. 
New components are in scope as a result of the acquisitions and one component that was full scope in the prior year is now 
specific scope as it is less material to the consolidated group.

IMPACT OF THE COVID 19 PANDEMIC – AUDIT LOGISTICS
The performance of the December 2020 audit has predominately been conducted remotely at both component and group locations. 
We were able to conduct physical inventory counts at all in scope locations. We engaged with INSPECS throughout the audit, using 
video calls and share screen functionality. Key meetings, such as closing meetings and Audit and Risk Committees were performed via 
video conference calls.

INVOLVEMENT WITH COMPONENT TEAMS
In establishing our overall approach to the group audit, we determined the type of work that needed to be undertaken at each of the 
components by us, as the primary audit engagement team, or by component auditors from other EY global network firms operating 
under our instruction, or by component auditors from other firms operating under our instruction. Of the 6 full scope components, 
audit procedures were performed on 3 of these directly by the primary audit team, 1 by an EY component audit team and the 
remainder by other (non-EY) component auditors. For the 5 specific scope components, audit procedures were performed on 1 of 
these directly by the primary audit team and the remainder by other (non-EY) component auditors. Where the work was performed by 
component auditors (EY and non-EY), we determined the appropriate level of involvement to enable us to determine that sufficient 
audit evidence had been obtained as a basis for our opinion on the group as a whole. In the current year this has involved using screen 
sharing and having remote access to the component teams working papers which we have been able to do for both EY and non EY 
component teams.

The Primary audit team intended to follow a programme of planned visits that has been designed to ensure that the Senior Statutory 
Auditor visits all full scope locations every second year. However, during the current year’s audit cycle, visits were all replaced by virtual 
meetings due to the travel restrictions imposed by the COVID-19 outbreak. Consequently, all full scope locations were visited virtually 
by the Senior Statutory Auditor in the current year. Virtual meetings were held with all in scope components and involved meeting 
with component teams to discuss and direct their audit approach, reviewing key working papers and understanding the significant 
audit findings in response to the risk areas including revenue recognition and uncertain tax positions, holding meetings with local 
management, and obtaining updates on local regulatory matters. The primary audit team interacted regularly with the component 
teams where appropriate during various stages of the audit, reviewed key working papers and were responsible for the scope and 
direction of the audit process. This, together with the additional procedures performed at group level, gave us appropriate evidence 
for our opinion on the group financial statements.

KEY AUDIT MATTERS
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements 
of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) that we 
identified. These matters included those which had the greatest effect on: the overall audit strategy, the allocation of resources in the 
audit; and directing the efforts of the engagement team. These matters were addressed in the context of our audit of the financial 
statements as a whole, and in our opinion thereon, and we do not provide a separate opinion on these matters.

63

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportKey observations communicated  
to the Audit Committee

We have involved specialists to challenge 
the estimates and judgements made by 
management to calculate purchase price 
adjustments and IFRS adjustments booked 
upon acquisition. We have performed 
substantive testing relating to manual 
adjustments calculated and assessed the 
appropriateness of disclosures in the financial 
statements. We concluded the methodology 
applied is appropriate but identified some 
instances where estimates fell outside our 
acceptable range.

Independent Auditor’s Report continued
to the Members of INSPECS Group plc

Risk

Our response to the risk

Acquisition Accounting 2020: $53.6m 
goodwill (2019: $0m)

Refer to the Audit Committee Report 
(page 50); Accounting policies (page 76); 
and Note 2 of the Consolidated Financial 
Statements (page 76)

The group has undertaken two 
acquisitions in the year: the trade and 
assets of Norville Group for £2.4m and 
the Eschenbach Group for €94m. The 
Eschenbach acquisition is a significant 
and material acquisition for the group and 
contains multiple global subsidiaries.

There have been estimates and 
judgements required to calculate fair 
values and IFRS conversion adjustments 
required under IFRS 3 and these estimates 
as subject to management bias. The 
following estimates and judgements 
have been determined to be the most 
significant:

•  Calculation of the negative goodwill 
arising on the Norville acquisition

•  Judgements relating to the cut off of 

the opening balance sheet

•  Calculation of IFRS 16 lease liabilities

•  Calculation of the IFRS 15 returns 

provision

•  Fair value adjustments booked relating 

to the intangible assets

There is also a further risk relating to 
the accounting for these non-routine 
transactions as they are booked as 
manual topside journals. A small error in 
accounting or booking of these journals 
could lead to a material misstatement.

We obtained management’s calculation of the fair value 
adjustments booked relating to Norville which give rise to the 
negative goodwill calculation. We challenged management’s 
calculation by performing independent calculations of the fair 
value adjustments booked relating to inventory and PPE. We 
considered contradictory evidence by obtaining market data for 
key items.

We walked through the methodology applied by management to 
calculate the roll back from the year-end to the opening balance 
sheet position and understood the key judgements made. 
We challenged these judgements by comparing them to our 
understanding of the business. We instructed our component 
teams to perform substantive testing relating to roll back 
adjustments booked and reviewed in detail all work performed.

For IFRS 16 liabilities we corroborated the calculation inputs to 
signed lease agreements for a sample of contracts. We involved 
our valuations specialists to challenge the incremental borrowing 
rate for the sample selected by calculating an independent range 
for each lease.

For the IFRS 15 returns provision we walked through the 
methodology applied by management to calculate the 
adjustment. We critically assessed the judgements applied to the 
provision and agreed a sample of items to source data.

To challenge the fair value adjustments booked relating to 
inventory we selected a sample of items and compared the fair 
values used in the calculation to recent market sales data for the 
inventory item.

To challenge the fair value adjustments booked relating to the 
intangible assets we involved our valuations specialists. They 
assessed the methodology applied by management to calculate 
the value of these assets. They challenged the estimates relating 
to growth rates and discount rates used in the calculation by 
determining an independent range for these estimates using 
market data.

We examined the journals posted by management to account for 
the acquisitions under IFRS 3. We obtained supporting evidence 
for material amounts and critically assessed the accounting for 
compliance with the accounting standards.

We validated that the journals that are booked into the 
consolidation are in line with the supporting accounting records.

We assessed whether the disclosures in the financial statements 
relating to the acquisitions are complete and meet the disclosure 
requirements of IFRS 3.

We performed full scope audit procedures over this risk area in the 
UK, which covered 100% of the risk amount. All procedures were 
performed by the EY primary audit team.

64

Risk

Our response to the risk

Inappropriate revenue recognition 
$47.4m, (2019: $61.2m)

Refer to the Audit Committee Report 
(page 50); Accounting policies (page 76); 
and Note 2 of the Consolidated Financial 
Statements (page 76)

Revenue performance is a focus for 
stakeholders who expect a year on 
year growth in revenues. Most of the 
group’s sales arrangements typically 
require little judgement to be exercised, 
with revenue being recognised on the 
delivery of goods. However, there is 
a risk that management may override 
controls to intentionally misstate revenue 
transactions by recording fictitious 
manual journals to revenue (e.g by 
inappropriate accounting relating to 
rebates or returns or manual journals 
around year-end.)

Valuation of Goodwill $68.1m,  
(2019: $12.8m)

Refer to the Audit Committee Report 
(page 50); Accounting policies (page 76); 
and Note 2 of the Consolidated Financial 
Statements (page 76)

There is a risk that goodwill arising from 
past and recent acquisitions is impaired. 
There is goodwill relating to legacy 
acquisitions (predominately Killine) of 
$3.3m and the current year acquisition 
of Eschenbach of $54.8m included in the 
balance sheet. Management is required 
to carry out an annual impairment review 
of goodwill under IFRS, which will involve 
judgements and estimates regarding 
the future cashflows and discount rates 
applied to calculate the value in use.

We performed walkthroughs of the revenue recognition process 
for all material revenue streams to assess the design and 
implementation of key controls.

We used data analytics and correlation techniques to assess 
whether revenue followed the expected flow of correlation of 
revenue to debtors to cash for INSPECS UK interrogating 100% 
of revenue transactions. Any postings falling outside of the 
expected correlations were tested by the audit team to confirm 
that the treatment was appropriate.

For other in scope components we performed appropriate 
alternative procedures. Our procedures applicable to all in scope 
components included the following:

•  Detailed, disaggregated analytical review to identify unusual 

trends

•  Inquiries of management outside of finance, to identify 
instances of late or unusual requests for shipments or 
extension of credit terms

•  Cut off testing for a sample of revenue transactions near 
the period end to check that they were recognised in the 
appropriate period

•  Targeted manual journal entry testing in response to the risk 

of fraud; and

•  Review of disclosures against the requirements of IFRS 15

We made enquiries of management as to the existence of 
rebate or return arrangements with key customers. We obtained 
the listing of all credit notes raised in the year to assess the 
completeness of the provision booked.

We selected a sample of rebate and returns provisions. We 
validated the inputs for these calculations and for returns 
provisions challenged the assumptions and estimations used 
by performing hindsight analysis over changes to prior period 
estimates and assessed the estimates for management bias. For 
rebate provisions we agreed calculations to customer contracts 
or agreements.

We performed full and specific scope audit procedures over this 
risk area in 6 locations, which covered 96% of the risk amount.

We understood the methodology applied in management’s 
impairment testing and walked through the controls over the 
process.

We validated that the CGUs identified are the lowest level at  
which management monitors goodwill.

We tested the methodology applied in the VIU models, 
as compared to the requirements of IAS 36, including the 
mathematical accuracy of management’s models.

We validated that the cash flow forecasts used in the valuation are 
consistent with information reviewed by the Board. We reviewed 
the historical accuracy of management’s forecasts to evaluate 
whether forecast cashflows are reliable based on experience.

In conjunction with our valuation specialists, we challenged the 
discount rate used by benchmarking it against market data and 
comparable organisations.

For all relevant CGUs, we performed sensitivity analyses by stress 
testing key assumptions in the model to evaluate the parameters 
that, should they arise, would cause an impairment of goodwill or 
indicate additional disclosures were appropriate.

We also assessed the adequacy of disclosures in note 14 of the 
consolidated financial statements including the disclosure of 
sensitivity analysis.

We performed full scope audit procedures over this risk area in 
the UK, which covered 100% of the risk amount. All procedures 
were performed by the primary team.

Key observations communicated  
to the Audit Committee

Based upon the procedures performed, 
including those in respect of manual 
adjustments to revenue and cut off, we did not 
identify any evidence of material misstatement 
in the revenue recognised during the year.

Based on the procedures performed, we are 
satisfied that the carrying value of goodwill is 
materially correct. We consider the disclosure in 
the annual report is appropriate, including the 
disclosures relating to sensitivity analysis.

65

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportIndependent Auditor’s Report continued
to the Members of INSPECS Group plc

Risk

Our response to the risk

Valuation of uncertain tax positions 
2020: $2.8m (2019: $2.2m)

Refer to the Audit Committee Report 
(page 50); Accounting policies (page 76); 
and Note 2 of the Consolidated Financial 
Statements (page 76)

There are existing transfer pricing and 
permanent establishment provisions 
recognised in relation to the Killine 
Group totalling $2.8m at 31 December 
2020. Given the level of judgement and 
estimation involved, there is a risk that this 
has been valued inappropriately.

In addition, the material acquisitions 
in the year mean that there is a risk 
that management has not identified all 
uncertain tax positions

Accounting for the IPO 2020: $1.3m 
share capital raised (2019: $0m)

Refer to the Audit Committee Report 
(page 50); Accounting policies (page 76); 
and Note 2 of the Consolidated Financial 
Statements (page 76)

Upon the IPO taking place in February 
2020 the historic C- class shares 
and related derivative liability were 
extinguished and a share for share 
exchange took place between INSPECS 
Holdings and INSPECS Group plc There 
were also costs that were associated 
with the equity listing that were one off 
in nature. There is a risk that these non-
routine transactions are not appropriately 
accounted for and appropriately 
disclosed in the financial statements.

We involved our tax specialists to understand the group’s 
process for determining the completeness and measurement of 
provisions for tax.

Our tax specialists walked through calculations prepared by 
management and validated them for clerical accuracy and 
consistency with the requirements of IFRIC 23.

We challenged the assumptions made to calculate the existing 
provisions by comparing them to prior year and noting that there 
have been no changes in the fact pattern or risk profile.

We had discussions with management’s specialists to understand 
their assessment of the tax risks related to the acquisitions.

We considered contradictory evidence by reading reports 
prepared as part of the acquisition process and formed our own 
view relating to the transfer pricing risk of the acquired group.

We assessed the disclosures made in note 29 of the financial 
statements.

We performed full scope audit procedures over this risk area in 
the UK, which covered 100% of the risk amount. All procedures 
were performed by the primary team

We understood the process undertaken by management to 
calculate the accounting entries to be booked in relation to: 

•  The revaluation of the C- class shares

•  The extinguishment of the derivative liability

•  The share for share exchange between INSPECS Holdings  

and INSPECS Group plc

•  The one off costs relating to the equity listing

We critically assessed the accounting treatment followed by 
management against the relevant accounting standards and 
legislation.

We validated the accounting entries booked to source 
documentation including legal documents and bank statements.

We challenged the disclosures in both the group and company 
accounts by considering whether they were complete and there 
was sufficient disaggregation in the equity notes and company 
accounts regarding the transactions taking place in the period.

We performed full scope audit procedures over this risk area in 
the UK, which covered 100% of the risk amount. All procedures 
were performed by the primary team.

Key observations communicated  
to the Audit Committee

Based on the procedures performed, we 
consider the amounts provided relating to 
uncertain tax positions are reasonable and 
complete. We consider the group’s disclosures 
are also appropriate.

Based on the procedures performed the 
accounting for the IPO is in line with relevant 
accounting standards and legislation. We 
consider the disclosure of these transactions 
in the group and company accounts are also 
appropriate.

In the prior year, our auditor’s report included a key audit matter in relation to the valuation of C-class shares. In the current year, 
these shares have ceased to exist following the IPO and therefore this is no longer a key audit matter.

66

OUR APPLICATION OF MATERIALITY
We apply the concept of materiality in planning and performing the audit, in evaluating the effect of identified misstatements on the 
audit and in forming our audit opinion.

Materiality
The magnitude of an omission or misstatement that, individually or in the aggregate, could reasonably be expected to influence the 
economic decisions of the users of the financial statements. Materiality provides a basis for determining the nature and extent of our 
audit procedures.

We determined materiality for the group to be $1,059,000 (2019: $509,000), which is 0.3% of total assets (2019: 5% of profit before tax 
and IPO costs.). We believe that total assets provides us with the most appropriate basis for the current year as the focus of the group 
has been on using the cash generated from the IPO to fund the acquisitions made in the year. Therefore, the users of the financial 
statements are more focused on the balance sheet measure at the year-end, especially given the proximity of the Eschenbach 
acquisition to the year-end date. This is a change from the previous year which was based on profit before tax and we expect to  
return to a profit based measure for materiality in future years.

We determined materiality for the parent company to be $952,000 (2019: $250,000), which is 0.5% (2019: 1%) of total assets. In the prior 
year the parent company of the group was INSPECS Holdings Limited and the comparative amounts relate to that entity. In the current 
year the parent company is INSPECS Group plc.

During the course of our audit, we reassessed initial materiality and no changes were made to the basis of materiality.

For components which had been a part of the INSPECS group before the Eschenbach acquisition we calculated a lower materiality 
level based upon normalised earnings. This materiality is $509,000 which is based upon the prior year materiality given that 2019 is 
determined to be an appropriate representation of normalised earnings for this part of the INSPECS group.

Performance materiality
The application of materiality at the individual account or balance level. It is set at an amount to reduce to an appropriately low level the 
probability that the aggregate of uncorrected and undetected misstatements exceeds materiality.

On the basis of our risk assessments, together with our assessment of the group’s overall control environment, our judgement was that 
performance materiality was 50% (2019: 50%) of our planning materiality, namely $530,000 (2019: $257,000). We have set performance 
materiality at this percentage due to a high number of corrected and uncorrected misstatements identified in the prior year and the 
significant change in the business during the year as a result of the acquisitions.

Audit work at component locations for the purpose of obtaining audit coverage over significant financial statement accounts is 
undertaken based on a percentage of total performance materiality. The performance materiality set for each component is based 
on the relative scale and risk of the component to the group as a whole and our assessment of the risk of misstatement at that 
component. In the current year, the range of performance materiality allocated to components was $64,000 to $397,000 (2019: 
$102,000 to $229,000).

Reporting threshold
An amount below which identified misstatements are considered as being clearly trivial.

We agreed with the Audit Committee that we would report to them all uncorrected audit differences in excess of $53,000 (2019: 
$26,000), which is set at 5% of planning materiality, as well as differences below that threshold that, in our view, warranted reporting  
on qualitative grounds.

We evaluate any uncorrected misstatements against both the quantitative measures of materiality discussed above and in light of  
other relevant qualitative considerations in forming our opinion.

67

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportIndependent Auditor’s Report continued
to the Members of INSPECS Group plc

OTHER INFORMATION
The other information comprises the information included in the annual report set out on pages 1 to 57, other than the financial 
statements and our auditor’s report thereon. The directors are responsible for the other information within the annual report.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated 
in this report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent 
with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated.  
If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a 
material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is  
a material misstatement of the other information, we are required to report that fact.

We have nothing to report in this regard.

OPINIONS ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006
In our opinion, based on the work undertaken in the course of the audit:

•  the information given in the strategic report and the directors’ report for the financial year for which the financial statements are 

prepared is consistent with the financial statements; and

•  the strategic report and directors’ report have been prepared in accordance with applicable legal requirements.

MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course 
of the audit, we have not identified material misstatements in the strategic report or the directors’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to  
you if, in our opinion:

•  adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been 

received from branches not visited by us; or

•  the parent company financial statements are not in agreement with the accounting records and returns; or

•  certain disclosures of directors’ remuneration specified by law are not made; or

•  we have not received all the information and explanations we require for our audit

RESPONSIBILITIES OF DIRECTORS
As explained more fully in the directors’ responsibilities statement set out on page 57, the directors are responsible for the preparation 
of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors 
determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to 
fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group and parent company’s ability to continue as 
a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless 
the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to 
do so.

AUDITOR’S RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material 
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance 
is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a 
material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or 
in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these 
financial statements.

68

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our 
responsibilities, outlined above, to detect irregularities, including fraud. The risk of not detecting a material misstatement due to fraud 
is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery 
or intentional misrepresentations, or through collusion. The extent to which our procedures are capable of detecting irregularities, 
including fraud is detailed below.

However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the 
company and management.

•  We obtained an understanding of the legal and regulatory frameworks that are applicable to the group and determined that the 
most frameworks which are directly relevant to specific assertions in the financial statements are those that relate to the reporting 
framework (IFRSs as adopted by the EU, United Kingdom Generally Accepted Accounting Practice and the Companies Act 2006) and 
the relevant tax laws and regulations in the jurisdictions in which the group operates.

•  We understood how INSPECS Group plc is complying with those frameworks by making enquiries of management, the directors and 
those responsible for legal and compliance procedures. We corroborated our inquiries through our review of board minutes, papers 
provided to the Audit Committee and attendance at meetings of the Audit Committee as well as consideration of the results of our 
audit procedures across the group.

•  We assessed the susceptibility of the group’s financial statements to material misstatement, including how fraud might occur by 

meeting with management from various parts of the business to understand where it is considered there was susceptibility to fraud. 
We also considered performance targets and their influence on efforts made by management to manage earnings of influence the 
perceptions of investors. We considered the programmes and controls that the group has established to address risks identified, 
or that otherwise prevent, deter and detect fraud; and how senior management monitors those programs and controls. Where the 
risk was considered to be higher, we performed audit procedures to address each identified fraud risk. These procedures included 
testing manual journals and were designed to provide reasonable assurance that the financial statements were free from fraud 
or error.

•  Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Our 
procedures involved : enquiries of group management and those charged with governance; journal entry testing, with a focus on 
manual consolidation journals and journals indicating large or unusual transactions based on our understanding of the business; and 
challenging the assumptions and judgements made by management in respect of significant one-off transactions in the financial 
year and significant accounting estimates as referred to in the key audit matters section above. At a component level, our full and 
specific scope component audit team’s procedures included enquiries of component management; journal entry testing; and 
focused testing, including in respect of the key audit matter of revenue recognition. We also leveraged our data analytics platform 
in performing our work on the order to cash process to assist in identifying higher risk transactions for testing.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s 
website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

USE OF OUR REPORT
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. 
Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to 
them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility 
to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we 
have formed.

John Howarth (Senior statutory auditor)

for and on behalf of Ernst & Young LLP, Statutory Auditor 
Bristol
18 June 2021

69

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportConsolidated Income Statement 
for the year ended 31 December 2020

Revenue

Cost of sales

Gross profit

Other operating income

Distribution costs

Administrative expenses

Operating (loss)/profit

Non-underlying costs

Negative goodwill on bargain purchase

Movement in derivatives

Exchange adjustment on borrowings

Finance costs

Finance income

Share of profit of associate

(Loss)/profit before income tax

Income tax credit/(charge)

(Loss)/profit for the year

Attributable to:  
Equity holders of the Parent

Earnings per share 

Basic profit for the year attributable to the equity holders of the Parent

Diluted profit for the year attributable to the equity holders of the Parent

Notes

4

8,11

5

2020 
$’000

47,415

(26,893)

2019 
$’000

61,247

(33,711)

20,522

27,536

–

(787)

133

(635)

8,11

(22,675)

(19,089)

9

7

30

10

10

17

12

13

13

(2,940)

(5,763)

506

(740)

(382)

(1,880)

36

–

(11,163)

2,250

(8,913)

7,945

(2,827)

–

2,865

715

(1,380)

15

14

7,347

(907)

6,440

(8,913)

6,440

$(0.13)

$(0.13)

$0.12

$0.11

70

Consolidated Statement of Other Comprehensive Income
for the year ended 31 December 2020

(Loss)/profit for the year

Other comprehensive income

Exchange differences on translation of foreign operations

Other comprehensive (loss)/income for the year, net of income tax

Total comprehensive (loss)/income for the year

Attributable to: Equity holders of the parent

The notes on pages 76 to 117 form part of these financial statements.

2020| 
$’000

(8,913)

(204)

(204)

(9,117)

(9,117)

2019 
$’000

6,440

1

1

6,441

6,441

71

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportConsolidated Statement of Financial Position
as at 31 December 2020

ASSETS

Non-current assets

Goodwill

Intangible assets

Property, plant and equipment

Right-of-use-asset

Investment in associate

Deferred tax

Current assets

Inventories

Trade and other receivables

Tax receivables

Cash and cash equivalents

Total assets

EQUITY

Shareholders’ equity

Called up share capital

Share premium

Foreign currency translation reserve

Share option reserve

Merger reserve

Retained earnings

Total equity

The notes on pages 76 to 117 form part of these financial statements.

Notes

2020 
$’000 

2019 
$’000

14

15

16

25

17

28

18

19

20

21

22

22

22

22

69,087

56,305

22,460

20,379

57

12,995

181,283

59,294

35,648

1,556

32,672

129,170

310,453

1,384

121,940

(99)

867

7,296

14,429

145,817

12,798

17,482

10,320

1,317

53

1,221

43,191

8,715

12,875

–

6,595

28,185

71,376

62

21,628

1,031

2,840

–

5,787

31,348

72

LIABILITIES

Non-current liabilities

Financial liabilities – borrowings

Interest bearing loans and borrowings

Deferred tax

Current liabilities

Trade and other payables

Right of return liabilities

Financial liabilities – borrowings

Interest bearing loans and borrowings

  Bank overdrafts

Invoice discounting

Derivatives

Tax payable

Total liabilities

Total equity and liabilities

Notes

2020  
$’000

2019 
$’000

 24

28

 23

 4

 24

 24

 24

 30

 29

70,391

24,694

95,085

42,895

12,824

6,830

2,642

–

–

4,360

69,551

164,636

310,453

12,651

2,917

15,568

10,192

476

4,974

93

2,577

3,536

2,612

24,460

40,028

71,376

The notes on pages 76 to 117 form part of these financial statements.

The financial statements were approved by the Board of Directors on 18 June 2021 and were signed on its behalf by:

R B C Totterman  
Director 

C D Kay
Director

73

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic Report 
 
 
       
 
Consolidated Statement of Changes in Equity
for the year ended 31 December 2020

Balance at 31 December 2019

21,22

62

21,628

1,031

Notes

21,22

Balance at 1 January 2019

Changes in equity

Profit for the year

Other comprehensive income

Total comprehensive income

Share-based payment

Changes in equity

Loss for the year

Other comprehensive loss

Total comprehensive loss

Issue of share capital

Exercise of share options

Share-based payment

Share for share exchange and creation of 
merger reserve

Capital reduction

Balance at 31 December 2020

22

21,22

21,22

22

21,22

22

Called up 
share 
capital 
$’000

Share 
premium 
$’000

Foreign 
currency 
translation 
reserve 
$’000

Share 
option 
reserve 
$’000

Retained 
earnings 
$’000

Merger 
reserve 
$’000

62

21,628

1,030

647

(653)

Total  
equity 
$’000

22,714

6,440

1

6,441

2,193

31,348

(8,913)

(204)

(9,117)

–

–

–

–

–

–

–

–

–

 –

 –

 –

 –

 –

 –

 –

 –

 –

1

1

 –

–

–

–

–

–

–

603

119,215

99

–

2,725

–

–

(204)

(204)

–

–

–

6,440

 –

6,440

 –

5,787

(8,913)

–

(8,913)

 –

 –

 –

2,193

2,840

–

–

–

–

–

(22)

119,796

(3,140)

2,973

1,133

–

–

–

2,657

1,133

620

(21,628)

(926)

-

-

1,384

121,940

–

(99)

34

–

(46,902)

68,802

61,484

(61,484)

–

–

867

14,429

7,296

145,817

The notes on pages 76 to 117 form part of these financial statements.

74

Consolidated Statement of Cash Flows
for the year ended 31 December 2020

Cash flows from operating activities

Interest paid

Tax paid

Net cash (used in)/from operating activities

Cash flows from investing activities

Purchase of intangible fixed assets

Purchase of property plant and equipment

Acquisition of subsidiaries, net of cash acquired

Interest received

Net cash used in investing activities

Cash flow from financing activities

Proceeds from the issue of shares

New bank loans in the year

Bank loan principal repayments in year

Repayment of other loans

Transaction costs on debt refinancing

Movement in invoice discounting facility

Principal payments on leases

Net cash (used in)/from financing activities

Increase in cash and cash equivalents

Cash and cash equivalents at beginning of the year

Effect of foreign exchange rate changes

Cash and cash equivalents at end of year

The notes on pages 76 to 117 form part of these financial statements.

Notes

27

15

16

7

10

21

24,26

26

26

26

26

20

2020
 $’000

403

(1,144)

(7)

(748)

(167)

(2,452)

(101,821)

36

2019 
$’000

12,224

(1,609)

(22)

10,593

(161)

(2,763)

–

15

(104,404)

(2,909)

115,761

17,187

(39)

–

(810)

(2,577)

(810)

128,712

23,560

6,502

(32)

30,030

–

628

(4,733)

(72)

–

975

(836)

(4,038)

3,646

2,834

22

6,502

75

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements
for the year ended 31 December 2020

1. GENERAL INFORMATION
INSPECS Group plc is a public company limited by shares and is incorporated in England and Wales (company number 11963910). 
The address of the company’s principal place of business is 7–10 Kelso Place, Upper Bristol Road, Bath BA1 3AU. On 10 January 2020, 
the reporting company incorporated in 2019 acquired the pre-existing INSPECS Holdings Limited in a ‘share for share exchange’ 
with no change in ultimate ownership. This has been accounted for under the basis of merger accounting given that the ultimate 
ownership before and after the transaction remained the same. Merged subsidiaries undertakings are treated as if they had always 
been a member of the group. Subsequently, on 27 February 2020 INSPECS Group Limited was re-registered from a private to a public 
company with its shares admitted to the AIM of the London Stock Exchange.

The principal activity of the group in the year was that of design, production, sale, marketing and distribution of high fashion eyewear, 
lenses and OEM products worldwide. The principal activity of the company was that of a holding company.

2. ACCOUNTING POLICIES

Basis of preparation
These financial statements have been prepared in accordance with International Financial Reporting Standards ('IFRSs') as adopted by 
the European Union, and those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

The consolidated financial statements have been prepared on a historical cost basis, except for share-based payments that have been 
measured at fair value in accordance with IFRS 2 Share-based payments.

The presentational currency for the consolidated and parent company financial statements is the United States Dollar (US$) rounded 
to the nearest thousand. The consolidated financial statements provide comparative information in respect of the year ended 
31 December 2019.

Going concern 
The financial statements have been prepared on the going concern basis as the directors have assessed that there is a reasonable 
expectation that the group will be able to continue in operation and meet its commitments as they fall due over the going 
concern period. 

The group continues to respond well to the challenges associated with the COVID-19 pandemic which did cause disruption to the 
business during 2020. This was predominantly experienced in the first half of the year when major distribution hubs and the optical 
retail markets were closed except for emergencies as lockdowns were introduced around the globe in response to the pandemic. 
During subsequent lockdowns later in the year, the optical retail market was deemed essential which resulted in the group gradually 
returning to normal trading levels. For the rest of the year the group was therefore able to trade profitably and generate cash with the 
supply chain unaffected.  

Looking to the future, the group has performed a going concern review, going out until December 2022, considering both a base case 
and a downside case (described below). Having reviewed this forecast and having applied a reverse stress test (also described below), 
the possibility that financial headroom could be exhausted, and a covenant could be breached is considered to be remote. 

The base case assumes COVID-19 related restrictions consistent with those in place in January 2021 remain for the duration of 2021 
with normal trading resuming in 2022, results in a 10% year on year increase to sales. The restrictions in place at this time restricted 
a return to office working, reduced footfall on the high streets and reductions in non-prescription sales as a result of the continuing 
closure of airports and non-essential retail. The base case also assumes no cash flow mitigations are actioned during the period 
covered by the going concern review. 

The downside case assumes the same restriction remain as in the base case but with a 10% reduction in sales from April 2021 
compared to the base case, and these same restrictions also being in place during 2022. In this scenario we also assumed some cost 
saving measures being implemented at a conservative level. These measures are consistent with those which were implemented in 
2020 and which we therefore know the group can achieve and relate to reductions in factory overheads. 

The directors consider the main risks to going concern to be liquidity and compliance with covenants, and so have performed a  
reverse stress test which incorporates the breach of the covenant. The group would breach a covenant before it runs out of cash  
in any scenario.

The group’s borrowings with HSBC, amounting to $35.0m, contains two covenants being one leverage ratio and one interest 
cover ratio. Compliance with these covenants is based on 12 month rolling EBITDA results and 12 month rolling interest payments 
respectively. In addition, the newly acquired Eschenbach group has covenants relating to equity ration, leverage ratio and EBITDA. 
These covenants are less sensitive than the HSBC covenants and the group would be able to repay these loans before a covenant 
breach using available cash. The group has the ability to transfer cash across different group entities as needed.

76

In order for the business to breach one of the HSBC covenants, the reverse stress test requires that, after implementing all available 
mitigating scenarios, there is a 22% reduction to the sales forecasted in the base case from April 2021 through to December 2022 
along with a 4% drop in gross margin. This scenario also factors in full repayment of all borrowings aside from the HSBC facility and 
settlement of an uncertain tax position at the highest possible range. 

This scenario would see the group breach the leverage ratio covenant test resulting in the total borrowed amount becoming payable 
on demand. In this case, cash flow mitigations would be implemented, mostly reductions in discretionary spending and changes 
to supplier payment timings which are based on the group’s previous ability to implement such steps. The directors believe that 
this scenario is remote as a result of the historic evidence gained from our performance during 2020, which was a year impacted 
significantly by COVID-19. Throughout 2020 the group’s cash collections have remained strong, with bad debt write offs similar to a 
usual year. In the current year to date the group is trading ahead of budget and cash collections remain strong.

Therefore, the directors are confident in the ongoing resilience of the group, and its ability to continue in operation and meet its 
commitments as they fall due over the going concern period. Accordingly, the directors adopt the going concern basis in preparing 
the financial statements.

Basis of consolidation
The consolidated financial information incorporates the financial statements of the group and all of its subsidiary undertakings. 
The financial statements of all group companies are adjusted, where necessary, to ensure the use of consistent accounting policies. 
Acquisitions are accounted for under the acquisition method from the date control passes to the group. On acquisition, the assets and 
liabilities of a subsidiary are measured at their fair values. Any excess of the cost of acquisition over the fair values of the identifiable net 
assets acquired is recognised as goodwill.

Business combination and goodwill
Business combinations are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of 
the consideration transferred, which is measured at acquisition date fair value, and the amount of any non-controlling interests in the 
acquiree. Acquisition-related costs are expensed as incurred.

When the group acquires a business, it assesses the financial assets and liabilities assumed for appropriate classification and 
designation in accordance with the contractual terms, economic circumstances and pertinent conditions as at the acquisition date. 

Goodwill is initially measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognised 
for non-controlling interests and any previous interest held over the net identifiable assets acquired and liabilities assumed). If the fair 
value of the net assets acquired is in excess of the aggregate consideration transferred, the group reassesses whether it has correctly 
identified all of the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to 
be recognised at the acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the 
aggregate consideration transferred, then the gain is recognised in profit or loss.

After initial recognition, goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, 
goodwill acquired in a business combination is, from the acquisition date, allocated to each of the group’s cash-generating units 
that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to 
those units.

Investment in associated undertaking
An associate is an entity over which the group has significant influence. Significant influence is the power to participate in the financial 
and operating policy decisions of the investee but is not in control or joint control over those policies.

The considerations made in determining significant influence or joint controls are similar to those necessary to determine control over 
subsidiaries. The group’s investment in its associate is accounted for using the equity method.

Under the equity method, the investment in an associate is initially recognised at cost. The carrying amount of the investment is 
adjusted to recognise changes in the group’s share of net assets of the associate since the acquisition date. 

The income statement reflects the group’s share of the results of operations of the associate. Any change in OCI of those investees is 
presented as part of the group’s OCI.

The aggregate of the group’s share of profit or loss of an associate is shown on the face of the income statement outside operating 
profit and represents profit or loss after tax and non-controlling interests in the subsidiaries of the associate.

The financial statement of the associate is prepared for the same reporting period as the group. When necessary, adjustments are 
made to bring the accounting policies in line with those of the group.

77

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

2. ACCOUNTING POLICIES CONTINUED

Investment in associated undertaking continued
After application of the equity method, the group determines whether it is necessary to recognise an impairment loss on its investment 
in its associate. At each reporting date, the group determines whether there is objective evidence that the investment in the associate 
is impaired. If there is such evidence, the group calculates the amount of impairment as the difference between the recoverable 
amount of the associate and its carrying value, and then recognises the loss within ‘Share of profit of an associate’ in the income 
statement.

Upon loss of significant influence over the associate, the group measures and recognises any retained investment at its fair value. Any 
difference between the carrying amount of the associate upon loss of significant influence or joint control and the fair value of the 
retained investment and proceeds from disposal is recognised in profit or loss.

Current and non-current classifications
The group presents assets and liabilities in the statement of financial position based on current/non-current classification.

An asset is considered current when it is:

•  Expected to be realised or intended to be sold or consumed within the usual parameters of trading activity and as a minimum  

within 12 months after the reporting period;

Or

•  Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12 months after the  

reporting period.

The group classifies all other assets as non-current.

A liability is current when:

•  It is expected to be settled in the normal parameters of trading activity and as a minimum is due to be settled within 12 months  

after the reporting period;

Or

•  There is no unconditional right to defer the settlement of the liability for at least 12 months after the reporting period.

The group classifies all other liabilities as non-current.

Deferred tax assets and liabilities are classified as non-current assets and liabilities.

Revenue recognition
Revenue from the sales of goods is recognised at the point in time when control of the asset is transferred to the customer, generally 
on delivery of the goods. Revenue is recognised at the fair value of the consideration received or receivable for sale of goods to 
external customers in the ordinary nature of the business. The fair value of the consideration takes into account trade discounts, 
settlement discounts, volume rebates and the right of return.

Rights of return
Under IFRS 15 a sale with right of return is recognised if the customer receives any combination of the following:

•  A full or partial refund of any consideration paid;

•  A credit that can be applied against amounts owed, or that will be owed, to the entity; and

•  Another product in exchange.

The group includes within the liability arrangements where the group has historically accepted a right to return with the combination 
of a credit being applied against amounts owed or where another product is offered in exchange. This includes returns that are as a 
result of quality issues, whereby a replacement is provided to the customer free of charge. The group estimates the impact of potential 
returns from customers based on historical data on returns. A refund liability is recognised for the goods that are expected to be 
returned (i.e. the amount not included in the transaction price). A right of return asset (and corresponding adjustment to cost of sales) 
is also recognised for the right to recover the goods from the customer, to the extent that these goods are not considered impaired.

78

Intangible assets (other than goodwill)
Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business 
combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any 
accumulated amortisation and accumulated impairment losses. Internally generated intangibles are not capitalised and the related 
expenditure is reflected in profit or loss in the period in which the expenditure is incurred.

Intangible assets with finite lives are amortised over the useful economic life and assessed for impairment whenever there is an 
indication that the intangible asset may be impaired. The amortisation period and the amortisation method for an intangible asset with 
a finite useful life are reviewed at least at the end of each reporting period. Changes in the expected useful life or the expected pattern 
of consumption of future economic benefits embodied in the asset are considered to modify the amortisation period or method, as 
appropriate, and are treated as changes in accounting estimates. The amortisation expense on intangible assets with finite lives is 
recognised in the profit or loss in the expense category that is consistent with the function of the intangible assets.

An intangible asset is derecognised upon disposal (i.e. at the date the recipient obtains control) or when no future economic benefits 
are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference between 
the net disposal proceeds and the carrying amount of the asset) is included in the profit or loss.

Amortisation is calculated on a straight-line basis over the estimated useful lives of the assets as follows:

Patents and licences 

1–4 years 

Computer software 

Trademarks 

3 years 

5 years

Customer relationships 

10–20 years

Customer order book 

6 months 

Property, plant and equipment
Property, plant and equipment are stated at cost less accumulated depreciation and any impairment losses. The cost of an item of 
property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the asset to its working 
condition and location for its intended use.

Expenditure incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is 
charged to profit or loss in the period in which it is incurred. In situations when it is probable that future economic benefits associated 
with the item will flow to the group and the cost can be measured reliably then the expenditure for a major inspection is capitalised 
in the carrying amount of the asset as a replacement. Where significant parts of property, plant and equipment are required to be 
replaced at intervals, the group recognises such parts as individual assets with specific useful lives and depreciates them accordingly.

Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets as follows:

Freehold Property   

over 33 years  

Leasehold Improvements  over the lease term 

Fixtures and Fittings 

over 5 years 

Computer Equipment 

over 3–5 years 

Plant and Machinery 

over 3–7 years 

Construction in Progress is not depreciated

The carrying values of property plant and equipment are reviewed for impairment when events or changes in circumstances indicate 
the carrying value may not be recoverable.

Where parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable 
basis among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, 
and adjusted if appropriate, at least at each financial year-end.

An item of property, plant and equipment including any significant part initially recognised is derecognised upon disposal or when no 
future economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognised in profit or loss in 
the year the asset is derecognised is the difference between the net sales proceeds and the carrying amount of the relevant asset.

79

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic Report 
Notes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

2. ACCOUNTING POLICIES CONTINUED

Leases
The group applied a single recognition and measurement approach for all leases for which it is the lessee, except for short-term leases 
and leases of low-value assets. The group recognises right-of-use assets representing the right to use the underlying assets and lease 
liabilities to make lease payments.

Right-of-use asset
The group recognises right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for 
use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses. The cost of right-of-use 
assets includes the amount of lease liabilities recognised, initial direct costs incurred, and lease payments made at or before the 
commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis over the shorter of 
the lease term and the estimated useful lives of the assets, as follows:

Leasehold Property 

over 2–5 years 

Plant and Machinery 

over 3 years

Motor vehicles 

over 3 years

Lease liabilities
At the commencement date of the lease, the group recognises lease liabilities measured at the present value of lease payments to be 
made over the lease term. The lease payments include fixed payments (including in substance fixed payments) less any lease incentives 
receivable. They also include any amounts expected to be paid under residual value guarantees. 

In calculating the present value of lease payments, the group uses its incremental borrowing rate at the lease commencement date 
because the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities 
is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease 
liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments or a change in the 
assessment of an option to purchase the underlying asset.

The group’s lease liabilities are included in interest-bearing loans and borrowings.

The group applies the short-term lease recognition exemption to its short-term leases of machinery and equipment (i.e. those leases 
that have a lease term of 12 months or less from the commencement date and do not contain a purchase option). It also applies the 
lease of low-value assets recognition exemption to leases of office equipment that is considered to be low value. Lease payments on 
short-term leases and leases of low-value assets are recognised as expenses on a straight-line basis over the lease term.

Inventories
Inventories are stated at the lower of cost and estimated selling price less costs to sell after making due allowance for obsolete and 
slow-moving items. Inventories are recognised as an expense in the period in which the related revenue is generated.

Cost is determined on an average cost basis. Cost includes the purchase price and other directly attributable costs to bring the 
inventory to its present location and condition.

At the end of each period, inventories are assessed for impairment. If an item of inventory is impaired, the identified inventory is 
reduced to its selling price less costs to complete and sell and an impairment charge is recognised in the income statement.

Royalties
Royalties payable reflect balances owed to brand owners for the right to use the brand name. The royalty is payable based on a pre-
agreed percentage of sales volumes, with some arrangements also having minimum royalty payments for specific periods. Royalties 
payable are recognised on delivery of the products covered by such arrangements, with an additional accrual made where it is 
considered that the sales level required to meet the minimum payment will not be met.

80

 
Financial instruments – initial recognition and subsequent measurement
A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of 
another entity.

Financial assets
Initial recognition and measurement

Financial assets are classified at initial recognition and subsequently measured at amortised cost. 

Subsequent measurement

For purposes of subsequent measurement, the financial assets of the group are classified as financial assets at amortised cost (debt 
instruments).

Financial assets at amortised cost (debt instruments) 

Financial assets at amortised cost are subsequently measured using the effective interest (EIR) method and are subject to impairment. 
Gains and losses are recognised in profit or loss when the asset is derecognised, modified or impaired.

The group’s financial assets at amortised cost includes trade receivables, other receivables and loans to group undertakings.

The group does not have any financial assets at fair value through OCI or financial assets at fair value through profit or loss.

Derecognition

A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily 
derecognised (i.e. removed from the group’s consolidated statement of financial position) when the rights to receive cash  
flows from the asset have expired.

When the group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it 
evaluates if, and to what extent, it has retained the risks and rewards of ownership.

When it has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the 
asset, the group continues to recognise the transferred asset to the extent of its continuing involvement. In that case, the group also 
recognises an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights  
and obligations that the group has retained.

Financial liabilities
Initial recognition and measurement

Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings  
or payables, as appropriate.

All financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables, net of directly 
attributable transaction costs.

The group’s financial liabilities include trade and other payables, loans and borrowings including bank overdrafts.

Subsequent measurement

For purposes of subsequent measurement, financial liabilities are classified in two categories:

•  Financial liabilities at fair value through profit or loss.

•  Financial liabilities at amortised cost (loans and borrowings).

As at 31 December 2020, the group has not designated any financial liability as at fair value through profit or loss. As at 31 December 
2019, options to subscribe for C equity shares were held as derivatives with the movement in fair value passing through profit or loss, 
with this liability being settled during the current year.

Financial liabilities at amortised cost (loans and borrowings)

After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortised cost using the EIR method. 
Gains and losses are recognised in profit or loss when the liabilities are derecognised as well as through the EIR amortisation process.

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral 
part of the EIR. The EIR amortisation is included as finance costs in the income statement. This category generally applies to interest-
bearing loans and borrowings.

81

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

2. ACCOUNTING POLICIES CONTINUED

Financial instruments – initial recognition and subsequent measurement continued
Financial liabilities continued
Derecognition

A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires. When an existing 
financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are 
substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition  
of a new liability. The difference in the respective carrying amounts is recognised in the income statement.

Refinancing

Where a loan arrangement is replaced with a subsequent facility which is materially different in relation to repayment structure or 
interest rate, any capitalised loan arrangement fees in respect of the previous loan are expensed, with transaction costs relating to the 
new loan capitalised and held against the value of the related liability.

Impairment of financial assets 
The group recognises an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or 
loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows 
that the group expects to receive.

For trade receivables and contract assets, the group applies a simplified approach in calculating ECLs. Therefore, the group does not 
track changes in credit risk, but instead recognises a loss allowance based on lifetime ECLs at each reporting date. 

The group considers a financial asset in default when internal or external information indicates that the group is unlikely to receive the 
outstanding contractual amounts in full before taking into account any credit enhancements held by the group. A financial asset is 
written off when there is no reasonable expectation of recovering the contractual cash flows.

Cash and cash equivalents
For the purpose of the consolidated statement of cash flows, cash and cash equivalents comprise cash on hand and demand deposits, 
and short-term highly liquid investments that are readily convertible into known amounts of cash, that are subject to an insignificant 
risk of changes in value, and have a short maturity of generally within three months when acquired, less bank overdrafts which are 
repayable on demand and form an integral part of the group’s cash management.

For the purpose of the consolidated statement of financial position, cash and cash equivalents comprise cash on hand and at banks, 
including term deposits, and assets similar in nature to cash, which are not restricted as to use.

Classification of shares as debt or equity instruments
Financial instruments issued by the group are classified as equity only to the extent that they do not meet the definition of a financial 
liability. An equity instrument is a contract that evidences a residual interest in assets or an entity after deducting all its liabilities. 
Accordingly, a financial instrument is treated as equity if:

•  there is no contractual obligation to delivery cash or other financial assets or to exchange financial assets or liabilities on terms that 

may be unfavourable; and

•  the instrument is a non-derivative that contains no contractual obligation to deliver a variable number of shares or is a derivative 

that will be settled only by the company exchanging a fixed amount of cash or other assets for a fixed number of the company’s own 
equity instruments.

Costs associated with the issue or sale of equity instruments are allocated against equity to the extent that the issue is a new issue, or 
expensed to the profit and loss for existing equity instruments.

Share-based payments
Employees (including senior executives) of the group receive remuneration in the form of share-based payments, whereby employees 
render services as consideration for equity instruments (equity-settled transactions). 

The cost of equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate 
valuation model, further details of which are given in the detailed notes to the accounts. That cost is recognised in employee benefits 
expense together with a corresponding increase in share option reserve, over the period in which the service and, where applicable, 
the performance conditions are fulfilled (the vesting period).

82

The cumulative expense recognised for equity-settled transactions at each reporting date until the vesting date reflects the extent 
to which the vesting period has expired and the group’s best estimate of the number of equity instruments that will ultimately vest. 
The expense or credit in the income statement for a period represents the movement in cumulative expense recognised as at the 
beginning and end of that period.

Service performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood 
of the conditions being met is assessed as part of the group’s best estimate of the number of equity instruments that will ultimately 
vest. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting 
conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless 
there are also service and/or performance conditions.

No expense is recognised for awards that do not ultimately vest because service conditions have not been met. Where awards include 
a non-vesting condition, the transactions are treated as vested irrespective of whether the non-vesting condition is satisfied, provided 
that all other performance and/or service conditions are satisfied.

If the terms of an equity-settled award are modified, the minimum expense recognised is the grant date fair value of the unmodified 
award provided the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is 
recognised for any modification that increases the total fair value of the share-based payment transaction or is otherwise beneficial to 
the employee. Where an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is 
expensed immediately through profit or loss. The dilutive effect of outstanding options is reflected as additional share dilution in the 
computation of diluted earnings per share, to the extent that they are dilutive.

Taxation
Income tax comprises current and deferred tax. Income tax relating to items recognised outside profit or loss is recognised outside 
profit or loss, either in other comprehensive income or directly in equity.

Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, 
based on the tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period, taking into 
consideration interpretations and practices prevailing in the countries in which the group operates.

Tax liabilities are recognised when it is considered probable that there will be a future outflow of funds to a taxing authority. 
Uncertainties regarding availability of tax losses, in respect of enquiries raised and additional tax measurements issued, may be 
measured using the expected value method or single best estimate approach, depending on the nature of the uncertainty. Tax 
provisions are based on management’s interpretation of country-specific tax law and the likelihood of settlement. Management uses 
professional firms and previous experience when assessing tax risks.

Deferred tax is provided, using the liability method, on all temporary differences at the end of the reporting period between the tax 
bases of assets and liabilities and their carrying amounts for financial reporting purposes. Deferred tax liabilities are recognised for all 
taxable temporary differences, except:

•  when the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a 
business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and

•  in respect of taxable temporary differences associated with investments in subsidiaries, when the timing of the reversal of the 

temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.

Deferred tax assets are recognised for all deductible temporary differences, the carry forward of unused tax credits and any unused 
tax losses. Deferred tax assets are recognised to the extent that it is probable that taxable profit will be available against which the 
deductible temporary differences, the carryover of unused tax credits and unused tax losses can be utilised, except:

•  when the deferred tax asset relating to the deductible temporary differences arises from the initial recognition of an asset or liability 

in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor 
taxable profit or loss; and

•  in respect of deductible temporary differences associated with investments in subsidiaries, deferred tax assets are only recognised 

to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be 
available against which the temporary differences can be utilised.

The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no 
longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilised. Unrecognised 
deferred tax assets are reassessed at the end of each reporting period and are recognised to the extent that it has become probable 
that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered.

83

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

2. ACCOUNTING POLICIES CONTINUED

Taxation continued
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realised or the 
liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax assets and deferred tax liabilities are offset if and only if a legally enforceable right exists to set off current tax assets 
against current tax liabilities and the deferred taxes relate to income taxes levied by the same taxation authority on either the same 
taxable entity and the same taxation authority or different taxable entities which intend either to settle current tax liabilities and assets 
on a net basis, or to realise the assets and settle the liabilities simultaneously, in each future period in which significant amounts of 
deferred tax liabilities or assets are expected to be settled or recovered.

Foreign currencies
These financial statements are presented in US$, which is the group’s presentational currency. Each entity in the group determines 
its own functional currency and items included in the financial statements of each entity are measured using that functional currency. 
Foreign currency transactions recorded by the entities in the group are initially recorded using their respective functional currency 
rates prevailing at the dates of the transactions.

Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange ruling at 
the end of the reporting period. Differences arising on settlement or translation of monetary items are recognised in profit or loss.

Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the 
dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange 
rates at the date when the fair value was measured.

The gain or loss arising on translation of a non-monetary item measured at fair value is treated in line with the recognition of the gain 
or loss on change in fair value of the item (i.e., translation difference on the item whose fair value gain or loss is recognised in other 
comprehensive income or profit or loss is also recognised in other comprehensive income or profit or loss, respectively).

The functional currency of INSPECS Group plc is GBP. The functional currencies of certain overseas subsidiaries are currencies other 
than the GBP. At the end of the reporting period, the assets and liabilities of these entities are translated into GBP at the exchange 
rates prevailing at the end of the reporting period and their income statements are translated into GBP at the average exchange rates 
for the year.

The resulting exchange differences are recognised in other comprehensive income and accumulated in the foreign currency translation 
reserve. On disposal of a foreign operation, the component of other comprehensive income relating to that particular foreign 
operation is recognised in profit or loss. On translation to US$ for presentation, the assets and liabilities of the consolidated entity  
are translated into US$ at the exchange rates prevailing at the end of the reporting period and the income statement is translated  
into US$ at the average exchange rates for the year.

Any goodwill arising on the acquisition of a foreign operation and any fair value adjustments to the carrying amounts of assets and 
liabilities arising on acquisition are treated as assets and liabilities of the foreign operation and translated at the closing rate at the 
period end.

For the purpose of the consolidated statement of cash flows, the cash flows of overseas subsidiaries are translated at the exchange 
rates ruling at the dates of the cash flows. Frequently recurring cash flows of overseas subsidiaries which arise throughout the period 
are translated at the average exchange rates for the year.

Pensions and other post-employment benefits
The group operates defined contribution pension schemes, where the amounts charged to the statement of comprehensive income 
are the contributions payable in the year. Differences between contributions payable in the year and the contributions actually paid are 
shown as either accruals or prepayments.

84

Non-underlying items
Non-underlying items are those that in the directors’ view should be separately disclosed due to their nature to enable a full 
understanding of the group’s financial performance.

New and amended standards and interpretations

Amendments to IFRS 16 COVID-19-Related Rent Concessions
On 28 May 2020, the IASB issued COVID-19-Related Rent Concessions - amendment to IFRS 16 Leases. The amendments provide relief 
to lessees from applying IFRS 16 guidance on lease modification accounting for rent concessions arising as a direct consequence of 
the COVID-19 pandemic. As a practical expedient, a lessee may elect not to assess whether a COVID-19 related rent concession from a 
lessor is a lease modification. A lessee that makes this election accounts for any change in lease payments resulting from the COVID-19 
related rent concession the same way it would account for the change under IFRS 16, if the change were not a lease modification. The 
amendment applies to annual reporting periods beginning on or after 1 June 2020. Earlier application is permitted. This amendment 
had no impact on the consolidated financial statements of the group.

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
The preparation of the group’s financial statements requires management to make judgements, estimates and assumptions that 
affect the reported amounts of revenues, expenses, assets and liabilities, and their accompanying disclosures, and the disclosure 
of contingent liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material 
adjustment to the carrying amounts of the assets or liabilities affected in the future.

Estimates involve the determination of the quantum of accounting balances to be recognised. Judgements typically involve decisions 
such as whether to recognise an asset or liability. 

The key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that 
have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year,  
are described below:

Impairment of goodwill
The group determines whether goodwill is impaired at least on an annual basis. This requires an estimation of the value in use of the 
cash-generating units to which the goodwill is allocated. Estimating the value in use requires the group to make an estimate of the 
expected future cash flows from the cash-generating units and also to choose a suitable discount rate in order to calculate the present 
value of those cash flows. The carrying amount of goodwill at 31 December 2020 was $68,088,000 (2019: $12,798,000). No provision for 
impairment of goodwill was made as at the end of the reporting period. See note 14 for further details.

Impairment of intangible assets
The carrying values of intangible assets are reviewed for impairment when events or changes in circumstances indicate that the 
carrying amount may not be recoverable in accordance with the accounting policies as disclosed in the financial statements. The 
recoverable amount is the higher of its fair value less costs of disposal and its value in use, the calculations of which involve the use of 
estimates about the future cash flows generated by each asset or the relevant cash-generating units to which the asset belongs. When 
value in use calculations are undertaken, management must estimate the expected future cash flows from the asset or cash-generating 
unit and choose a suitable discount rate in order to calculate the present value of those cash flows. Further details in relation to 
impairment tests completed in the current year are given in note 15.

Uncertain tax positions
Tax authorities could challenge and investigate the group’s transfer pricing or tax domicile arrangements. As a growing, international 
business, there is an inherent risk that local tax authorities around the world could challenge either historical transfer pricing 
arrangements between other entities within the group and subsidiaries or branches in those local jurisdictions, or the tax domicile of 
subsidiaries or branches that operate in those local jurisdictions.

As a result, the group has identified that it is exposed to uncertain tax positions, which it has measured using an expected value 
methodology. Such methodologies require estimates to be made by management including the relative likelihood of each of the 
possible outcomes occurring, the periods over which the tax authorities may raise a challenge to the group’s transfer pricing or tax 
domicile arrangements; and the quantum of interest and penalties payable in additions to the underlying tax liability. Further details 
are given in note 29.

85

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY CONTINUED
Judgements made by management which are considered to have a material impact on the financial statements are as follows:

Recognition of intangible assets
In recognising the intangible assets arising on acquisition of subsidiary entities, the intangible assets must first be identified. This 
requires management judgement as to the value drivers of the acquired business and its interaction with the marketplace and 
stakeholders. In calculating the fair value of the identified assets, management must use judgement to identify an appropriate 
calculation technique and use estimates in deriving appropriate forecasts and discount rates as required. Management have used 
external experts to mitigate the risk of these judgements and estimates on the intangible assets identified and valued.

Deferred tax
Deferred tax assets are recognised for unused tax losses to the extent that it is probable that taxable profit will be available against 
which the losses can be utilised. Significant management judgement is required to determine the amount of deferred tax assets that 
can be recognised, based upon the likely timing and the level of future taxable profits, together with future tax planning strategies.  
See note 29 for further details.

4. REVENUE
The revenue of the group is attributable to the one principal activity of the group.

a) Geographical analysis
The group’s revenue by destination is split in the following geographic areas:

United Kingdom

Europe (excluding UK)

North America

South America

Asia

Australia

2020 
$’000

14,014

14,097

12,040

450

4,032

2,782

47,415

2019 
$’000

15,242

18,657

16,038

975

6,187

4,148

61,247

In the year ended 31 December 2020, the group had one customer which accounted for more than 10% of the group’s revenues. 
The revenue generated from this customer was $9,483,000 (2019: $11,289,000). The revenue from this customer is generated across  
all segments as identified in note 6.

b) Right of return assets and liabilities

Right of return asset

Right of return liability

2020 
$’000

1,967

(12,824)

2019 
$’000

96

(476)

The right of return asset is presented as a component of inventory (note 18) and the right of return liability is presented separately on 
the face of the balance sheet.

86

5. OTHER INCOME

Royalty income

Sundry income

2020 
$’000

–

–

–

2019 
$’000

62

71

133

Royalty income relates to remuneration received from customers for the design of concept frames. Sundry income in 2019 relates to 
income from an insurance claim.

6. SEGMENT INFORMATION
The group operates in three operating segments, which upon application of the aggregation criteria set out in IFRS 8 Operating 
Segments results in three reporting segments:

•  Frames and Optics (previously Branded) product distribution.

•  Wholesale – being OEM and manufacturing distribution.

•  Lenses – being manufacturing and distribution of lenses.

The acquisition of Norville (20/20) Limited during 2020 (see note 7) has led to an additional operating and reporting segment 
of ‘Lenses’ in 2020. In addition, the acquisition of Eschenbach Holdings GmbH (see note 7) has resulted in a change to the 
‘Branded’ reporting segment, to form the ‘Frames and Optics’ reporting segment of which Eschenbach is a part during the year 
to 31 December 2020. 

The criteria applied to identify the operating segments are consistent with the way the group is managed. In particular, the disclosures 
are consistent with the information regularly reviewed by the CEO and the CFO in their role as Chief Operating Decision Makers, to 
make decisions about resources to be allocated to the segments and to assess their performance.

87

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

6. SEGMENT INFORMATION CONTINUED
The reportable segments subject to disclosure are consistent with the organisational model adopted by the group during the financial 
year ended 31 December 2020 and are as follows:

Frames and 
Optics 
$’000

Wholesale 
$’000

Lenses 
$’000

Total before 
adjustments 
& eliminations 
$’000

Adjustments 
& eliminations 
$’000

Total 
$’000

21,259

2,204

23,463

21,979

2,381

24,360

4,177

59

4,236

47,415

4,644

52,059

–

47,415

(4,644)

(4,644)

–

47,415

(14,987)

(13,678)

(2,203)

(30,868)

3,975

(26,893)

8,476

10,682

2,033

21,191

(669)

20,522

(12,898)

(636)

(514)

(5,572)

(5,594)

(1,422)

(1,093)

2,573

(1,634)

(20,126)

570

(19,556)

(241)

–

158

(2,299)

(1,607)

(2,841)

–

–

(99)

(2,299)

(1,607)

(2,940)

(382)

(740)

(5,763)

506

(1,880)

36

–

2,250

(8,913)

401,874

(304,479)

72,021

(6,809)

7,409

481,304

(183,846)

297,458

(6,185)

(317,473)

259,112

(58,361)

12,995

(4,360)

(24,694)

(77,221)

145,817

203

1,864

736

2,803

–

2,803

Revenue

  External

Internal

Cost of sales

Gross profit

Expenses

Depreciation

Amortisation

Operating (loss)/profit

Exchange adjustment on borrowings

Movement in derivatives

Non-underlying costs 

Negative goodwill on bargain purchase

Finance costs

Finance income

Share of profit of associate

Taxation

Loss for the year

Total assets

Total liabilities

Deferred tax asset

Current tax liability

Deferred tax liability

Borrowings

Group net assets

Other disclosures

  Capital additions

88

 
The reportable segments subject to disclosure are consistent with the organisational model adopted by the group during the financial 
year ended 31 December 2019 and are as follows:

Revenue

  External

Internal

Cost of sales

Gross profit

Expenses

Other income

Depreciation

Amortisation

Operating profit

Exchange adjustment on borrowings

Movement in derivatives

Non-underlying costs – Initial public offering

Finance costs

Finance income

Share of profit of associate

Taxation

Profit for the year

Total assets

Total liabilities

Deferred tax asset

Current tax liability

Deferred tax liability

Derivative liability

Borrowings

Group net assets

Other disclosures

  Capital additions

Branded  
$’000

Wholesale  

$’000

Total before 
adjustments & 
eliminations 
$’000

Adjustments & 
eliminations  

$’000

27,729

2,175

29,905

(18,723)

33,518

3,256

36,773

(20,194)

61,247

5,431

66,678

(38,917)

11,182

16,579

27,761

(9,772)

35

(417)

(18)

1,010

(6,743)

98

(1,620)

(1,070)

7,244

(16,515)

133

(2,037)

(1,088)

8,254

–

(5,431)

(5,431)

5,206

(225)

(84)

–

–

–

(309)

 56,815

 (42,618)

 14,197

 66,018

 (4,676)

 61,342

 122,833

 (47,294)

 75,539

(52,678)

 33,956

(18,722)

Total  
$’000

61,247

–

61,247

(33,711)

27,536

(16,599)

133

(2,037)

(1,088)

7,945

715

2,865

(2,827)

(1,380)

15

14

(907)

6,440

 70,155

 (13,338)

 56,817

 1,221

(2,612)

 (2,917)

(3,536)

 (17,625)

 31,348

 143

 2,782

 2,924

–

 2,924

Total assets are the group’s gross assets excluding deferred tax asset. Total liabilities are the group’s gross liabilities excluding loans 
and borrowings, current and deferred tax liabilities and derivative liabilities.

Non-underlying costs, as well as net finance costs and taxation are not allocated to individual segments as they relate to group-wide 
activities as opposed to individual reporting segments. 

89

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic Report 
 
Notes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

6. SEGMENT INFORMATION CONTINUED
Deferred tax and borrowings are not allocated to individual segments as they are managed on a group basis.

Adjusted items relate to elimination of all intra group items including any profit adjustments on intra-group sales that are eliminated on 
consolidation, along with the profit and loss items of the parent company.

Adjusted items in relation to segmental assets and liabilities relate to the elimination of all intra group balances and investments in 
subsidiaries, and assets and liabilities of the parent company.

Non-current operating assets

United Kingdom

Europe

North America

Asia

2020 
$’000

3,256

112,848

10,686

41,441

168,231

2019 
$’000

5,410

183

150

36,175

41,918

Non-current assets for this purpose consist of property, plant and equipment, right-of-use assets, goodwill and intangible assets.

7. BUSINESS COMBINATIONS

Acquisition of Norville (20/20) Limited
Norville (20/20) Limited was incorporated on 10 July 2020 with INSPECS Limited as its immediate parent. On 13 July 2020 this entity 
acquired assets of The Norville Group Ltd (in administration) for a cash consideration of $3,027,000 from the Administrators. As the 
total fair value of the net assets acquired of $3,523,000 exceeds the initial consideration of $3,027,000 the gain on the bargain purchase 
of $506,000 has been recognised in profit and loss at the acquisition date.

Assets acquired and liabilities assumed
The fair values of the identifiable assets and liabilities of Norville (20/20) Limited as at the date of acquisitions were:

Assets 

Property, plant and equipment 

Inventories 

Total identifiable assets at fair value

Liabilities

Deferred tax liability

Total identifiable liabilities at fair value

Total identifiable net assets at fair value

Negative goodwill arising on acquisition 

Foreign exchange on consolidation

Purchase consideration transferred

90

Fair value recognised 
on acquisition 
$000 

1,931

2,070

4,001

(478)

(478)

3,523

(506)

10

3,027

 
 
Under UK tax legislation, a gain on bargain purchase is taxable to the extent that it relates to the bargain purchase of intangible fixed 
assets. After review there was no fair value assigned to the intangible assets acquired, therefore none of the goodwill arising from the 
bargain purchase is expected to be taxable for income tax purposes.

From the date of acquisition, Norville (20/20) Limited contributed $4,236,000 of revenue and a profit of $664,000 to the group loss 
before tax from continuing operations. Norville (20/20) Limited was not trading prior to its acquisition by the group. 

Transaction costs of $123,000 were expensed and are included within ‘Non-underlying costs – Acquisitions’.

Acquisition of Eschenbach Holdings GmbH
On 16 December 2020, INSPECS Limited acquired the entire share capital of Eschenbach Holdings GmbH and its subsidiaries, 
for a cash consideration of $115,496,000. Eschenbach held shareholder loans which were purchased at fair value, with the residual 
consideration for the remaining net assets of Eschenbach.

Assets acquired and liabilities assumed
The fair values of the identifiable assets and liabilities of Eschenbach Holdings GmbH as at the date of acquisitions were:

Assets 

Property, plant and equipment 

Intangible assets

Right-of-use asset

Cash and cash equivalents

Trade and other receivables

Tax receivable

Inventories

Deferred tax assets

Total identifiable assets at fair value

Liabilities

Trade and other payables

Interest bearing loans and borrowings

Overdraft

Lease liability

Income tax payable

Deferred tax liability

Total identifiable liabilities at fair value

Total identifiable net assets at fair value

Goodwill arising on acquisition 

Purchase consideration transferred

Fair value recognised 
on acquisition  

$000

8,466

39,407

19,552

19,322

24,477

2,452

48,343

9,174

171,193

44,623

21,462

2,620

19,552

1,341

21,199

110,797

60,396

55,100

115,496

From the date of acquisition, Eschenbach Holdings GmbH contributed $2,881,000 of revenue and $(1,999,000) to loss before tax from 
continuing operations. If the combination had taken place at the beginning of the year, revenue from continuing operations for the 
group would have been $186,817,000 and loss before tax from continuing operations for the group would have been $(7,424,000).

Transaction costs of $2,931,000 were expensed and are included within ‘Non-underlying costs – Acquisitions’.

91

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic Report 
 
Notes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

7. BUSINESS COMBINATIONS CONTINUED

Analysis of cash flows on acquisitions
The combined impact on cash flow of the two acquisitions made during the year was as follows:

Consideration for Norville (20/20) Limited

Consideration for Eschenbach Holdings GmbH

Acquired with Eschenbach Holdings GmbH:

  Cash and cash equivalents

  Overdraft

Net cash flow on acquisition

8. EMPLOYEES AND DIRECTORS

Included in cost of sales

Wages and salaries

Social security costs

Pension costs

Included in administration costs

Wages and salaries

Social security costs

Pension costs

Share-based payment expense

The average number of employees during the year was as follows:

Administration

Selling and operations

Production

92

$’000

(3,027)

(115,496)

19,322

(2,620)

 (101,821)

2019 
$’000

4,329

96

8

4,434

9,268

580

162

1,917

11,926

2020 
$’000

4,899

102

39

5,040

8,238

955

360

1,706

11,259

16,299

16,360

2020

153

72

873

1,098

2019

176

54

992

1,222

Directors’ remuneration during the year was as follows:

Directors’ salaries

Directors’ pension contributions

Share options

Information regarding the highest paid director is as follows:

Total remuneration

2020 
$’000

455

33

159

647

2020 
$’000

311 

2019 
$’000

1,148

3

539

1,690

2019 
$’000

 792

The number of directors to whom employer pension contributions were made by the group during year is 2 (2019: 2). This was in the 
form of a defined contribution pension scheme. 

Further information about the remuneration of individual directors is provided in the Remuneration and Nomination Committee 
Report on pages 52 and 53. 

9. NON-UNDERLYING COSTS
Non-underlying items are those that in the directors’ view should be separately disclosed by virtue of their size, nature or incidence 
to enable a full understanding of the group’s financial performance in the year and business trends over time. Non-underlying costs 
incurred during the year are as follows:

Initial public offering

Acquisitions

2020 
$’000

2,709

3,054

5,763

2019 
$’000

2,827

–

2,827

On 27 February 2020, INSPECS Group plc was admitted to the AIM of the London Stock Exchange. In relation to this, costs of 
$2,709,000 (2019: $2,827,000) were incurred through the Income Statement in relation to the listing of existing shares.

Acquisition costs of $123,000 and $2,931,000 were incurred during the period relating to the purchase of Norville (20/20) Limited  
and Eschenbach Holdings GmbH respectively (see note 7).

93

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

10. FINANCE COSTS AND FINANCE INCOME

Finance costs

Bank loan interest

Other loan interest

Invoice discounting interest and charges

Loan transaction costs

Lease interest

Total finance costs

Finance income

Interest receivable

11. PROFIT BEFORE INCOME TAX
The profit before income tax is stated after charging/(crediting):

Cost of inventories recognised as expense

Short term leases

Depreciation own assets (note 16)

Depreciation – Right-of-use assets (note 25)

Amortisation – Intangibles (note 15)

Restructuring costs

Post acquisition insurance costs

Foreign exchange on funding for acquisitions

Other foreign exchange differences

Fees payable to the company’s auditor for audit services:

Audit of the company and group accounts

Audit of the subsidiaries

Fees payable to the company’s auditor for non-audit services:

Costs associated with IPO

IFRS conversion costs

Tax services

94

2020 
$’000

516

39

50

1,249

26

1,880

2019 
$’000

930

92

41

286

31

1,380

36

15

2020 
$’000

21,045

83

1,539

760

1,607

185

563

1,085

305

2020 
$’000

26

1,213

285

–

–

2019 
$’000

21,579

200

1,301

736

1,088

–

–

–

(623)

2019 
$’000

20

644

1,229

232

33

12. INCOME TAX

Analysis of tax expense

Current tax:

Current tax on profits for the year

Overseas current tax expense

Adjustment re prior years

Total current tax

Deferred tax: (see note 28)

Deferred tax income relating to the origination and reversal of timing differences

Effect of changes in tax rates

Total deferred tax

Total tax expense reported in the consolidated income statement

2020 
$’000

2019 
$’000

24

208

–

232

(2,478)

(4)

(2,482)

(2,250)

485

453

12

950

(43)

–

(43)

907

Factors affecting the tax expense
The tax assessed for the year is (higher)/lower than the standard rate of corporation tax in the UK. The difference is explained below: 

(Loss)/profit before income tax

(Loss)/profit multiplied by standard rate of corporation tax in the UK of 19.00% (2019: 19.00%)

Effects of:

Non-deductible expenses – Amortisation of intangible assets

Non-deductible expenses – Other expenses

Increase in provision for uncertain tax liabilities

Income taxed in nil rate regime

Share-based payment

Different tax rate for overseas subsidiaries

Transfer pricing adjustments

Tax rate changes

Income not taxable

Effects of group relief

Amounts not recognised on deferred tax

Adjustments in respect of prior year

Tax expense

2020 
$’000

(11,163)

(2,121)

184

1,622

381

(404)

(1,924)

(84)

51

(4)

(176)

70

155

–

(2,250)

2019 
$’000

7,347

1,396

183

(42)

463

(1,222)

42

59

6

(54)

–

–

–

76

907

Income not taxable for tax purposes relates to income generated in jurisdictions within which there is a nil taxation rate. Movements in 
other comprehensive relating to foreign exchange on consolidation are not taxable. 

95

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

13. EARNINGS PER SHARE ("EPS")
Basic EPS is calculated by dividing the profit or loss for the year attributable to ordinary equity holders of the Parent by the weighted 
average number of Ordinary Shares outstanding during the year.

Diluted EPS is calculated by dividing the profit or loss attributable to ordinary equity holders of the Parent by the weighted average 
number of Ordinary Shares outstanding during the year plus the weighted average number of Ordinary Shares that would be issued on 
conversion of all the dilutive potential Ordinary Shares into Ordinary Shares, to the extent that the inclusion of such shares is not anti-
dilutive. A loss has been made in the year to 31 December 2020. In accordance with IAS33, potential ordinary shares shall be treated as 
dilutive when, and only when, their conversion to Ordinary Shares would decrease earnings per share, or increase loss per share from 
continuing operations. As a loss is made, including the dilution of potential Ordinary Shares reduces the loss per share and therefore 
the outstanding options should not be treated as dilutive when calculating EPS. The comparative figure has been adjusted for the 
impact of the subdivision of shares and the share for share exchange as discussed in note 21, as if these shares had always been in issue 
to allow comparability. Basic earnings per share is therefore $(0.13) loss (2019: $0.12 profit), with diluted earnings per share $(0.13) loss 
(2019: $0.11 profit).

The following table reflects the income and share data used in the basic and diluted EPS calculations:

ORDINARY SHARES

Loss attributable to the ordinary equity 
holders of the Parent for basic earnings

Weighted average number of Ordinary Shares for basic EPS

Effect of dilution from:

Share options

Weighted average number of Ordinary Shares adjusted  
for the effect of dilution where appropriate

B ORDINARY SHARES

Profit attributable to the ordinary equity holders of the Parent for basic earnings

Weighted average number of Ordinary Shares for basic EPS

Effect of dilution from:

Share options

Weighted average number of Ordinary Shares adjusted  
for the effect of dilution where appropriate

C ORDINARY SHARES

Profit attributable to the ordinary equity holders of the Parent for basic earnings

Weighted average number of Ordinary Shares for basic EPS

Effect of dilution from:

Share options

Weighted average number of Ordinary Shares adjusted  
for the effect of dilution where appropriate

2020 
$’000

(8,913)

2019 
$’000

–

Number of shares

Number of shares

69,227,355

31,301,362

–

5,771,538

69,227,355

37,072,900

2020 
$’000

–

2019 
$’000

6,440

Number of shares

Number of shares

–

–

–

2020 
$’000

–

18,597,160

–

18,597,160

2019 
$’000

–

Number of shares

Number of shares

–

–

–

4,120,950

–

4,120,950

Refer to note 21 for details in relation to the shares in issue and their rights, and changes in the equity structure during the year.

96

14. GOODWILL

Group

COST

At 1 January 2020

Additions

Exchange adjustment

At 31 December 2020

NET BOOK VALUE

At 31 December 2020

COST

At 1 January 2019

Exchange adjustment

At 31 December 2019

NET BOOK VALUE

At 31 December 2019

$’000

12,798

55,100

1,189

69,087

69,087

12,394

404

12,798

12,798

Impairment testing of goodwill 
Goodwill acquired through business combinations has been allocated to the Cash-generating Unit of Twenty20 Limited ($13,002,000 
as at 31 December 2020), Eschenbach Group GmbH ($55,825,000 as at 31 December 2020) and INSPECS Limited ($237,000 as at 
31 December 2020) for impairment testing.

Twenty20 Limited
The recoverable amount of the cash-generating unit has been determined based on a value in use calculation using cash flow 
projections based on financial budgets covering a five-year period approved by senior management.

The discount rate applied to the cash flow projections was 8.9% plus a 5.0% company specific risk premium and cash flows beyond 
the five-year period were extrapolated using a growth rate of 2% in perpetuity. Based on management’s assessment there is no 
impairment adjustment required on goodwill.

To recognise an impairment provision, the discount rate would have to exceed 27.0%.

To recognise an impairment provision the cash flow into perpetuity would need to be discounted by 49% with the applicable discount 
rate for the five-year period to 2025 remaining at 13.9%

INSPECS Limited
The recoverable amount of the cash-generating unit has been determined based on a value in use calculation using cash flow 
projections based on financial budgets covering a five-year period approved by senior management.

The discount rate applied to the cash flow projections was 7.5% and cash flows beyond the five-year period were extrapolated using 
a growth rate of 2% in perpetuity. Based on management’s assessment there is no impairment adjustment required on goodwill.

To recognise an impairment provision, the company would have cash flows only for a three-year period and have a discount rate 
at 12.4%.

To recognise an impairment provision the CGU’s revenue would have no growth for the five-year period with the applicable discount 
rate at 73.3%.

To recognise an impairment on discount rate alone, the rate would need to increase to 78.7%.

97

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

14. GOODWILL CONTINUED

Impairment testing of goodwill continued

Eschenbach Holdings GmbH
The recoverable amount of the cash-generating unit has been determined based on a value in use calculation using cash flow 
projections based on financial budgets covering a five-year period approved by senior management.

The discount rate applied to the cash flow projections was 14.7% and cash flows beyond the five-year period were extrapolated using a 
growth rate of 2% in perpetuity. Based on management’s assessment there is no impairment adjustment required on goodwill.

To recognise an impairment provision the CGU’s revenue would have no growth for the five-year period with the applicable discount 
rate at 11.6%.

To recognise an impairment on discount rate alone, the rate would need to increase to 16.9%.

Assumptions were used in the value in use calculation of the cash-generating unit for the year ended 31 December 2020. These are 
detailed as follows:

Forecasted revenue and results of operations
The forecasts for 2021 have been prepared assuming the COVID-19 restrictions that were in place in January 2021 continue through 
2021 with a resumption to normal trading in 2022. The COVID-19 restrictions in place at the time led to a reduced footfall on the high 
street and non-prescription eyewear sales were reduced by continuing closure of airports and non-essential retail. Financial years 
2023 to 2025 were forecasted assuming a 7% increase in turnover based on synergies within the expanding Group of companies. 
Management have assumed a constant gross profit margin and increased administration expenses by 5% per annum (3% above the 
expected rate of inflation). From 2025 onwards we have assumed a 2% terminal growth rate.

Discount rate
The discount rate used is before tax and reflects specific risks relating to the cash-generating unit.

Business environment
No major changes have occurred in the existing political, legal and economic conditions in those locations in which the cash-
generating unit operates.

15. INTANGIBLE ASSETS

Group

COST

At 1 January 2020

Acquisition of a subsidiary

Additions

Disposals

Exchange differences

At 31 December 2020

AMORTISATION

At 1 January 2020

Amortisation for the year

Disposals

Exchange differences

At 31 December 2020

NET BOOK VALUE

Patents and 
licences  
$’000

Customer 
relationships  

$’000

Trademarks  

$’000

Customer  
order book  

$’000

Computer 
software  

$’000

233

11

92

–

(14)

322

128

59

–

(7)

180

19,909

18,849

–

–

2,516

41,274

2,904

1,127

–

1,818

5,849

–

18,637

–

–

151

18,788

–

291

–

19

310

1,582

68

–

(1,640)

58

68

1,582

5

(1,640)

58

5

63

Totals  
$’000

22,429

39,407

167

(1,640)

2,739

63,102

4,947

1,607

(1,640)

1,883

6,797

705

1,842

75

–

28

2,650

333

125

–

(5)

453

At 31 December 2020

142

35,425

18,478

98

2,197

56,305

COST

At 1 January 2019

Additions

Exchange differences

At 31 December 2019

AMORTISATION

At 1 January 2019

Amortisation for the year

Exchange differences

At 31 December 2019

NET BOOK VALUE

At 31 December 2019

Patents and 
licences  
$’000

Customer 
relationships  

$’000

Customer  
order book  

$’000

Computer 
software  

$’000

163

67

3

233

78

48

2

128

19,268

–

641

19,909

1,847

964

93

2,904

1,531

–

51

1,582

1,531

–

51

1,582

605

94

6

705

252

76

5

333

Total  
$’000

21,567

161

701

22,429

3,708

1,088

151

4,947

105

17,005

–

372

17,482

The individual intangible assets, excluding goodwill, which are material to the financial statements are:

Intangible asset

Customer relationships

2020

$’000

35,425

Remaining amortisation  

period (years)

Between 10 and 16

2019

$’000

17,005

Remaining amortisation 
period (years)

17

Impairment review of individual customer relationship
During the period, an indicator of impairment was noted relating to a customer relationship with a carrying value of $3,946,000 as at 31 
December 2020. As a result, an impairment review was completed to compare the recoverable amount of the asset against its carrying 
value. Following this review, the directors consider that no impairment was considered necessary.

The discount rate applied to the cash flow projections was 13.9% and cash flows beyond a three-year period were extrapolated using a 
growth rate of 2% in perpetuity. Based on management’s assessment there is no impairment adjustment required on goodwill.

To recognise an impairment on discount rate alone, the rate would need to increase to 15.4%.

Acquisition of a subsidiary
For each acquisition, an exercise to value the net assets and apportion the consideration paid has taken place, with the determined 
balances recognised within these financial statements. We engaged external consultants to assist in the valuation of the intangible 
assets, which have been valued using the income method. Adjustments to provisional fair values are made up to 12 months from the 
original acquisition date with any revisions asset or liability values being adjusted through goodwill. Goodwill represents the value of 
the accumulated workforces and synergies expected to be realised following the acquisition.

99

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

16. PROPERTY PLANT AND EQUIPMENT
Some of the group’s property, plant and equipment are subject to a charge to secure against the group’s bank loans.

Freehold 
property  

Leasehold 
improvement  

$’000

$’000

Plant & 
machinery  

$’000

Fixtures & 
fittings 
$’000

Computer 
equipment  

Construction 
in progress  

$’000

$’000

6,484

3,695

39

–

372

10,590

348

209

–

12

569

398

523

6

(82)

17

862

210

68

(82)

4

200

6,433

3,040

1,186

(187)

357

278

2,989

8

(40)

34

745

150

182

(14)

39

163

–

1,046

–

73

10,829

3,269

1,102

1,282

27,934

2,870

1,131

(187)

33

3,847

217

32

(40)

10

219

536

99

(14)

18

639

–

–

–

–

–

4,181

1,539

(323)

77

5,474

Total  
$’000

14,501

10,397

2,467

(323)

892

10,021

662

6,982

3,050

463

1,282

22,460

Freehold 
property  

Leasehold 
improvement  

$’000

$’000

Plant & 
machinery  

$’000

Fixtures & 
fittings 
$’000

Computer 
equipment  

Construction 
in progress  

$’000

$’000

5,444

1,242

 (58)

 (144)

6,484

304

196

–

(152)

348

 282

116

–

–

5,521

1,144

(12)

(220)

262

8

–

8

398

6,433

278

 147

63

–

–

2,122

942

–

(194)

210

2,870

184

26

–

7

217

645

90

–

10

745

453

74

–

9

536

Total  
$’000

 12,154

2,763

(70)

(346)

–

163

–

–

163

14,501

–

–

–

–

–

 3,210

1,301

–

(330)

4,181

6,136

188

3,563

61

209

163

10,320

Group

COST 

At 1 January 2020

Acquisition of a subsidiary

Additions

Disposals

Exchange differences

At 31 December 2020

DEPRECIATION

At 1 January 2020

Charge for the year

Eliminated on disposals

Exchange differences

At 31 December 2020

NET BOOK VALUE

At 31 December 2020

COST 

At 1 January 2019

Additions

Disposals

Exchange differences

At 31 December 2019

DEPRECIATION

At 1 January 2019

Charge for the year

Eliminated on disposals

Exchange differences

At 31 December 2019

NET BOOK VALUE

At 31 December 2019

100

17. INVESTMENTS IN ASSOCIATE

Group

Share of net assets of associate

COST

At 1 January 2020

Share of profit

Exchange difference

At 31 December 2020

NET BOOK VALUE

At 31 December 2020

Revenue

Expenses

Profit before tax

Income tax

Share of profit of associate for the year ended 31 December 2020

Interest in 
associate 
$’000

 53

–

4

57

57

$’000

154

(154)

–

–

–

The group’s associated undertaking is Ruain Zuoyou Glasses Co Ltd, a company registered in China. 25% of the share capital of Ruain 
Zuoyou is owned by the group, with Zhongshan Torkai Optical Co Limited being the direct owner of these shares.

18. INVENTORIES

Raw materials

Work in progress

Finished goods

The above includes amounts in respect of right of return assets and the amount for each year is as below; 

Finished goods – Right of return asset

Inventories are stated after provisions for impairment of $2,249,000 (2019: $1,841,000). 

2020 
$’000

5,102

2,646

51,546

59,294

2020 
$’000

1,967

2019 
$’000

1,409

2,725

4,581

8,715

2019 
$’000

96

101

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

19. TRADE AND OTHER RECEIVABLES

Current:

Trade receivables

Amounts owed by related parties

Prepayments

Other receivables

Group

2020 
$’000

25,149

–

6,419

4,080

35,648

2019 
$’000

9,815

34

2,288

738

12,875

Other receivables includes $1,955,000 (2019: $nil) relating to an invoice factoring receivable.

An ageing analysis of the trade receivables as at the end of the reporting period, based on the invoice date and net of loss allowance, 
is as follows:

Invoiced in last month

1–2 months

2–3 months

Over 3 months

Set out below is the movement in the allowance for expected credit losses of trade receivables.

At 1 January

Acquired with acquisition of subsidiary

Movement in the year

Exchange adjustment

At 31 December

2020 
$’000

11,787

6,948

4,069

2,345

25,149

2020 
$’000

19

520

20

(3)

556

2019 
$’000

8,846

437

395

137

9,815

2019 
$’000

29

–

(10)

–

19

Amounts owed by related undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.

The group’s trading terms with its customers are mainly on credit. The credit period is generally 30 to 90 days. Each customer has a 
maximum credit limit. The group seeks to maintain strict control over its outstanding receivables and has a credit control department 
to minimise credit risk. Overdue balances are reviewed regularly by senior management. The group’s large retail chain customers 
order on purchase orders which are paid within 30 to 60 days and the remaining customer base is well diversified and hence there 
is considered to be no significant credit risk. Acquisitions during the year have further diversified the reliance on major customers 
and therefore have further mitigated credit risk. The group does not hold any collateral or other credit enhancements over its trade 
receivable balances. Trade receivables are non-interest-bearing and are stated net of loss allowance.

Impairment under IFRS 9 
An impairment analysis is performed at each reporting date to measure expected credit losses. The provision rates are based on days 
past due for groupings of customer segments with similar loss patterns (i.e. by customer type and rating). The calculation reflects the 
probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting 
date about past events, current conditions and forecasts of future economic conditions. Generally, trade receivables are written off if 
past due for more than one year and are not subject to enforcement activity.

102

20. CASH AND CASH EQUIVALENTS

Cash at bank and in hand

2020 
$’000

32,672

32,672

2019 
$’000

6,595

6,595

At the end of the reporting period, the cash and cash equivalents of the group denominated in Renminbi (‘RMB’) amounted to 
$2,879,000 (2019: $458,000). The RMB is not freely convertible into other currencies, however, under Mainland China’s Foreign 
Exchange Control Regulations and Administration of Settlement, Sale and Payment of Foreign Exchange Regulations, the group is 
permitted to exchange RMB for other currencies through a bank authorised to conduct foreign exchange business.

Cash at banks earns interest at floating rates based on daily bank deposit rates. Short-term time deposits are made for varying 
periods of between one day and three months depending on the immediate cash requirements of the group and earn interest at the 
respective short-term time deposit rates. The bank balances and time deposits are deposited with creditworthy banks with no recent 
history of default.

For the purposes of the statement of cash flows, cash and cash equivalents comprise the following at 31 December:

Cash at bank and in hand

Bank overdrafts

21. CALLED UP SHARE CAPITAL
Authorised and issued share capital:

Number:

101,290,898 (2019: nil)

Nil (2019: 227,870)

Nil (2019: 135,385)

2020 
$’000

32,672

(2,642)

30,030

2020 
$’000

1,384

–

–

1,384

2019 
$’000

6,595

(93)

6,502

2019 
$’000

–

44

18

62

Class:

Nominal value

Ordinary

Ordinary

B Ordinary

 £0.01

 £0.10

 £0.10

Each Ordinary Share carries the right to participate in distributions, as respects dividends and as respects capital on winding up. 

On 10 January 2020, all B Ordinary Shares of INSPECS Holdings Limited were converted into Ordinary Shares of INSPECS Group 
Limited and a subdivision of INSPECS Holdings Limited shares was enacted, with 363,255 shares with a nominal value of £0.10 each 
converted into 3,632,550 share with a nominal value of £0.01 each. Also on 10 January 2020, a share for share exchange occurred 
between INSPECS Holdings Limited and INSPECS Group Limited, subsequently INSPECS Group plc. As part of this share for share 
exchange, all Ordinary Shares in INSPECS Holdings were exchanged for Ordinary Shares of INSPECS Group. Share options in INSPECS 
Holdings were also exchange for share options in INSPECS Group, including the options over C Ordinary Shares, which were converted 
to options over Ordinary Shares in INSPECS Group. Lastly, as part of the share for share exchange on 10 January 2020, one share in 
INSPECS Holdings Limited after the subdivision was exchanged for 13.7 shares in INSPECS Group Limited, leaving 49,898,522 Ordinary 
Shares as the entire share capital of INSPECS Group Limited.

On 27 February 2020, as part of the initial public offering of shares of INSPECS Group plc, 12,051,282 new shares were issued to the 
London AIM at £1.95 generating a cash inflow of $30,313,000 (£23,500,000).

On 11 December 2020 a further 30,476,191 shares were issued to the London AIM at a share price of £2.10, generating a cash inflow of 
$85,448,000 (£64,000,000).

A further 8,864,903 shares have been created during the year as a result of the exercise of share options.

103

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

22. RESERVES

Share premium
This reserve records the amount above the nominal value of the sums received for shares issued, less transaction costs.

At 1 January

Share for share exchange

Issue of shares to third parties on initial public offering

Issue of shares to PE investors on initial public offering (note 30)

Issue of shares on secondary placing

Exercise of share options

At 31 December

2020 
$’000

21,628

(21,628)

30,659

4,452

84,104

2,725

121,940

2019 
$’000

21,628

–

–

–

–

–

21,628

The share premium reserve was not novated from INSPECS Holdings Limited to INSPECS Group plc as part of the share for share 
exchange and therefore the share premium reserve as at 31 December 2020 includes only the reserve generated during the year since 
the share for share exchange.

Foreign currency translation reserve
This reserve records the foreign currency translation adjustment on consolidation.

At 1 January

Share for share exchange

Other comprehensive income

At 31 December

2020 
$’000

1,031

(926)

(204)

(99)

2019 
$’000

1,030

–

1

1,031

Share option reserve
The share option reserve is used to recognise the value of equity-settled share-based payments provided to employees, including key 
management personnel, as part of their remuneration.

At 1 January

Share for share exchange

Share-based payment charge

Exercise of share options

At 31 December

2020 
$’000

2,840

34

1,133

(3,140)

867

2019 
$’000

 647

–

2,193

–

 2,840

As part of the share for share exchange with INSPECS Holdings Limited on 10 January 2020, the share option reserve was novated 
into INSPECS Group plc. The share-based payment charge for the year is recognised against the reserve as per IFRS 2 Share-Based 
Payments. As options have been exercised during the year, the reserve relating to these options has been released to retained 
earnings, with a further $167,000 released against the deferred tax asset held in relation to the options exercised (see note 28).

104

Merger reserve
This reserve arose on the share for share exchange between INSPECS Holdings Limited and INSPECS Group plc.

At 1 January

Issue of share capital

Share for share exchange and creation of merger reserve

Capital reduction

At 31 December

2020 
$’000

–

(22)

68,802

(61,484)

7,296

2019 
$’000

–

–

–

–

–

On 27 February 2020 immediately prior to IPO, options over Ordinary Shares held by PE investors were exercised (see note 30), with the 
nominal value of the share capital issued via a reduction of the merger reserve of $22,000. 

As discussed in note 21, in relation to the share for share exchange, INSPECS Group plc issued 49,898,522 shares for an aggregate value 
of $69,484,000 (£50,856,000). This gives rise to share capital of $682,000 (£499,000) and a merger reserve in accordance with section 
612 Companies Act 2006 of $68,802,000 (£50,357,000). The company’s merger reserve was subsequently reduced by $61,484,000 
(£45,000,000) and the amount so reduced was credited to retained earnings and treated as realised profits.

23. TRADE AND OTHER PAYABLES

Group

Current:

Trade payables

Amounts owed to related parties

Other payables

Social security and other taxes

Royalties

Accruals 

2020 
$’000

2019 
$’000

22,404

5,193

169

1,435

5,422

5,911

7,554

42,895

258

280

132

852

3,477

10,192

The trade payables are non-interest-bearing and are normally settled on cash-on-delivery or 90-day terms.

Amounts owed to related parties are unsecured, interest free, have no fixed date of repayment and are repayable on demand. 
Accruals include $1,999,000 (2019: $nil) relating to acquisition costs.

105

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

24 . FINANCIAL LIABILITIES – BORROWINGS

Current:

Bank overdraft

Invoice discounting

Bank loans

Lease liabilities

Non-current: 

Bank loans

Lease liabilities

2020 
$’000

2,642

–

3,855

2,975

6,830

2020 
$’000

53,092

17,299

70,391

2019 
$’000

93

2,577

4,228

746

4,974

2019 
$’000

12,168

483

12,651

At the balance sheet date, the available invoice discounting facility was $3,000,000 (2019: $3,000,000).

The invoice discounting facility bears interest at 1.85% over base rate throughout 2020 (2019: 1.85%). The invoice discounting facility is 
secured by way of fixed and floating charges over the trade receivables of INSPECS Limited. The facility has no fixed end date, with a 
notice period of three months.

On 27 February 2020, the group entered into a new multi-currency RCF facility with HSBC allowing it to draw down up to $25,000,000, 
an increase of $7,187,000 on the previous facility. This facility was subsequently increased to the current $35,000,000 on 18 November 
2020, with this facility being fully drawn down as at 31 December 2020, giving a total cash inflow to the group as a result of this new 
financing of $17,187,000. An arrangement fee of $810,000 was payable on the new and subsequently amended agreement. Only interest 
and charges are repayable during the length of this arrangement, with no capital requiring repayment. The loan runs until January 
2023. Interest is payable at the applicable Margin Rate plus LIBOR calculated daily on a 360-day year basis. The Margin Rate is 1.90%, 
2.15% or 2.40% dependent upon the group’s leverage ratio. The loan is stated net of transaction costs amounting to $653,000 (2019: 
$1,082,000). The loan is US Dollar denominated and sits within the books of INSPECS Limited. It is therefore translated from US Dollars 
into the functional currency of that entity (being GBP), therefore leading to an exchange adjustment of $382,000 loss (2019: $715,000 
gain) for the year to 31 December 2020. See note 34 for further information in relation to foreign currency risk.

A further $12,278,000 of the loans held by the group are held at a fixed interest rate of 2.0%, repayable in June 2026. Remaining loans in 
the group of $9,669,000 are at LIBOR plus 2.0% and are repayable in between one and five years.

The group’s bank loans and overdrafts are secured against the business assets of the group.

The group’s lease liabilities are secured against the assets concerned.

106

25. RIGHT-OF-USE ASSETS AND LEASES
The group has lease contracts for various items of plant, machinery, vehicles and other equipment used in its operations. Leases of 
plant and machinery, motor vehicles and leasehold properties generally have lease terms between three and five years. The group’s 
obligations under its leases are secured by the lessor’s title to the leased assets. The group’s right-of-use assets are as follows:

COST

At 1 January 2020

Acquisition of a subsidiary

Additions

End of lease

Exchange differences

At 31 December 2020

DEPRECIATION

At 1 January 2020

Charge for the year

Eliminated on end of lease

Exchange differences

At 31 December 2020

NET BOOK VALUE

At 31 December 2020

Leasehold 
properties  

$’000

 Plant &  
machinery  

$’000

Motor  
vehicles  
$’000

2,953

17,550

114

(1,251)

190

19,556

1,839

664

(1,251)

79

1,331

38

674

–

–

6

718

25

5

–

1

31

222

1,328

28

(84)

23

1,517

32

91

(84)

11

50

Total  
$’000

3,213

19,552

142

(1,335)

219

21,791

1,896

760

(1,335)

91

1,412

18,225

687

1,467

20,379

107

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

25. RIGHT-OF-USE ASSETS AND LEASES CONTINUED

COST

At 1 January 2019

Additions

End of lease

Exchange differences

At 31 December 2019

DEPRECIATION

At 1 January 2019

Charge for the year

Eliminated on end of lease

Exchange differences

At 31 December 2019

NET BOOK VALUE

At 31 December 2019

Leasehold 
properties  

$’000

 Plant &  
machinery  

$’000

Motor  
vehicles  
$’000

 2,425

472

–

57

2,953

1,125

667

–

47

1,839

1,114

 49

–

(12)

1

38

 26

9

(12)

1

25

14

 199

131

(112)

4

222

 82

59

(112)

4

32

189

Total  
$’000

 2,673

603

(124)

61

3,213

1,233

736

(124)

51

1,896

1,317

Set out below are the carrying amounts of lease liabilities (included under interest bearing loans and borrowings) and the movements 
during the period:

2020 
$’000

1,229

19,552

142

26

(810)

(44)

179

20,274

2,975

17,299

2019 
$’000

 1,401

–

678

31

(867)

–

(14)

1,229

746

483

At 1 January

Acquisition of a subsidiary

Additions

Interest charge

Payments

Reduction in lease terms

Exchange adjustment

As at 31 December

Current

Non-current

108

26. CHANGES IN LIABILITIES FROM FINANCING ACTIVITIES

1 January  
2020  
$’000

New  
loans  
$’000

Reclassification 
between 
current and 
non-current  

Repayments  

$’000

$’000

Transaction 
costs on debt 
refinancing 
$’000

New  
leases  
$’000

Acquired on 
acquisition of 
subsidiary  

Foreign 
exchange on 
consolidation  

$’000

$’000

31 December 
2020  
$’000

Due in one year

Bank loans

Lease liabilities

(4,228)

(746)

Invoice discounting 
facility

(2,577)

Due after one year

-

–

–

39

810

5,357

(257)

2,577

–

Bank loans

(12,168)

(17,187)

Lease liabilities

(483)

–

-

–

(5,357)

257

(1,249)

–

–

-

–

–

–

–

-

(3,771)

(2,714)

–

(17,691)

(98)

(16,838)

(3)

(68)

–

(3,855)

(2,975)

–

(689)

(137)

(53,092)

(17,299)

Total liabilities 
from financing 
activities

(20,202) (17,187)

3,426

–

(1,249)

(98)

(41,014)

(897)

(77,221)

Balances at the end of each reporting period are summarised in note 24, with balances above being shown under interest bearing 
loans and borrowings on the balance sheet.

1 January  
2019  
$’000

New  
loans  
$’000

Repayments  

$’000

Reclassification 
between  
current and 
non-current  

Transaction 
 costs on debt 
refinancing  

$’000

$’000

New  
leases  
$’000

Foreign 
exchange on 
consolidation  

$’000

31 December 
2019  
$’000

(42)

(4,337)

(685)

–

(33)

–

72

4,733

836

(1,602)

(975)

(29)

(15,932)

(716)

–

(595)

–

–

–

–

–

(29)

(4,358)

(911)

–

29

4,358

911

–

(286)

–

–

–

–

–

–

–

–

–

–

–

(678)

–

53

13

–

–

–

–

–

(4,228)

(746)

(2,577)

–

(12,168)

(483)

(23,343)

(1,603)

5,641

–

(286)

(678)

66

(20,202)

Due in one year

Other loans

Bank loans

Lease liabilities

Invoice discounting 
facility

Due after one year

Other loans

Bank loans

Lease liabilities

Total liabilities 
from financing 
activities

Balances at the end of each reporting period are summarised in note 24, with balances above being shown under interest bearing 
loans and borrowings on the balance sheet.

109

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

27. ANALYSIS OF CASH FLOWS GIVEN IN THE STATEMENT OF CASH FLOWS
A reconciliation of profit for the year to cash generated from operations is shown below:

(Loss)/profit before income tax

Adjustments for:

  Depreciation charges

  Amortisation charges

  Share of profit of associate

  Gain on bargain purchase

  Share-based payment

  Movement in fair value of derivatives

  Exchange adjustment on borrowings

  Finance costs

  Finance income

Changes in working capital

  Decrease in inventories

  Decrease in trade and other receivables

  Decrease in trade and other payables

Cash flows from operating activities

28. DEFERRED TAX

On 1 January 2020

Acquired on acquisition of subsidiary

Credit/(charge) for the year:

Losses in the year

  Temporary timing differences

  Gain on bargain purchase

  Other

Deferred tax credit to profit and loss

Deferred tax charge to share option reserve

Exchange adjustment

On 31 December 2020

110

Notes

16,25

15

17

7

33

24

10

10

18

19

23

2020 
$’000

(11,163)

2,299

1,607

–

(506)

1,706

740

382

1,880

(36)

648

3,005

(159)

403

Deferred  
tax asset  

Deferred  
tax liability  

$’000

1,221

9,174

3,043

(551)

–

(3)

2,489

(167)

278

12,995

$’000

(2,917)

(21,198)

–

–

(486)

265

(221)

–

(358)

(24,694)

2019 
$’000

7,347

2,037

1,088

(14)

–

1,917

(2,875)

(715)

1,380

(15)

2,074

912

(912)

12,224

Total  
$’000

(1,696)

(12,024)

3,043

(551)

(486)

262

2,268

(167)

(80)

(11,699)

 
On 1 January 2019

Credit/(charge) for the year:

  Share-based payment

  Utilisation of losses

  Other

Deferred tax credit to profit and loss

Deferred tax credit to share option reserve

Exchange adjustment

On 31 December 2019

The deferred tax balances consist of the tax effect of timing differences in respect of: 

Unused trade losses

Right of return liability

Lease liability

Other short-term differences

Total deferred tax asset

Right of use asset

Right of return asset

Intangible assets

Inventory

Property, plant and equipment

Other short-term differences

Total deferred tax liability

Deferred  
tax asset  

$’000

1,025

Deferred  
tax liability  

$’000

(2,886)

536

(523)

–

13

158

25

1,221

–

–

30

30

–

(62)

(2,917)

2020
$’000

3,448

2,254

6,349

944

12,995

2020
$’000

(6,032)

(524)

(12,991)

(2,438)

(1,882)

(827)

(24,694)

Total  
$’000

(1,861)

536

(523)

30

43

158

(37) 

(1,696)

2019  
$’000

323

27

3

868

1,221

2019  
$’000

(21)

–

(1,921)

–

(975)

–

(2,917)

In addition to the deferred tax assets and liabilities recognised, the group has tax losses that arose in a subsidiary of $1,150,000  
(2019: $1,145,000) that are available indefinitely for offsetting against future taxable profits of the company in which the losses arose.  
A deferred tax asset has not been recognised in respect of these losses as these losses may not be used to offset against taxable 
profits elsewhere in the group and there is no evidence of these losses being utilised by the subsidiary in the future.

If the group were able to recognise all unrecognised deferred tax assets, the profit would increase by $219,000 (2019: $187,000).

111

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

29. TAX PAYABLE

Corporation tax payable

Uncertain tax liabilities

2020 
$’000

1,521

2,839

4,360

2019 
$’000

377

2,235

2,612

The group has identified it is exposed to uncertain tax positions in relation to tax authorities challenging that local subsidiaries are not 
being remunerated under historical transfer pricing arrangements or that the group has created a taxable presence and asset taxing 
rights over profits they consider to be allocable in the given territory. The group considers that it is possible that these uncertain tax 
positions will result in a future outflow of funds to one or more local tax authorities and has recognised current tax liabilities for these 
uncertainties.

Due to the range of potential outcomes that the directors have identified, these liabilities have been measured using an expected 
value methodology. Key assumptions underpinning the expected value calculations, in addition to relative probabilities of such tax 
liabilities crystallising in one or more of the jurisdictions in which the group operates, are (i) the tax periods over which tax authorities 
would seek to challenge the group’s transfer pricing or tax domicile arrangements; and (ii) the quantum of interest and penalties that 
would be applicable in the event that the group was found to be liable for tax amounts by one or more tax authorities.

It is reasonably possible, on the basis of the directors’ existing knowledge, that different outcomes to the assumptions set out above, 
within the next financial year, could require a material adjustment to the carrying amount of the uncertain tax liabilities.

The group plans to perform a more detailed review of its international tax arrangements, both historically and prospectively, with 
COVID-19 having impacted on the planned work during 2020. It is expected to conclude in 2021. However, the directors, on the basis of 
their existing knowledge, do not expect the outcome of this exercise to be materially different to the liability recognised, except for an 
incremental increase in the uncertain tax liability solely due to the passage of time. In the eventuality that any outcome is concluded at 
the higher end of the outflow range, then the group would implement mitigating actions.

30. DERIVATIVES
On 9 February 2017, options over C Ordinary Shares in INSPECS Holdings Limited were issued to private equity investors. These 
options were exercisable upon (i) the completion of a relevant exit event, including an initial public offering; and (ii) cumulative returns 
to the private equity investors on their B Ordinary Shares being below a minimum return amount prescribed in the option agreement. 
These options were considered to meet the definition of a derivative over the group’s own equity instruments and were recognised as 
a financial liability measured at fair value through profit or loss due to the variable number of C Ordinary Shares that could be issued. 

As part of the share for share exchange on 10 January 2020, these options were exchanged for options over Ordinary Shares in 
INSPECS Group plc, with the corresponding derivative liability held over these options novated to INSPECS Group plc. On 27 February 
2020, these options were exercised with the derivative being revalued at this date to reflect the fair value of options being exercised 
before the derivative itself was then utilised. This revaluation gave rise to the $740,000 charge recognised through the Income 
Statement during the year ended 31 December 2020.

Movements in the derivative during the current and comparative year are shown below:

Novated to INSPECS Group plc on 10 January 2020

Revaluation of derivative on 27 February 2020

Foreign exchange movement

Derivative utilised on exercise of options

Derivative held as at 31 December 2020

112

$’000

(3,536)

(740)

(176)

4,452

–

31. ULTIMATE CONTROLLING PARTY
On 27 February 2020 INSPECS Group Limited was re-registered to form INSPECS Group plc following admission of its shares on  
to the London AIM. As a result, the directors believe that there is no ultimate controlling party of the group. 

32. RELATED PARTY DISCLOSURES
The group has taken advantage of the exemption, not to disclose related party transactions with wholly owned subsidiaries within  
the group. Note 18 provides information about the group’s structure, including details of the subsidiaries. Below are transactions  
and balances with related parties that are not owned.

a) Kelso Place LLP
Mr R Totterman is a designated member and controlling owner of Kelso Place LLP. During the year Kelso Place LLP leased the Bath 
head office building to INSPECS Limited. As at 31 December 2020, a right-of-use asset with net book value of $127,000 (2019: $323,000) 
and lease liability of $124,000 (2019: $322,000) related to this lease, with depreciation of $152,000 (2019: $152,000) and interest of $6,000 
(2019: $6,000) charged to the income statement. At the year-end, the group owed Kelso Place LLP $169,000 (2019: $247,000) in respect 
of the above.

b) Thorne Lancaster Parker
Mr C D Kay, a director of the company is also a partner in Thorne Lancaster Parker. During the year the partnership charged INSPECS 
Limited $65,000 (2019: $201,000) in respect of professional services provided. On 31 December 2020, INSPECS Limited owed Thorne 
Lancaster Parker $nil (2019: $11,000) in respect of the above, with this balance included within trade payables. During the year the 
partnership charged Norville (20/20) Limited $7,000 (2019: $nil) in respect of professional services provided, with nil being owed at  
the end of the year (2019: $nil). 

c) Farm Street Partners
C M J Hancock is a partner of Farm Street Partners which charged the group monitoring fees of $13,000 (2019: $15,000) during the  
year. No balance was outstanding at 31 December 2020 (2019:$nil).

d) BXS Projects Limited

A Farrugia is a Director of BXS Projects Limited which charged the group $10,000 (2019: $Nil). No balance was outstanding at 31 
December 2020 (2019: $Nil).

e) Key management personnel
The key management personnel of INSPECS Group plc at 31 December 2020 are R B C Totterman, M R A L Lefebvre and C D Kay.  
The total employee benefits payable in the period were $189,000 (2019: $217,000), $766,000 (2019: $792,000) and $152,000 (2019: 
$138,000) respectively. In addition, share based payments totalled $508,000 (2019: $539,000) in relation to these individuals. 

33. SHARE-BASED PAYMENTS
Certain employees of the group have been granted options over the shares in INSPECS Group plc. The options are granted with a 
fixed exercise price and are exercisable between one and ten years after the date of grant.

The company recognises a share-based payment expense based on the fair value of the awards granted, and an equivalent credit 
directly in equity to share option reserve. On exercise of the shares by the employees, the company is charged the intrinsic value of 
the shares by INSPECS Group plc and this amount is treated as a reduction of the capital contribution, and it is recognised directly in 
equity. Share options previously held within INSPECS Holdings Limited were converted to share options within INSPECS Group plc 
as part of the share for share exchange on 10 January 2020 with one option in INSPECS Holdings being exchanged for 137 options 
in INSPECS Group plc. Share options outstanding at the end of the year have the following expiry date and exercise prices:

Grant date

11 October 2019

27 February 2020

22 December 2020

Expiry date

Between 1 July 2021 and 1 July 2022

27 February 2025

22 December 2025

 Exercise price  
per option  

$

1.27

2.52

2.87

 Number of share 
options

824,197

1,923,110

1,580,000

The option weighted average exercise price is $2.41 per share. Options were valued at the date of grant.

113

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

33. SHARE-BASED PAYMENTS CONTINUED
The expense recognised for employee services received during the year is shown in the following table:

Expense arising from equity-settled share-based payment transactions

Taxes charged to the group in respect of options exercised

Total expenses arising from share-based payment transactions

2020 
$’000

1,133

573

1,706

2019 
$’000

1,917

–

1,917

Movements during the year
The following tables illustrates the number and weighted average exercise price (‘WAEP’) of and movements in share options during 
the year:

At 1 January

Granted as part of share for share exchange

Granted during the year

Exercised during the year

Forfeited during the year

As at 31 December

WAEP

At 1 January

Share for share exchange

Granted during the year

Exercised during the year

Forfeited during the year

As at 31 December

Number  
2020

58,965

8,054,558

3,503,110

(7,275,589)

(13,737)

4,327,307

2020  

$

67.46

(66.07)

1.44

(0.39)

(0.03)

2.41

Number  

2019

36,855

–

22,570

–

(460)

58,965

2019 
$

2.94

–

65.88

–

(1.37)

67.46

The following table lists the inputs to the models used for the valuation of the options issued during the year.

Options granted 
11 October 2019

Options granted 
27 February 2020

Options granted 
22 December 2020

Number of options in issue as at 31 December 2020

Dividend yield (%)

Expected volatility

Risk-free interest rate

Exercise price

Ordinary share price at grant date

824,197

1.0%

25.8%-29.8%

1.58%-1.66%

$175.00

$310.00

1,923,110

1,580,000

1.0%

28.2%

0.33%

$2.52

$2.52

1.0%

30.4%

(0.12)%

$2.87

$3.63

5 years

Expected life of share options/SARs (years)

1–3 years

5 years

Model used

Black Scholes option analysis

The determination of the risk-free interest rate has been based on the UK Sovereign Curve for each grant made during 2020.

114

34. FINANCIAL RISK MANAGEMENT
The financial assets of the group comprise trade receivables, deposits and other receivables, and cash and cash equivalents which 
are categorised as financial assets at amortised cost. The carrying amounts of these financial assets are the amounts shown on the 
consolidated statement of financial position or in the corresponding notes to the financial statements.

The financial liabilities of the group comprise trade payables, bank loans, other loans, financial liabilities included in other payables 
and accruals, and lease liabilities which are categorised as financial liabilities at amortised cost. The carrying amounts of these 
financial liabilities are the amounts shown on the consolidated statement of financial position or in the corresponding notes to 
financial statements.

The fair values of the financial assets and liabilities are included at the amounts at which the instruments could be exchanged in current 
transactions between willing parties, other than in forced or liquidation sale transactions. At the end of the reporting period, the 
carrying amounts of the financial assets and financial liabilities of the group approximated to their fair values.

The group’s principal financial instruments comprise cash and cash equivalents, bank loans and other loans. The main purpose of these 
financial instruments is to raise finance for the group’s operations. The group has various other financial assets and liabilities such as 
trade receivables and trade payables, which arise directly from its operations.

The main risks arising from the group’s financial instruments are foreign currency risk, credit risk and liquidity risk which arise in the 
normal course of its business. The Board of Directors reviews and agrees policies to analyse and formulate measures to manage each 
of these risks which are summarised below.

Interest rate risk 
Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market 
interest rates. The group’s exposure to the risk of changes in market interest rates relate primarily to the group’s long-term debt 
obligations with floating interest rates.

Interest rate sensitivity
The following table demonstrates the sensitivity to a reasonable possible change in interest rates on that proportion of loans and 
borrowings affected. With all other variables held constant, the group’s loss/profit before tax is affected through the impact on floating 
rate borrowings as follows, based on the outstanding loan to the bank as at 31 December 2020:

2020

2019

Loan balance 
$’000

Increase/decrease 
in basis points

56,947

16,875

50 BP

50 BP

Effect on profit 
before tax 
$’000

285

102

Foreign currency risk 
Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign 
exchange rates. The group’s exposure to the risk of changes in foreign exchange rates relates to both the group’s operating activities 
(when revenue or expense is denominated in a foreign currency) and the group’s borrowing when held in a different currency to the 
functional currency of the company in which they are held.

The group manages its foreign currency risk by selling and buying in the same currencies where possible but does not enter into any 
material hedging transactions or derivatives. The ability of the group to organise its sales and purchases in similar currencies allows a 
natural hedge in some circumstances against currency fluctuations.

115

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Consolidated Financial Statements continued
for the year ended 31 December 2020

34. FINANCIAL RISK MANAGEMENT CONTINUED

Foreign currency risk continued
The following table demonstrates the sensitivity at the end of the reporting period to a reasonable possible change in the Pound 
Sterling (GBP), Chinese Renminbi (RMB) and Macau Pataca (MOP) exchange rates, with all other variables held constant, of the group’s 
profit before tax (due to changes in the fair value of monetary assets and liabilities). These currencies have been selected for sensitivity 
analysis as they represent the local currencies covering the majority of the trading locations of the group. Moving into 2021, movement 
in the Euro will have an impact following the acquisition of Eschenbach Holdings GmbH, however due to the acquisition occurring late 
in the year the impact on 2020 is not considered material. There is no impact on the group’s equity except on the retained profits.

2020

If the US$ weakens against the GBP

If the US$ strengthens against the GBP

If the US$ weakens against the RMB

If the US$ strengthens against the RMB

If the US$ weakens against the MOP

If the US$ strengthens against the MOP

Increase/(decrease) in 
exchange rate 
%

 5

 (5)

 5

 (5)

 5

 (5)

Increase/(decrease) in 
profit before tax  

$

2,372,000

(2,372,000)

–

–

(229,000)

229,000

Credit risk
The group trades only with related companies and third parties who have been assessed via a Dunn and Bradstreet credit check. 
Receivables balances are monitored on an ongoing basis and the group’s history of credit losses of trade receivables is not significant. 
The credit risk of the group’s other financial assets arises from default of the counterparty, with a maximum exposure  
equal to the carrying amounts of these financial assets. 

The group maintains regular control over its trade receivables and normal terms are between 30 and 60 days across the group.  
The percentage of debtors outside of these terms is shown in the analysis below.

Trade receivables

Current

Past due 1–30 days

Past due 31–60 days

Past due 61+ days

Total 

Percentage over terms

2020 
$’000

16,584

3,904

3,330

1,331

25,149

33%

2019 
$’000

Increase/(decrease) 
$’000

8,115

1,254

158

288

9,815

17%

8,469

2,650

3,172

1,043

15,334

Raw material costs
The group subcontracts with third party suppliers on fixed terms and thus any immediate commodity risk is mitigated in the short  
term on these transactions. On the group’s own manufactured products, raw materials in 2020 accounted for 32% of cost of sales  
(2019: 43%). This risk is mitigated by the use of different suppliers and the diversification of production locations across the group.  
Over the long term, the group can also mitigate the loss of any margins through an increase in its selling price.

Cash deposits
The group invests its excess cash in either weekly or monthly deposits with either HSBC or OCBC. The group considers these  
deposits to carry a very low risk and typically return an interest rate of around 0.5%.

116

Liquidity risk
For the management of the liquidity risk, the group monitors and maintains a sufficient level of cash and bank balances deemed 
adequate by management, along with utilising an invoice discounting facility, to finance the group’s operations and mitigate the 
effects of fluctuation in cash flows. Management reviews and monitors its working capital requirements regularly.

The group reviews on a monthly basis the cash generation and the requirement for capital repayments on the bank loan in its detailed 
working capital model to ensure sufficient liquidity for operating purposes across the group.

The table below summarises the gross undiscounted cash flows of the group’s non-derivative financial liabilities:

Less than 1 year 
$’000

1 to 2 years  

2 to 5 years  

Over 5 years  

$’000

$’000

$’000

Total  
$’000

Bank overdrafts (including invoice 
discounting facility)

Interest bearing loans and borrowings 
(excluding items below)

Lease liabilities

Other financial liabilities – right of return

Trade and other payables

2,642

4,354

3,522

12,824

42,895

Capital risk management
The group’s capital management objectives are:

–

1,011

2,935

–

–

–

–

2,642

54,736

6,345

–

–

138

9,427

–

–

60,239

22,229

12,824

42,895

•  to ensure the group’s ability to continue as a going concern so that it can continue to provide returns for shareholders and  

benefits for other stakeholders; and

•  to provide an adequate return to shareholders by pricing products and services commensurate with the level of risk.

To meet these objectives, the group reviews the budgets and forecasts on a regular basis to ensure there is sufficient capital to  
meet the needs of the group.

The capital structure of the group consists of shareholders’ equity as set out in the consolidated statement of changes in equity.  
All working capital requirements are financed from existing cash resources and borrowing.

The loan covenant ratios achieved by the group, and required by the bank, as at the end of each year were as follows:

Leverage

Debt service cover

Interest cover

2020

2019

Actual

Required

Actual

Required

1.6

N/A

17.1

Below 2.5

N/A

Above 4.0

0.8

2.1

12.1

Below 2.0

Above 1.1

Above 5.0

In February 2020 ahead of the initial public offering, the group entered into a new loan arrangement increasing the available facility. 
The debt service cover covenant was not included within this new facility. This facility was amended to further increase available funds 
in November 2020 in advance of the acquisition of Eschenbach Group GmbH. As part of this amendment, the leverage covenant was 
increased to 2.5 times for the next four quarters, after which it will drop back down to 2.0 times.

35. POST BALANCE SHEET EVENTS
Since the balance sheet date, but before these financial statements were approved, there were no material events that the directors 
consider material to the users of these financial statements.

117

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportCompany Statement of Financial Position
as at 31 December 2020

ASSETS

Non-current assets

Investments

Current assets

Loans to group undertakings

Total assets

EQUITY

Shareholders’ equity

Called up share capital

Share premium

Foreign currency translation reserve

Share option reserve

Merger reserve

Retained earnings

Total equity

LIABILITIES

Total liabilities

Total equity and liabilities

Notes

2020 
$’000

2019 
 $’000

 3

4

 5

 6

 6

 6

 6

76,147

117,202

193,349

1,384

121,940

(157)

867

7,296

62,019

193,349

–

193,349

–

–

–

–

–

–

–

–

–

–

–

–

The notes on pages 120 to 126 form part of these financial statements

As permitted by section 408(3) of the Companies Act 2006, a separate Income Statement dealing with the results of the Parent 
Company, has not been presented. The Parent Company loss for the period ended 31 December 2020 was $2,438,000 (2019: $nil).

The financial statements were approved by the Board of Directors on 18 June 2021 and were signed on its behalf by:

R B C Totterman  
Director 

C D Kay
Director

118

 
       
 
Company Statement of Changes in Equity
for the year ended 31 December 2020

Called up 
share capital 
$’000

Share 
premium 
$’000

Notes

Foreign 
currency 
translation 
reserve 
$’000

Share option 
reserve  
$’000

Retained 
earnings 
$’000

Merger 
reserve 
$’000

Total  
equity 
$’000

Balance at 
incorporation

Balance at 31 
December 2019

Changes in equity

Loss for the year

Other comprehensive 
income

Total comprehensive 
income

Issue of share capital

Exercise of share options

Share-based payments

Share for share exchange 
and creation of merger 
reserve

Capital reduction

Balance at 31 
December 2020

6

5,6

5,6

6

5,6

6

–

–

–

–

–

603

99

–

682

–

–

–

–

–

–

119,215

2,725

–

–

–

–

–

–

(157)

(157)

–

–

–

–

–

–

–

–

–

–

–

(3,140)

1,133

2,874

–

–

(2,438)

–

(2,438)

–

2,973

–

–

–

–

–

–

–

–

–

(2,438)

(157)

(2,595)

(22)

119,796

–

–

2,657

1,133

68,802

72,358

–

61,484

(61,484)

–

1,384

121,940

(157)

867

62,019

7,296

193,349

The notes on pages 120 to 126 form part of these financial statements.

119

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Company Financial Statements
for the year ended 31 December 2020

1. GENERAL INFORMATION
INSPECS Group plc is a public company limited by shares and is incorporated in England and Wales. The address of the company’s 
principal place of business is 7–10 Kelso Place, Upper Bristol Road, Bath BA1 3AU. 

On 10 January 2020 a share for share exchange occurred between INSPECS Group Limited and INSPECS Holdings Limited, resulting 
in INSPECS Group Limited being the ultimate parent company of the group. Refer to note 22 of the consolidated group accounts for 
more information. Subsequently, on 27 February 2020 INSPECS Group plc was admitted to the AIM of the London Stock Exchange.

The principal activity of the company was that of a holding company.

2. ACCOUNTING POLICIES
These financial statements were prepared in accordance with the Companies Act 2006 as applicable to Financial Reporting Standard 
101 Reduced Disclosure Framework (FRS 101), FRS 101 and applicable accounting standards. The financial statements have been 
prepared on the historical cost basis, and as a going concern. Historical cost is generally based on the fair value of the consideration 
given in exchange for the assets. 

As permitted by section 408(3) of the Companies Act 2006, no separate profit and loss account has been presented for the company. 
As permitted by FRS 101, the company has taken advantage of the disclosure exemptions available in the preparation of the financial 
statements in relation to the presentation of a statement of cash flows.

Investments
Investments held as fixed assets comprise the company’s investment in subsidiaries and are shown at fair value on the date of 
acquisition, less any provision for impairment. In the case of the share for share exchange which occurred in the period, the number 
and aggregate value of the shares issued was specified in the share for share exchange agreement. 

An annual review of investments is performed for indicators of impairment. If indicators of impairment are identified investments are 
tested for impairment to ensure that the carrying value of the investment is supported by their recoverable amount.

Current and non-current classifications
The group presents assets and liabilities in the statement of financial position based on current/non-current classification.

An asset is considered current when it is:

•  Expected to be realised or intended to be sold or consumed within the usual parameters of trading activity and as a minimum  

within 12 months after the reporting period;

Or

•  Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least 12 months after the 

reporting period.

The group classifies all other assets as non-current.

Financial instruments – initial recognition and subsequent measurement
A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of 
another entity.

Financial assets
Initial recognition and subsequent measurement

Financial assets are classified, at initial recognition and subsequently measured at amortised cost, and are subject to impairment. 
Gains and losses are recognised in profit or loss when the asset is derecognised, modified or impaired.

The company’s financial assets at amortised cost include loans to group undertakings.

The company does not have any financial assets at fair value through OCI or financial assets at fair value through profit or loss.

Derecognition

A financial asset is primarily derecognised when the rights to receive cash flows from the asset have expired.

120

Impairment of financial assets 
The company recognises an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or 
loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows 
that the group expects to receive.

The company considers a financial asset in default when internal or external information indicates that the company is unlikely to 
receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the company. A 
financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows.

Share based payments
Employees (including senior executives) of the group receive remuneration in the form of share-based payments, whereby employees 
render services as consideration for equity instruments (equity-settled transactions). 

The cost of equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate 
valuation model, further details of which are given in the detailed notes to the consolidated accounts. That cost is recognised 
in employee benefits expense in the company within which the relevant employee is employed, together with a corresponding 
increase in share option reserve, over the period in which the service and, where applicable, the performance conditions are fulfilled 
(the vesting period).

The cumulative expense recognised for equity-settled transactions at each reporting date until the vesting date reflects the extent to 
which the vesting period has expired and the company’s best estimate of the number of equity instruments that will ultimately vest. 
The expense or credit in the income statement for a period represents the movement in cumulative expense recognised as at the 
beginning and end of that period.

Details of the group’s share option scheme are provided in note 33 of the consolidated financial statements.

Taxation
Income tax comprises current and deferred tax. Income tax relating to items recognised outside profit or loss is recognised outside 
profit or loss, either in other comprehensive income or directly in equity.

Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, 
based on the tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period, taking into 
consideration interpretations and practices prevailing in the countries in which the group operates.

Tax liabilities are recognised when it is considered probable that there will be a future outflow of funds to a taxing authority.

Foreign currencies
These financial statements are presented in US$, which is the company’s presentational currency. The functional currency of the 
company is GBP. Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency rates of 
exchange ruling at the end of the reporting period. Differences arising on settlement or translation of monetary items are recognised 
in profit or loss. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the 
exchange rates at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated 
using the exchange rates at the date when the fair value was measured. The resulting exchange differences are recognised in other 
comprehensive income and accumulated in the foreign currency translation reserve.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the group’s financial statements requires management to make judgements, estimates and assumptions that 
affect the reported amounts of revenues, expenses, assets and liabilities, and their accompanying disclosures, and the disclosure 
of contingent liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material 
adjustment to the carrying amounts of the assets or liabilities affected in the future.

Estimates involve the determination of the quantum of accounting balances to be recognised. Judgements typically involve decisions 
such as whether to recognise an asset or liability.

121

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Company Financial Statements continued
for the year ended 31 December 2020

2. ACCOUNTING POLICIES CONTINUED

Critical accounting judgements and key sources of estimation uncertainty continued
The key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period, that 
have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are 
described below:

Expected credit loss
In accordance with IFRS 9, the expected credit loss model is used to determine an expectation of an economic loss of an asset. 
Application of this model to the loans to group undertakings within the company requires estimation by management. No provisions 
have been recognised in relation to the loans to group undertakings shown in note 4 as they are considered to be fully recoverable.

Carrying value of investments
An annual review of investments is performed to identify any indicators of impairment which, if found, would result in an impairment 
review being performed. Judgement is required by management in performing this review, including in the identification and 
interpretation of any indicators.

3. INVESTMENTS

COST AND NET BOOK VALUE

At 1 January 2020

Share for share exchange

Additions for share based payments in subsidiaries

At 31 December 2020

Shares in 
subsidiaries
 $’000

–

69,484

6,663

76,147

Investments held are shown below. Investments held directly by the company are marked *. The remaining investments are held 
indirectly by the company.

Subsidiaries

Registered office

Nature of business

INSPECS Holdings Limited*

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Holding company

INSPECS Limited8

INSPECS USA LC8

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Eyewear trading

18401 US Highway 19N, Clearwater,  
Florida 33764, USA

Eyewear trading

Class  
of shares

Ordinary

Ordinary

Ordinary

Algha Group Limited8

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Eyewear manufacturing Ordinary

INSPECS Scandinavia AB8

184 40 Akersberga, Stockholm, Sweden

Eyewear trading

Maronglow Limited1

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Dormant

UK Optical Limited8

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Dormant

American Optical UK Limited8

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Dormant

Holding company

% holding

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

Twenty20 Limited2

Bandoma Limited3

Ice Foster Limited3

Killine Group Limited4

Elian Fiduciary Services (Cayman) Limited, 89 
Nexus Way, Camana Bay, Grand Cayman  
KY1-9007, Cayman Islands

Suite 6, Watergardens 4, Gibraltar

Nemours Chambers, Road Town, Tortola,  
British Virgin Islands

Elian Fiduciary Services (Cayman) Limited,  
89 Nexus Way, Camana Bay, Grand Cayman  
KY1-9007, Cayman Islands

122

Holding company

Holding company

Ordinary

Ordinary

100.00

100.00

Holding company

Ordinary

100.00

Subsidiaries

Registered office

Nature of business

Class  
of shares

% holding

Killine Optical Limited3

Alameda Dr. Carlos D’Assumpcao, nos 335–341, 
Edificio Centro Hotline, 21 andar A, em Macau

Eyewear trading

Ordinary

100.00

Neo Optical Company Limited5 Neo Town Industrial Zone, Yen Dung District,  

Eyewear manufacturing Ordinary

100.00

Bac Giang Province, Vietnam

On Sight Services-Sociedade 
Unipessoa, Lda3

O.W. Ventures Limited3

Rua Soares de Passos, 10A/10B

Eyewear design

Ordinary

100.00

Unit 305–7, 3/F, Laford Centre, 838 Lai Chi Kok 
Road, Cheung Sha Wan, Kowloon, Hong Kong

Corporate management Ordinary

100.00

Zhongshan Torkai Optical Co 
Limited6

Shagou Industrial Park, Banfu County,  
Zhongshan, Guangdong, China

Eyewear manufacturing Ordinary

100.00

Neway (Macao Commercial 
Offshore) Limited9

Alameda Dr. Carlos D’Assumpcao, nos 335–341 
Edificio Hot line, 21 andar D, em Macau

Eyewear trading

Ordinary

100.00

Kudos S.R.L.1

Primoptic Limited7

Yardine Limited3

INSPECS Asia Limited8

Via Noai 5, Domeggi Di Cadore, CAP 32040, Italy

Eyewear manufacture

Ordinary

Alameda Dr. Carlos D’Assumpcao, nos 335–341, 
Edificio Centro hotline, 21 andar A, em Macau

Eyewear trading

Ordinary

100.00

100.00

Nemours Chambers Limited, Road Town,  
Tortola, British Virgin Islands

10F Sing Ho Finance Building, 166–168  
Gloucester Road, Hong Kong

Holding company

Ordinary

100.00

Quality Control Services Ordinary

100.00

Duval Company Group Limited3 Nemours Chambers, Road Town, Tortola,  

Holding company

Ordinary

100.00

British Virgin Islands

Norville (20/20) Limited 2

7–10 Kelso Place, Bath, Somerset, BA1 3AU, UK

Lens manufacturer

Ordinary

Eschenbach Holding GmbH 2

Fürther Straße 252, 90429, Nuremberg, Germany Holding company

Eschenbach Beteiligungs  
GmbH10

Fürther Straße 252, 90429, Nuremberg, Germany Holding company

Eschenbach Optik GmbH14

Althardstraße 70, Regensdorf, Switzerland

Eyeware trading

Eschenbach Optik B.V.14

Osloweg 134, Groningen, Netherlands

Eschenbach Optik spol s. r.o.14

K Fialce 35, Prague, Czech Republic

Eschenbach Optik sp. z o.o.14

ul. Biedronki 60, Warsaw, Poland

Eschenbach Optik GmbH14

Brunnenfeldstraße 14, Linz, Austria

Eschenbach Optik s.a.r.l14

64 rue Claude Chappe, Plaisir, France

Eschenbach Optik s.r.l.14

Via C.Colombo 10, Torino, Italy

Eschenbach Optik of America, 
Inc.14

22 Shelter Rock Lange, Danbury, USA

Eyeware trading

Eyeware trading

Eyeware trading

Eyeware trading

Eyeware trading

Eyeware trading

Eyeware trading

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

Ordinary

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100.00

Eschenbach Optik of Japan 
Co.Ltd.14

2-15-4 Kanda-Tsukasamachi, Chiyoda-ku,  
Tokyo, Japan

Eyeware trading

Ordinary

100.00

Eschenbach Optik S.L.14

Consell de Cent 106-108, Barcelona, Spain

Eyeware trading

Eschenbach Optik GmbH11

Fürther Straße 252, 90429, Nuremberg, Germany

Eyeware trading

Eschenbach Optik (Shenzhen)14 Block A, Tian An Cyber Times Che Gong Miao, 

Eyeware trading

Ordinary

Ordinary

Ordinary

100.00

100.00

100.00

Futian District, Shenzhen, China

123

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Company Financial Statements continued
for the year ended 31 December 2020

3. INVESTMENTS CONTINUED

Subsidiaries

Registered office

Nature of business

Class  
of shares

% holding

Josef Eschenbach  
GmbH'+ Co.14

Josef Eschenbach  
Verwaltung GmbH15

Eschenbach International  
GmbH11

Fürther Straße 252, 90429, Nuremberg, Germany

Eyeware trading

Ordinary

100.00

Fürther Straße 252, 90429, Nuremberg, Germany

Eyeware trading

Ordinary

100.00

Fürther Straße 252, 90429, Nuremberg, Germany Holding company

Ordinary

100.00

Eschenbach UK Holdings Ltd12

27 Blackberry Lane, Halesowen¸ B63 4NX, UK

Holding company

Ordinary

International Eyewear Ltd13

27 Blackberry Lane, Halesowen¸ B63 4NX, UK

Eyeware trading

TURA, Inc.12

123 Girton Drive, Muncy, USA

Eschenbach Optik A/S11

Boskærvej 18, Vejle, Denmark

Eyeware trading

Eyeware trading

Ordinary

Ordinary

Ordinary

100.00

100.00

100.00

100.00

1  The shares are held by Algha Group Limited 

9  The shares are held by Yardine Limited

2  The shares are held by INSPECS Limited 

10  The shares are held by Eschenbach Holding GmbH

3  The shares are held by Killine Group Limited 

11  The shares are held by Eschenbach Beteiligungs GmbH

4  The shares are held by Twenty20 Limited 

12  The shares are held by Eschenbach International GmbH

5  The shares are held by Killine Optical Limited 

13  The shares are held by Eschenbach UK Holdings Ltd

6  The shares are held by Bandoma Limited 

14  The shares are held by Eschenbach Optik GmbH

7  The shares are held by Duval Company Group Limited 

15  The shares are held by Josef Eschenbach GmbH

8  The shares are held by INSPECS Holdings Limited

4. LOANS TO GROUP UNDERTAKINGS

At 31 December 2019

Additions during the year

Interest during the year

Foreign exchange

At 31 December 2020

Loans to Group 
undertakings 
$’000

–

116,303

845

54

117,202 

Amounts owed by group undertakings are unsecured, with interest charged at a market rate and have no set repayment date. Due to 
the amounts having no set repayment date they have been classified as current assets.

124

5. CALLED UP SHARE CAPITAL

Authorised and issued share capital:

Number:

101,290,898 (2019: 100)

Class:

Ordinary

Nominal value

£0.01

2020
 $’000

1,384

1,384

2019 
$’000

–

–

On 10 January 2020, a share for share exchange occurred between INSPECS Holdings Limited and INSPECS Group Limited 
(subsequently plc). As part of this share for share exchange, all Ordinary Shares in INSPECS Holdings were exchanged for Ordinary 
Shares of INSPECS Group. Share options in INSPECS Holdings were also exchanged for share options in INSPECS Group, including 
the options over C Ordinary Shares, which were converted to options over Ordinary Shares in INSPECS Group. On the admission of 
shares to the AIM of the London Stock Exchange on 27 February 2020, these options previously over C Ordinary Shares were exercised 
and the related derivative liability was revalued at that date before being extinguished, giving rise to a $740,000 charge to the income 
statement in the period.

As part of the initial public offering of shares of INSPECS Group plc, 12,051,000 new shares were issued to the market, with a further 
8,796,000 shares being created following the exercise of options. On 11 December 2020 a further share placing occurred, creating an 
additional 30,476,000 shares.

6. RESERVES

Share premium
This reserve records the amount above the nominal value of the sums received for shares issued, less transaction costs.

At 1 January

Issue of share capital

Exercise of share options

At 31 December

2020 
$’000

–

119,215

2,725

121,940

2019
 $’000

–

–

–

–

Foreign currency translation reserve
With regards to the foreign currency translation reserve in the company, this is in relation to translating the parent company’s accounts 
into the presentation currency of US$.

At 1 January

Other comprehensive income

At 31 December

2020 
$’000

–

(157)

(157)

2019 
$’000

–

–

–

125

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportNotes to the Company Financial Statements continued
for the year ended 31 December 2020

6. RESERVES CONTINUED

Share option reserve
The share option reserve is used to recognise the value of equity-settled share-based payments provided to employees, including key 
management personnel, as part of their remuneration.

At 1 January

Share for share exchange

Share-based payment charge

Exercise of share options

At 31 December

2020 
$’000

–

2,874

1,133

(3,140)

867

2019
 $’000

–

–

–

–

–

As part of the share for share exchange with INSPECS Holdings Limited on 10 January 2020, the share option reserve was novated 
into INSPECS Group plc. The share-based payment charge for the year is recognised against the reserve as per IFRS 2 Share-Based 
Payments. As options have been exercised during the year, the reserve relating to these options has been released to retained 
earnings, with a further $167,000 released against the deferred tax asset held in relation to the options exercised.

Merger reserve
This reserve arose on the share for share exchange between INSPECS Holdings Limited and INSPECS Group plc.

At 1 January

Issue of share capital

Share for share exchange and merger reserve

Capital reduction

At 31 December

2020 
$’000

–

(22)

68,802

(61,484)

7,296

2019
 $’000

–

–

–

–

–

On 27 February 2020 immediately prior to IPO, options over Ordinary Shares held by PE investors were exercised (see note 30), with the 
nominal value of the share capital satisfied by capitalisation of the merger reserve of $22,000. 

In relation to the share for share exchange, INSPECS Group plc issued 49,898,522 shares for an aggregate value of $69,484,000 
(£50,856,000). This gives rise to share capital of $682,000 (£499,000) and a merger reserve in accordance with section 612 of the 
Companies Act 2006 of $68,802,000 (£50,357,000). The company’s merger reserve was subsequently reduced by $61,484,000 
(£45,000,000) and the amount so reduced was credited to retained earnings and treated as realised profits.

7. CONTINGENT LIABILITIES
The company’s UK subsidiary Algha Group Limited (registered number 03240950) has taken advantage of the audit exemption 
under Section 479A of the Companies Act 2006 for the year ended 31 December 2020. Consequently, the company has provided the 
statutory guarantee in relation to the subsidiary’s liabilities. The third-party liabilities of the subsidiary at 31 December 2020 amounted 
to $63,000 (2019: $295,000).

8. POST BALANCE SHEET EVENTS
Since the balance sheet date, but before these financial statements were approved, there were no material events that the directors 
consider material to the users of these financial statements.

126

Appendix 1

RECONCILIATION OF UNDERLYING EBITDA (UNAUDITED)

for the year ended 31 December 2020

Revenue

Gross profit

Operating and distribution expenses, net of other operating income

Operating (loss)/profit

Movement in fair value on derivative

2020 
$’000

2019 
$’000

47,415

61,247

20,522

(23,462)

(2,940)

(740)

27,536

(19,591)

7,945

2,865

Operating (loss)/profit after movement in fair value on derivative

(3,680)

10,810

Add back: Amortisation

Add back: Depreciation

EBITDA

Add back: Share-based payment expense

Add back: Restructuring costs

Add back: Foreign exchange on funding for acquisitions

Add back: Post acquisition insurance costs

(Less)/add back: Movement in fair value on derivative

Underlying EBITDA

Operating (loss)/profit

Non-underlying costs

Negative goodwill on bargain purchase

Movement in fair value on derivative

Exchange adjustment on borrowings

Less: Net finance costs

Add: Share of profit of associate

(Loss)/profit before income tax

Tax

(Loss)/profit for the year

Underlying EBITDA

Add back Eschenbach underlying EBITDA loss

Underlying EBITDA excluding Eschenbach

1,607

2,299

226

1,706

185

1,085

563

740

1,088

2,037

13,935

1,917

–

–

–

(2,865)

4,505

12,987

(2,940)

(5,763)

506

(740)

(382)

(1,844)

–

(11,163)

2,250

(8,913)

2020
 $’000

4,505

1,295

5,800

7,945

(2,827)

–

2,865

715

(1,365)

14

7,347

(907)

6,440

2019 
$’000

12,987

–

12,987

127

> Corporate GovernanceINSPECS Annual Report & Accounts 2020> Financial Statements> Strategic ReportCompany Information and Advisers

REGISTRARS
Equiniti, 
Aspect House, 
Spencer Road, 
Lancing BN99 6DA

FOR INVESTOR RELATIONS ENQUIRIES 
PLEASE CONTACT:
investor.relations@inspecs.com

FOR ENQUIRIES PLEASE  
CONTACT FTI CONSULTING:
Alex Beagley, James Styles, Fern Duncan 
on 0203 727 1000 or  
inspecs@fticonsulting.com

REGISTERED OFFICE
INSPECS Group plc, 
7–10 Kelso Place 
Upper Bristol Road, 
Bath BA1 3AU

NOMINATED ADVISER AND  
BROKER TO THE COMPANY
Peel Hunt LLP, 
120 London Wall, 
London EC2Y 5ET

LEGAL ADVISERS TO  
THE COMPANY
Macfarlanes LLP, 
20 Cursitor Street, 
London EC4 1LT

AUDITORS
Ernst & Young LLP, 
The Paragon Counterslip, 
Bristol BS1 6BX

Annual Report 2020 
inspecs.com/investors-results-and-reports/

128

REGISTERED OFFICE
INSPECS Group plc 
7–10 Kelso Place 
Upper Bristol Road, 
Bath, BA1 3AU 

www.inspecs.com